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ABSTRACT OF DISSERTATION

THE DEVELOPMENT OF COLORIMETRIC ASSAYS TO DETERMINE THE IDENTITY
AND FREQUENCY OF SPECIFIC NUCLEOBASES IN DNA OLIGOMERS

Colorimetric methods combined with color-changing chemical probes are
widely used as simple yet effective tools for identifying and quantifying a wide
variety of molecules in solution. For nucleic acids (DNA and RNA), perhaps the most
commonly used colorimetric probe is potassium permanganate, which can be used
to identify single-stranded pyrimidines (thymine and cytosine) in polymers.
Unfortunately, permanganate is not an effective probe for identifying purines
(adenine and guanine), especially in the presence of the more reactive pyrimidines.
Therefore, robust methods for discriminating between the purines remain elusive,
thereby creating a barrier toward developing more complex colorimetric
applications. In this dissertation, we demonstrate that chromophores such as
permanganate and bicinchoninic acid (BCA) and copper, however, when combined
with nucleobase-specific chemical cleavage reactions, can be a colorimetric probe
for the identification and quantification of cytosines, adenines and/or guanines in
single-stranded DNA oligomers, even in the presence of thymines. Furthermore, the
reactions are stoichiometric, which allows for the quantification of cytosine, adenine
and/or guanine frequency in these oligomers. The BCA/copper reagent detects the
reducing sugar, 2-deoxyribose, resulting from the chemical cleavage of a given
nucleotide’s N-glycosidic bond. Therefore, these colorimetric assays are effectively
detecting abasic sites in DNA oligomers, which are known to occur in damaged DNA.
Our analytic approach termed colorimetric identification of exposed nucleic acids
(CIENA) combines the use of BCA/copper, permanganate, and diphenylamine
chromophores along with digital image capture to identify and quantify each
nucleobase within DNA. The digital image color properties are quantified in terms of
the image’s hue, saturation, and lightness using the CIELAB color space and ∆E
quantification of color. CIENA is a simple, low-cost tool that could be applicable in
various types of nucleic acid analyses, such as the quantification of nucleobase
composition and the identification of damaged DNA.
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Chapter 1

Introduction

This dissertation discusses the development of inexpensive colorimetric assays to

characterize nucleic acid oligomers by identifying and measuring the frequency of
each nucleobase within single stranded deoxyribonucleic acid (ssDNA). Nucleic

acids include both ribonucleic acids and deoxyribonucleic acids. Nucleic acids are

most often found in nature as biopolymers containing large numbers of nucleobases
covalently bonded along the polymeric chain (Figure 1.1). Oligomers however are

smaller polymers often consisting of less than 20 nucleobases (20-mer DNA or 20mer RNA). In the studies outlined below, small oligonucleotides, 5-mer DNA, were

chosen for several reasons: i, there are few studies examining the use of colorimetric
assays for characterization of oligomeric nucleic acids; ii, the complexity of

secondary structure and base composition is simplified in 5-mer DNA; iii, the cost to
characterize a diverse array of sequences in colorimetric assays is significantly
reduced with 5-mer DNA; and iv, nucleobase-specific colorimetric assays

successfully developed for 5-mer DNA can be further tested in longer oligomers to
demonstrate their utility for characterizing oligomers of various lengths.
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Figure 1.1. Canonical Watson-Crick base pairing of the four nucleotides in
DNA (adenine with thymine and guanine with cytosine) give rise to the
the double helix structure of DNA (shown on the left). Two strands of
DNA intertwine through intermolecular hydrogen bonding between
specific nucleobases on each strand of the DNA (shown on the right).
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The motivation for writing this dissertation is to provide laboratories a simple,

inexpensive method for analyzing oligonucleotide sequences for base composition
and structure. Colorimetric assays can do just that. Colorimetric assays offer an

image that can be captured with readily available technology such as a smartphone.

The first chapter of this dissertation discusses how color can be quantified and used
specifically for the technique we coined “Colorimetric Identification of Exposed

Nucleic Acids” (CIENA). Chapters 2-4 discuss the development of the colorimetric

chemical methods to estimate the frequency of specific nucleobases present within
oligomeric ssDNA. Chapter 5 combines the optimized colorimetric methods from

Chapters 2 and 3 with CIENA analysis as a proof of concept application to determine
the base composition of 5-mer ssDNA. The last chapter presents preliminary data

for future research illustrating how colorimetric methods and CIENA analysis can be
used to determine base composition of longer oligomers (i.e. 20-mer ssDNA),

explores other possible chromophores like ninhydrin, and demonstrates how these
methods can detect abasic sites within ssDNA.
1.1

Background: Discovery of Deoxyribonucleic Acid

Deoxyribonucleic acid (DNA) is what all living matter must possess, as life is defined
as an organism having “the capacity for growth, reproduction, functional activity,

and continual change preceding death”(1). The race for determining the chemical
structure of DNA essentially began when Erwin Schrodinger first introduced the

idea of an “aperiodic crystal” in his book, “What is Life? Mind and Matter” (1). He
proposed this idea that within DNA’s chemical structure, there contained genetic

information in its configuration of chemical bonds, that gave living cells “life” (1).
Watson and Crick both accredited Schrodinger’s book for their inspirational

discovery in the 1950’s discovery of the structure of DNA (Figure 1.1)(2). Francis

Crick, James Watson, and Maurice Wilkins won the 1962 Nobel Prize in chemistry

for their proposed double helical structure of DNA published in Nature in April 1953
(3). This discovery was a key component for establishing molecular biology today.
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Molecular biology focuses on how molecular properties generate life. The

relationship between the sequence of nucleotides in DNA (genetic code), and the

sequence of nucleotides in RNA, thus, determines the structure of proteins within
the cell (Central Dogma of Life). Since DNA is central to life, and all organisms

contain varying lengths of DNA, deciphering the sequence of DNA belonging to
different organisms has become a high priority among the science community.
1.1.1 Sequencing Deoxyribonucleic Acid

It was not until the early 1970’s that fragments of DNA could be reliably sequenced.
Frederick Sanger developed the dideoxy synthethic approach to DNA sequencing
(4), while Walter Gilbert and Allan Maxam published DNA sequencing through a
chemical degradation method (5). These novel sequencing techniques led to the
1980 Nobel Prizes in chemistry. Being able to sequence large DNA sequences

created interests in the Human Genome Project (HGP). The Human Genome Project
was an international scientific research project with the goal of determining the

sequence of nucleobases that make up human DNA; a $3.8 billion investment that

took 13 years (6). The Human Genome Project was declared complete in April 2003

(6). During this time, major advancements occurred in the sequencing technology of
nucleic acids, which is termed next generation sequencing (NGS) (7).

Although sequencing entire DNA genomes have been of utmost importance, the

sequencing of short oligomeric nucleic acids is of importance as well. Short

oligomeric nucleic acid sequences (e.g. microRNA) are essential for nucleic acid
regulation in cells (8), and can be useful for many standard molecular biology

experiments, like polymerase chain reaction (PCR). This discovery has made it

important to be able to sequence short oligomers, for example, for the development

of nucleic acid diagnostics and therapeutics (9). In additon, short oligomeric nucleic
acids, such as aptamers, have been used as ligands for binding receptors and other
targets (10). Aptamers consist of small nucleic acid ligands that are composed of
RNA or ssDNA oligonucleotides that have been discovered through (random)
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selection methods. These molecules have a high specificity and affinity for their
targets (10). These single stranded nucleic acids offer unique chemical and

biological characteristics based on their oligonucleotide properties. For this reason,
aptamer technology is a growing area of interest in synthetic biology.

Today, synthetic biology is a major research focus in industry, research, and

employment in the life sciences. The global synthetic biology market is expected to
reach $16.7 billion by 2018 (11). Despite this growing trend, there is still a great

need for analytical procedures necessary to ensure the identity, strength, quality,

purity, and potency of biologics, which includes small nucleic acid oligomers. This is
especially important in regards to meeting Food and Drug Administration (FDA)
requirements for drug products (12,13). Thus, simple, low-cost assays for

characterizing the sequence, base composition, and purity of oligonucleotides will
be valuable tools in the development of DNA and RNA technologies.
1.1.2 Structure of Deoxyribonucleic Acid

Deoxyribonucleic acid typically consists of two biopolymer strands hydrogen
bonded together by the nucleobases to form a double helix (Figure 1.1). Each

biopolymer strand is made up of nucleotide monomers which consist of three parts:
a phosphate covalently bonded to a deoxyribose sugar at the 5’ carbon on one side
of the sugar, and on the other side of the sugar, covalently bonded to one of four

nucleobases (i.e. adenine, guanine, cytosine, or thymine). Each of these nucleosides
(i.e. the deoxyribose sugar bonded to the nucleobase) is shown in Figure 1.2. The

covalent bond connecting the deoxyribose sugar with the nucleobase is known as a

N-glycosidic bond. In addition, the nucleotides are classified based on their chemical
structures as purines (adenine and guanine) and pyrimidines (thymine and
cytosine).
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Figure 1.2. The chemical structures of the four nucleosides in DNA
are shown, which include the purines, adenosine and guanosine, as
well as the pyrimidines, thymidine and cytidine.

The driving force to form the double helical structure of DNA is mainly due to inter-

strand hydrogen bonding between the nucleobases and intra-strand nucleobase-

stacking interactions between adjacent nucleobases. Inter-strand hydrogen bonding
occurs when adenine forms two hydrogen bonds with a thymine of the opposing
DNA strand, while guanine forms three hydrogen bonds with a cytosine of the

opposing DNA strand (Figure 1.1). Intra-strand nucleobase stacking interactions
are hydrophobic. Since the nucleobases are planar aromatic structures, van der
Waals forces occur, leading to nucleobase stacking.

DNA is labeled from the 5’-end to the 3’-end, indicating the orientation of the

nucleobases present in a sequence (i.e. 5’ATAGC3’ often written ATAGC where the 5’
and 3’ are implied) (Figure 1.1). This directionality within DNA, and the specific

order of nucleobases from the 5’ end to the 3’ end, is important for understanding

the genetic code. This code imparts biological information for mRNA transcription,
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and protein translation. It provides a code in a manner similar to the sequence of

letters in words, imparting information through word meaning. Thus, characterizing
the sequence of DNA, the order of nucleotides from the 5’-end to the 3’-end, can
provide important information about protein coding. In addition, both DNA

sequence and base composition analysis can be important for understanding the
structure of DNA. Base composition identifies each nucleobase and its frequency

within DNA. For example, in the sequence, 5’ATAGC3’, the base composition would

be 2 adenines, 1 guanine, 1 thymine, and 1 cytosine. Base composition is essential to
verifying DNA sequencing data for many techniques, as well as can provide

information about both the function and structure of a DNA sequence (e.g. C-G rich

regions and poly-A regions in DNA sequences). For example, nucleobase distribution
within genomic DNA is critical for taxonomical classification of organisms and
viruses (14, 15).
1.2

Background: Colorimetry

Color is perhaps the simplest physical property of a reaction to visualize directly or
quantify using a camera or vis-spectrometer, yet color is underexploited as a

molecular method for determining local sequence, structure, and base composition.
Colorimetry is a beneficial detection method because it involves simple apparati

that can be used for qualitative and quantitative experimental measurements. There
is a wide array of situations where the visual, qualitative determination of color

change is the sole determinant of a colorimetric assay’s results; for example, tests
for pregnancy (16) , pH (17), soil and water components (18), narcotics (19), to

name a few.

Alternatively, colorimetric assays have typically used vis-spectroscopy to quantify
the reflectance, transmittance, or relative irradiance of color generated from a

chromophore. These colorimetric measurements produce accurate and precise data
on the intensity of reflection or transmission of a light source as a function of a

specific wavelength to quantify color change. Though spectroscopy analysis has
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been widely used in colorimetric assays, the technique does not typically output a

numerical representation of a sample’s color (20). A diode-array instrument and/or
a traditional UV-Vis scanning instrument have been used traditionally for color
analysis within the laboratory. Diode-array instruments take a snapshot of the

entire spectrum in less than one second while UV-Vis instruments typically take 2060 second to perform the same analyses. These spectrophotometers provide

necessary color analysis but are relatively expensive and not always accessible for
use outside of the laboratory setting. By contrast, other low, cost techniques are
available that utilize color imaging and color space analysis to measure subtle

changes in color that are more representative of human color perception (21).
Color is perceived by the human eye as light in the visible region (400 nm to 700

nm) of the electromagnetic spectrum (Figure 1.3) (22). Perception is based on such
physical properties as light absorption, reflection, and emission spectra (22). The
human eye’s ability to distinguish colors is based upon the varying sensitivity of

different cells in the retina to convert light of different wavelengths to biologically

usable electro-chemical signals within neurons (22). The retina contains two types

of photoreceptors involved in vision, which are the rods and the cones. The rods and
the cones share anatomical structures that vary in their ability to process light (22).

The rods are very sensitive to light and can record even one photon (22). Moreover,
there are about 120 million rod cells in the human eye (22).

The cones are involved in color vision. There are three types of color photoreceptor
cones cells which are classified based on the cells’ sensitivity to detecting the

different wavelengths, S (short) detects wavelengths around 437 nm, M (medium)

detects wavelengths around 534 nm, and L (long) detects wavelengths around 564

nm (Figure 1.3). Moreover, there are around 6 million cones in the retina (22).

Therefore the cones are trichromatic, in that the short cones are most responsive to
light that we perceive as violet, the medium cones are most sensitive to light as

greenish yellow, while the third type of cone, the long cones, are most sensitive to
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light which we perceive as orange-red (22). Thus, light is reduced to three color

components by the eye. The three types of cones within the eye yield three signals
based on the extent to which each is stimulated. Therefore, the amount of

stimulation is known as tristimulus values. The set of all possible tristimulus values
determine the color space for humans to be about 10 million different colors (22).

Colorimetric measurement strategies that utilize three dimensional color space

(Figure 1.4) better simulate human perception of color, and are advantageous for
sensitive detection of color change.

Electromagnetic Spectrum

Gamma
Rays

X-Rays

Ultravioltet
Rays

Infrared Rays

Radar Rays FM TV Shortwave AM

Visible Light

Figure 1.3. Electromagnetic spectrum of light in the visible region, 400 nm to
700 nm . The response sensitivities to specific wavelengths of light are shown
for each of the three types of cones in the eye (S-Cones, M-Cones, and L-Cones).
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1.2.1 CIELAB Color Space

There are several choices of color-space models that can be utilized to quantify

colors, including CMYK, HSL, CIELAB, RGB, and XYZ, among others (20). We chose to
use CIELAB color space for a variety of reasons: i) it is simple to understand, ii) it is
simple to determine result from images, iii) it is light source independent so that

data obtained through different methods can be directly compared (20), iv) it is the
standard color space model used in color industries like paints and textiles (20), v)

it is simple to calculate and compare changes in color (∆E) (20), and vi) these color
change equations are continually being improved (20).

In the CIELAB color space model, colors are numerically identified by a set of 3-

dimensions, relating lightness (L*), red verses green (a*), and yellow verses blue

(b*), which defines a color space (Figure 1.4). In 1931, the International Commission
on Illumination, known as CIE, studied human color perception and developed a
standard that is still widely used today (21). CIE created L*, a*, b* color space in

1976. Prior to this, CIELAB was based on a system introduced by Richard Hunter in
1942 using L, a, b values. The L, a, b coordinates are based on a square root

transformation of color whereas L*, a*, b* coordinates on based on a cube root
transformation of the color data (19). The L*, a*, b* coordinates correlate with

discoveries in the mid-1960s that the optical nerve and the brain, retinal color

stimuli are translated into distinctions between light and dark, red and green, blue
and yellow (19). It was designed to approximate human vision (Figure 1.4) (21).

Moreover, L*, a*, b* describes all colors visible to the human eye and was created to
serve as a device independent model (23). The three components of CIELAB are L*,

which is the lightness of color (L = 0 black whereas L = 100 is white), a*, which is the
position between red and green (a* negative values is green and positive values is
red), and b*, which is the position between yellow and blue (b* negative values
indicate blue whereas positive values indicate yellow) (Figure 1.4) (23).
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Figure 1.4. The three-dimensional color space defined by lightness (L*),
red verses green (a*), and yellow verses blue (b*).
1.2.2 ∆E Equation

When we are comparing color changes (∆E) between two samples, the L*, a*, b* data
used from each sample being compared is used to calculate a single ∆E value (Figure
1.5) (23). This ∆E value is a mathematical expression for calculating the difference
between two colors. The CIE L*, a*, b*, and ∆E values have been calculated using

several different ∆E formulas (∆E76 (21), ∆E94 (21), ∆E CMC (21), and ∆E2000 (21)).
We use the ∆E2000 formula as it is the most accurate and most recently developed.
The full ∆E 2000 formula is shown in Appendix 1 (20), whereas the abbreviated

∆E2000 equation is shown in Figure 1.5. The “∆” stands for difference and the “E”

stands for Empfindung (German for “sensation”) (23). In theory, a ∆E of under 2.6 is

indistinguishable unless the samples are side by side (23).
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A

∆E =

B

[∆L’/kLSL]2+[∆C’/kCSC]2+[∆H’/kHSH]2+RT[∆C’/kCSC][∆H’/kHSH]
Control

TTTTT

GGGGG

1 min
L*
a*

56.0 ± 0.6 59.0 ± 1.0 80.3 ± 0.6
85.7 ± 0.6 77.3 ± 3.2 17.3 ± 1.5

b*

-18.7 ± 1.5 -13.0 ± 8.9 75.3 ± 0.6

∆E

6.2 ± 1.5 59.4 ± 0.8

Figure 1.5. This example illustrates how CIENA uses a single ∆E (full equation
Appendix 1) value to correlate the reactivity of a sample (TTTT which is pink or
GGGGG which is yellow in the color swatches above) relative to a control (no DNA
which is darker pink color swatch). A larger ∆E value for a sample means there is a
larger color difference relative to the control. Photoshop was used to quantify the
color within the digital image to L*, a*, b* values in the control (no DNA) and L*, a*, b*
values in the sample. These two sets of L*, a*, b* values are entered into the ∆E
equation to provide a single value reflecting how different the colors are numerically.
GGGGG produces a ∆E value of 59.4 which correlates to a larger color change than the
TTTTT sample with a ∆E value of 6.2.
The CIE have revised the ∆E formula over the years in order to account for

perceptual non-uniformities, which come into play because the human eye is more
sensitive to certain colors than others (23). The single number generated from the
∆E equation is the difference in a reference color (negative control sample

containing no DNA) and another color (the sample containing DNA) (Figure 1.5).
Since color change in our experiments is a function of reaction kinetics, we can

correlate ∆E with chemical reactivity (See Appendix 1 for complete ∆E equation and
example of its use (20)).
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1.3

Colorimetric Identification of Exposed Nucleic Acids (CIENA)

Colorimetric identification of exposed nucleic acids (CIENA) is a term coined by our
lab that digitally quantifies color changing chromophores in a DNA sample relative
to a negative control (no DNA) sample using the CIELAB color space L*, a*, b*, and
∆E values to specifically measure nucleotides within nucleic acid sequences. Since

CIENA is a label-free, nonradioactive, inexpensive bench top colorimetric method, it
meets our labs motivational goal described above. In order to analyze DNA samples
in our CIENA assays, nucleobase specific colorimetric assays have had to be

developed for each individual DNA nucleobase (adenine, guanine, cytosine, and

thymine). The development of novel nucleobase-specific CIENA assays requires
either chromophores that directly detect specific nucleobases or reactions that

modify specific nucleobases to generate an analyte that can be detected by a chosen
chromophore. Review of the literature on nucleic acid chemical probes, and
chemical modification strategies used on DNA samples, illustrate several

approaches that could be tested in the hopes of developing novel nucleobasespecific CIENA assays.
1.4

Background: Nucleic Acid Chemical Colorimetric Probes

A few colorimetric techniques have utilized chemical probes to examine nucleobase
identity in DNA oligonucleotide samples. Two of the most common are the

pyrimdine-directed probe, potassium permanganate (discussed in chapter 2) (24),
and the purine-directed probe, diphenylamine (discussed in chapter 4) (25).

Potassium permanganate dihydroxylates extrahelical thymine to produce a yellow
color (24). This characteristic has been exploited for detection of DNA mismatches
(26), as well as in a method called the chemical cleavage method (CCM) (27).

Although potassium permanganate is used in the CCM, its colorimetric properties
have had limited use in assays that determine DNA sequence information.

Chemical approaches to obtain sequence information of DNA using potassium

permanganate and other nucleobase-specific reagents, utilize specific nucleobase
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modification reactions with electrophiles on radiolabeled DNA (Scheme 1.1) (28).

These reactions are then followed with strand scission reactions, usually involving a
reaction of heat and basic conditions (like in a piperidine solution).

Scheme 1.1. Electrophiles first modify electron rich purine and
pyrimidine heterocycles. This initiates the nucleic acid cleavage that
occurs site specifically in the second chemical step.
Permanganate is used to modify thymine within the chemical cleavage method

(CCM) (27) to sequence DNA, and also serves as a nucleic acid probe specific for

thymine identification. In the CCM assays, chemicals are added to selectively modify
the N-heterocyclic nucleobases, thus making the N-glycosidic bond labile under

alkaline conditions. These conditions promote β-elimination that ultimately leads to

strand scission of the phosphodiester backbone of the DNA. In the CCM assays, the
DNA is radiolabeled, and so, the fragmented pieces of DNA undergoes gel

electrophoresis to determine the presence of the chemically modified nucleobases
(27). This procedure is cumbersome; it utilizes radiolabeled DNA, takes days to
conduct, and requires specific expertise.

Diphenylamine is one of the most common chemical colorimetric probe for

detection of purines in DNA samples (29). This probe forms a Schiff base in the

presence of cleaved purines to generate a blue color under acidic conditions (25).
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The blue chromophore generated in the diphenylamine assay is typically measured

using UV spectrophotometer in conjuction with Beer’s Law and calibration curves to
estimate the amount of unknown DNA present in a sample (30). Unfortunately, the
acidic conditions for generating the blue chromophore are not amenable for use in
nucleobase specific assays, as both adenine and guanine are cleaved non-

specifically. The purines require neutral or alkaline conditions for specific cleavage

of one purine relative to the other purine (28). Thus, diphenylamine cannot be used
as a colorimetric probe for identifying base-specific information in DNA samples.
Potassium permanganate (31), diphenylamine (25), and CCM (5) methodologies

have offered important insights in the development of our CIENA assays. The probes
can specifically interact with certain nucleobases, causing a measurable change in
color of the resultant solutions. CCM provides an array of strategies for the use of

electrophilic reagents for nuclebase-specific cleavage of DNA samples in neutral and
alkaline conditions (27). Thus, the CIENA assays could utilize several chromophores
that interact with specific nucleobases or other elements of the nucleotides (e.g.

deoxyribose or the phosphate), in combination with specific nucleobase cleavage, to
colorimetrially identify the quantity of all four nucleobases in DNA samples. The

CIENA approach thus utilizes several electrophilic reagents from CCM and examines
incubation times, temperatures, and concentrations to obtain quantitative

nucleobase specific cleavage reactions that can be colorimetrically detected using

various chromophores. In addition to generating selective reactions for CIENA, there
are other requirements that must be met so that the assays are applicable for

CIENA. The reactions must generate a measurable color change in a chomophore

relative to a negative control (no-DNA sample) so as to generate a single ∆E value
that represents the relative quantity of a specific nucleobase. It will also be

preferable that all electrophilic reagents be compatible (i.e. non-interfering, non-

color quenching) in the aqueous environment required for both DNA samples and
chromophores.
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1.4.1 Electrophiles

The purines and pyrimidines are electron rich and therefore react with electrophiles
readily (Scheme 1.1) (28). The non-metal electrophiles used in our colorimetric

assays are dimethyl sulfate (DMS), inorganic acids, diethyl pyrocarbonate (DEPC),

hydroxylamine (NH2OH), and acetic acid. These electrophiles do not generate color
upon nucleobase modification. Rather, these electrophiles selectively modify the

nucleobases, thus promoting N-glycosidic bond cleavage in a second reaction step
(Scheme 1.1). Therefore, chromogenic reagents are added in the second step.

Therefore, the electrophile modifies the nucleobase first, followed by a second

reaction that generates the chromogen. For this reason, the electrophiles chosen (i.e.
non-reducing reagents) are compatible with the chemical reagents generating the

chromogen, and avoid the use of intermediate purification steps in our assays (28).

Purification steps increase the cost and time of the assay, and can deleteriously
affect the quantitative property of the assay.

Examples of electrophiles studied in our laboratory that are incompatible for CIENA
include: hydrazine (N2H2), sodium bisulfite (Na2SO3), hydroxylamine (NH2OH), and
hydrogen peroxide (H2O2). Unfortunately, these electrophiles are required for

cytidine-specific modification. Although NH2OH is not ideal for CIENA, our assays

use NH2OH for cytidine specific modification reactions discussed in Chapter 3.

Therefore, this cytidine-specific colorimetric assay requires a purification step.

Purification of 5-mer ssDNA oligomers was successfully performed by using the

lowest molecular weight cut off (MWCO 500-1000 Dalton) cellulose dialysis tubing
to exchange buffers prior to the addition of the transition metal chromagen.
1.4.2 Chromogens

For the colorimetric identification of individual nucleobases in solution, several

chromophores have been presented in the literature, including permanganate (26),

diphenylamine (25), and iridate (32). In Chapter 2, colorimetric assays are explored
that utilize permanganate (26) for the detection of thymine, cytosine, and guanine.
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These CIENA assays measure color changes in permanganate that change from

violet to clear relative to the quantity of the specific nucleobase being detected. For

diphenylamine assays (25), the chromophore being monitored is created as a result

of cleaved purines which we developed in a CIENA assay discussed in chapter 4. The
iridate assay is specific for guanine (32) with no interference from side reactions

with adenine, cytosine, or thymine. However, at least in our hands (data not shown),
we could not correlate reaction color with the number of guanines in oligomers.

This is partly due to the inconsistency between reactions, and partly because the
solution changes from pale yellow to clear during the reaction (32), which is not

enough of a color change to make a reasonable correlation with guanine content. In
Chapter 3, we describe a novel CIENA assay that uses bicinchoninic acid (BCA) and

copper chromophore for the detection and quantification of the cleaved nucleosides,
adenosine, guanosine, cytidine, and total purine. Bicinchoninic acid/copper is a well
known colorimetric assay used in protein quantification (29), however, this is the

first report of using bicinchoninic acid/copper for the colorimetric determination of
nucleobases in DNA.
1.5

Problem Statement

A simple method for identifying and quantifying each nucleobase within single
stranded DNA (ssDNA) oligomers is still not available. Most methods used to

determine DNA base composition focus on percent guanine-cytosine (G-C) content
or adenine-guanine (A-G) ratios in long, double stranded DNA (12, 13, 33, 34, 35),

rather than identifying and quantifying each nucleobase specifically. High

performance liquid chromatography (HPLC) using mass spectrometry detection

(LC/MS) has been the method of choice for protein and peptide analysis, but is not
widely used to characterize oligonucleotides (33). This is due to incompatibilities
between ion pairing mobile phases used for reverse phase (RP) separations and

mass spectroscopy, as well as, creating complicated MS chromatograms for analysis
(33).
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The CIENA analysis approach, however, offers a simple, low-cost alternative to the
techniques mentioned above. In Chapters 2-4, CIENA assays provide DNA

nucleobase-specific color reactions that can be visualized with the eye and captured
with a digital camera such as a smartphone (Figure 1.5). Using instrument

independent CIE L*, a*, b* color space to quantify the color of each sample, and

using the ∆E equation to calculate this color difference, provides a single value to be
analyzed. In Chapter 5, the magnitude of these single ∆E values generated from the
nucleobase-specific colorimetric reactions, are correlated to identify each specific

nucleobase, as well as, to determine its frequency within 5-mer ssDNA. In Chapter 6,

preliminary data is presented to offer other applications of these CIENA assays, such
as identifying and determining nucleobase frequency in 20-mer ssDNAs and

detecting abasic sites in damaged DNA. Moreover, this approach to analyzing

oligonucleotide sequences for base composition and structure may find great

application outside the laboratory and within the educational classroom setting.
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Chapter 2
2.1

Developing the Permanganate CIENA Assay for Detection of Thymine,
Cytosine, and Guanine

Introduction to Permanganate

Potassium permanganate (KMnO4) oxidation of thymine deoxynucleotide within

double stranded deoxyribose nucleic acid (dsDNA) has been extensively used in the
chemical cleavage mismatch (CCM) method for the detection of single nucleotide

polymorphisms (SNPs) (24). Permanganate oxidation of DNA under mild conditions

is also a chemical probe for DNA, giving information regarding DNA conformations
and DNA sequencing (26). Dr. Richard G. H. Cotton and researchers in 2006

reported results indicating that the order of reactivity of the deoxynucleotides with
KMnO4 can be determined by the change in color of solution (36). This order was

determined to be dT≥ dC >>dG >>dA, where dT is deoxythymidine, dC is

deoxycytidine, dG is deoxyguanosine, and dA is deoxyadenosine, respectively (36).
Scheme 2.1 is the proposed oxidation reaction of thymine with permanganate
described by Dr. Richard Cotton (37). Thymine, 1, gives a cyclic manganese

intermediate, 2, that gives rise to the thymine diol, 3, hydroxy-ketone, 4, and

manganese dioxide(MnO2) products (37). In the beginning, the permanganate

solution is violet and then proceeds through a yellow color and eventually turns

clear with a brown MnO2 precipitate. This yellow color is proposed to be the cyclic

manganese intermediate, 2, Scheme 2.1.

Scheme 2.1. Direct colorimetric reaction of permanganate oxidation of
thymine/thymidine.
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Moreover, permanganate oxidation of DNA produces a variety of characteristic

colors due to manganese’s different oxidation states and possible coordination with
different nucleobases [Mn7+(aq) is violet; Mn6+(aq) is green; Mn5+(aq) is blue;

Mn4+(aq) is yellow. Mn2+(aq) is pale pink] (38). The resultant colors in aqueous
solutions make permanganate an excellent colorimetric probe for the CIENA

application for the determination of base composition within ssDNA. This chapter

develops CIENA assays using sodium permanganate, NaMnO4, to selectively detect

and quantify thymine, cytosine, and guanine within monomeric DNA and 5-mer
single stranded DNA (ssDNA).
2.2

Materials and Methods: Permanganate CIENA Assays

This section of the chapter includes all the chemicals, sample preparations,

procedures for each reaction, and the CIENA protocols including optimized image
capture times and constant values (kL, kC, and kH) required for the ∆E equation

located in Appendix I (20). These constants are are weight values that are optimized

in each assay.

2.2.1 Chemicals: Permanganate CIENA Assays

All chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise

specified. This includes: sodium cacodylate (NaC2H6AsO2), sodium permanganate,
(NaMnO4), 5’-monophosphodeoxyguanosine (dGMP, 5’-

monophosphodeoxyadenosine (dAMP), 5’-monophosphodeoxycytidine (dCMP), 5’monophosphodeoxythymine (dTMP), adenine, guanine, dihydrouracil, cytosine,
thymine, dimethylsulfate (DMS), sodium phosphate dibasic (Na2HPO4), sodium

phosphate monobasic (NaH2PO4), sodium chloride (NaCl), potassium chloride (KCl),
ammonium hydroxide (NH4OH), and hydrochloric acid (HCl). Oligomeric 5-mer

ssDNA were selected randomly and purchased from Integrated DNA Technologies
(Coralville, Iowa): see Tables 2.1, 2.2, and 2.3 for individual sequences.
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Table 2.1. Average L*, a*, b*, and ΔE values for thymine-specific 5-mer DNA.
# Thymines
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
3
3
3
3
3
3
3
4
4
4
4
5

Sequences
GCGGG
AGAGC
CCCCC
GAGAC
CACCC
AACAG
GGAGG
GGGGG
AGAGC
AGGGG
CCGCC
CGAGC
GAAAA
CATGC
CGTCC
AACTG
CGAGT
GTCCC
ATAAG
AACGT
GTGGA
GTGGC
TCGGA
GCTGC
CCTCC
TGTGC
TAAAT
TTGAA
CCGTT
AGTAT
TGGTG
CTCTC
ATGTT
TTTGA
CGTTT
GTTTA
TCTGT
ATTTC
TATCT
CTTTT
TTTCT
TTATT
TTGTT
TTTTT

L* value

63.7 ± 0.6
58.0 ± 0.0
56.3 ± 0.6
57.0 ± 0.0
51.3 ± 1.5
51.3 ± 0.6
51.0 ± 0.0
51.0 ± 0.0
51.3 ± 0.6
51.3 ± 0.6
50.7 ± 0.6
60.3 ± 0.6
50.7 ± 1.2
51.3 ± 0.6
52.3 ± 0.6
51.3 ± 0.6
52.3 ± 0.6
59.3 ± 1.2
63.3 ± 1.5
65.0 ± 0.0
59.3 ± 0.6
56.3 ± 0.6
56.7 ± 0.6
56.3 ± 0.6
63.7 ± 2.9
57.7 ± 2.9
62.3 ± 1.5
58.0 ± 0.0
62.3 ± 0.6
54.0 ± 1.0
54.7 ± 0.6
54.7 ± 0.6
55.0 ± 0.0
60.0 ± 0.0
67.3 ± 0.6
67.7± 0.6
67.0± 0.0
64.0± 0.0
66.7± 0.6
72.3 ± 2.3
71.7 ± 0.6
71.3 ± 0.6
66.5 ± 2.1
75.3 ± 0.6

a* value

95.3 ± 1.2
88.3 ± 0.6
85.0 ± 1.0
87.0 ± 0.0
80.3 ± 1.5
87.0 ± 0.6
80.0 ± 0.0
80.0 ± 1.0
80.3 ± 0.6
80.3 ± 1.0
79.3 ± 0.6
90.7 ± 0.6
80.0 ± 1.7
78.3 ± 0.6
75.0 ± 1.7
79.7 ± 0.6
77.3 ± 1.2
78.7 ± 1.5
85.0 ± 1.0
93.3 ± 2.3
81.7 ± 1.2
84.0 ± 0.0
81.3 ± 0.6
83.0 ± 1.0
77.3 ± 2.5
78.0 ± 1.7
74.0 ± 1.0
75.7± 0.6
74.0 ± 1.0
72.7 ± 0.6
73.3 ± 0.6
67.3 ± 0.6
66.7 ± 1.5
69.0 ± 1.0
67.0 ± 0.0
67.0 ± 0.0
69.3 ± 0.6
33.7 ± 0.6
67.7 ± 1.2
53.7 ± 4.2
55.0 ± 1.0
58.7 ± 0.6
63.0 ± 2.8
45.7 ± 1.5

b* value

-37.7 ± 0.6
-32.3 ± 1.5
-13.3 ± 4.6
-23.0 ± 1.0
-16.7 ± 3.1
-24.7 ± 0.6
-25.7 ± 1.2
-25.7 ± 1.2
-23.7 ± 1.5
-26.0 ± 1.7
-20.7 ± 0.6
-27.3 ± 0.6
-25.7 ± 1.2
-5.3 ± 1.5
2.3 ± 2.1
-8.3 ± 1.5
-0.3 ± 0.6
1.3 ± 1.5
-14.0 ± 1.0
-20.7 ± 3.8
-12.7 ± 0.6
-6.0 ± 1.7
3.7 ± 1.5
-4.3 ± 1.5
-3.3 ± 2.1
7.7 ± 0.6
13.0 ± 1.0
14.7 ± 0.6
18.3 ± 1.5
7.7 ± 1.2
10.3 ± 1.2
14.3 ± 0.6
19.7 ± 1.2
23.7 ± 0.6
25.7 ± 1.5
30.0 ± 0.0
26.7 ± 1.5
27.0 ± 0.4
30.3 ± 2.1
43.0 ± 1.0
43.0 ± 2.0
39.7 ± 0.6
35.5 ± 0.7
50.0 ± 1.0

Average ∆E
0.6 ± 0.5
0.8 ± 0.3
5.4 ± 1.6
2.3 ± 0.4
4.5 ± 1.6
1.6 ± 0.5
1.1 ± 0.2
1.1 ± 0.2
1.6 ± 0.5
1.6 ± 0.5
3.2 ± 0.5
2.4 ± 0.3
1.9 ± 1.4
9.4 ± 2.1
11.2 ± 1.0
6.9 ± 0.7
9.9 ± 0.2
10.5 ± 0.6
5.6 ± 0.3
5.7 ± 1.5
6.0 ± 0.2
7.8 ± 0.4
11.4 ± 0.5
8.4 ± 0.4
9.7 ± 0.6
13.2 ± 0.5
15.3 ± 0.6
16.1 ± 0.1
17.6 ± 0.7
13.1 ± 0.5
14.1 ± 0.6
16.2 ± 0.3
19.0 ± 0.4
20.5 ± 0.3
22.2 ± 0.7
24.9 ± 0.2
23.0 ± 0.7
23.0 ± 0.7
24.8 ± 1.1
34.7 ± 2.1
34.2 ± 1.3
31.7 ± 0.5
27.9 ± 0.1
41.0 ± 1.1

Each value is the average of three independent assays. The L*, a*, b* values for the control samples (no
DNA) used to calculate the ∆E values are shown in Table 2.1A (see Appendix II).
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Table 2.2. Average L*, a*, b*, and ΔE values for cytosine-specific 5-mer DNA.
# Thymines

Sequences

1
1
1
1
1
1
1
1
1
1
1
1

AATAA
GAGTA
GTGGA
AACTG
GTGGC
CGAGT
GCTGC
CATGC
CATAC
CATCC
CGTCC
CCTCC

2
2
2
2
2
2
2

0
0
0
0
0
0
0
0
0
0
0
0
3
4
5

L* value

TAAAT
AGTAT
TGGTG
TACTG
TACTA
CACTT
CTCTC

84.7 ± 0.6
87.3 ± 0.6
61.0 ± 1.0
86.3 ± 0.6
85.3 ± 0.6
89.3 ± 2.1
92.7 ± 0.6

GAAAA
GGGGG
GGAGG
AGGGG
AACAG
AGAGC
GAGAC
ACACA
CGCGC
CACCC
CCGCC
CCCCC

66.3 ± 0.6
51.0 ± 0.0
51.3 ± 0.6
51.0 ± 1.0
69.0 ± 0.0
52.3 ± 0.6
71.0 ± 1.0
70.0 ± 0.0
71.3 ± 3.8
74.3 ± 3.8
75.3 ± 3.8
77.3 ± 3.8

ATGTT
TTGTT
TTTTT

73.0 ± 0.0
75.7 ± 0.6
54.7 ± 0.6
78.3 ± 0.6
56.0 ± 1.0
55.3 ± 0.6
56.7 ± 1.2
78.7 ± 1.5
79.3 ± 1.5
84.0 ± 0.0
85.3 ± 1.5
84.7 ± 0.6

65.0 ± 1.7
71.0 ± 2.0
72.3 ± 1.2

a* value

b* value

Average ∆E

# Cytosines

11.7 ± 0.6
25.3 ± 0.6
21.7 ± 0.6
28.3 ± 0.6
34.0 ± 1.0
31.0 ± 1.0
36.0 ± 2.0
35.3 ± 1.2
35.3 ± 1.5
44.7 ± 0.6
45.7 ± 2.3
50.7 ± 0.6

16.9 ± 0.4
23.7 ± 0.4
17.7 ± 0.1
26.3 ± 0.1
24.6 ± 0.6
22.7 ± 0.6
25.7 ± 1.2
30.4 ± 1.4
33.0 ± 1.6
44.2 ± 0.4
43.5 ± 0.7
49.4 ± 1.0

0
0
0
1
1
1
2
2
2
3
3
4

26.0 ± 4.0
22.0 ± 2.0
52.0 ± 1.7
20.0 ± 0.0
24.0 ± 2.0
11.3 ± 5.8
2.3 ± 1.2

44.3 ± 2.1
47.7 ± 4.2
44.0 ± 2.0
49.3 ± 1.2
49.7 ± 1.2
54.0 ± 3.5
59.7 ± 0.6

96.7 ± 0.6
79.3 ± 0.6
80.0 ± 0.0
80.0 ± 1.0
86.7 ± 1.5
74.3 ± 1.2
75.0 ± 1.7
77.3 ± 1.2
68.3 ± 9.3
51.0 ± 0.0
55.0 ± 10.4
47.0 ± 11.5

-31.7 ± 0.6
-15.0 ± 1.0
-17.7 ± 0.6
-19.0 ± 0.0
-17.0 ± 1.0
12.3 ± 0.6
-3.0 ± 1.0
-0.7 ± 10.6
21.7 ± 5.7
32.0 ± 6.1
32.0 ± 3.6
45.7 ± 4.6

66.7 ± 1.5
54.7 ± 1.2
70.7 ± 1.2
46.7 ± 0.6
62.3 ± 1.5
64.7 ± 1.5
61.3 ± 0.6
44.7 ± 2.9
42.3 ± 3.1
28.3 ± 0.6
24.3 ± 4.2
24.3 ± 1.5

40.3 ± 2.1
23.7 ± 4.2
16.7 ± 2.5

52.0 ± 3.6
61.3 ± 1.5
59.0 ± 4.6

44.3 ± 3.7
48.5 ± 1.3
32.0 ± 1.5
50.4 ± 0.9
46.3 ± 1.4
54.6 ± 4.6
61.5 ± 0.8

2.2 ± 0.5
3.0 ± 0.2
2.1 ± 0.1
1.8 ± 0.5
5.8 ± 0.3
13.5 ± 0.7
10.5 ± 0.3
11.4 ± 0.3
20.6 ± 1.3
27.2 ± 0.7
27.9 ± 0.8
37.0 ± 1.6
40.0 ± 3.0
51.9 ± 2.5
54.5 ± 0.8

0
0
0
1
1
2
3

0
0
0
0
1
1
1
2
3
3
4
5
0
0
0

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 2.2A (see Appendix II).

21

Table 2.3. Average L*, a*, b*, and ΔE values for guanine-specific 5-mer DNA.
# Guanines
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
4
4
4
4
4
5

Sequences
CTCTC
TCCCT
CCCCC
TCTTC
TTTCT
TACTA
CACCC
CCTCC
AAAAA
TTTTT
GAAAA
CATGC
CCGCC
AACAG
TTTTG
ATGTT
AACTG
AGTAT
CGTCC
GTCCC
TTGTT
TTGAA
TTTGA
GAGTA
GCTCG
GCTGC
CGAGT
TCGGA
AGAGC
CCCGG
GAGAC
CGAGC
TGGTG
GGGAC
GTGGC
CGGCG
GAAGG
GTGGA
GAGGA
GCGGG
GGGGA
AGGGG
GGAGG
GGGAG
GGGGG

L* value

44.0 ± 0.0
63.7 ± 2.5
56.0 ± 0.0
61.3 ± 1.5
58.7 ± 1.2
47.0 ± 2.0
45.3 ± 1.5
45.3 ± 1.5
47.0 ± 1.7
43.3 ± 0.6
50.3 ± 1.5
48.3 ± 0.6
44.5 ± 0.7
50.3 ± 1.2
66.3 ± 1.2
49.0 ± 1.4
49.0 ± 0.0
47.0 ± 1.7
46.3 ± 1.2
60.3 ± 0.6
65.0 ± 0.0
63.7 ± 0.6
64.0 ± 1.0
55.3 ± 2.1
66.3 ± 0.6
51.7 ± 0.6
56.0 ± 2.8
67.7 ± 1.2
67.3 ± 1.5
74.3 ± 1.5
68.0 ± 1.7
69.3 ± 0.6
55.7 ± 1.2
66.7 ± 0.6
73.7 ± 0.6
75.3 ± 2.1
74.7 ± 1.5
74.7 ± 1.5
76.0 ± 0.0
79.3 ± 2.1
79.5 ± 0.7
77.0 ± 1.7
78.0 ± 2.0
79.3 ± 0.6
80.3 ± 0.6

a* value

68.5 ± 0.5
73.7 ± 3.1
82.0 ± 1.0
85.0 ± 1.0
78.3 ± 2.1
63.3 ± 1.5
69.3 ± 1.2
72.0 ± 1.0
62.7 ± 2.1
68.3 ± 2.1
47.7 ± 2.3
51.3 ± 2.3
55.0 ± 0.0
48.0 ± 3.6
53.0 ± 1.7
48.0 ± 1.4
51.0 ± 2.8
49.7 ± 1.5
54.0 ± 1.0
66.7 ± 0.6
53.3 ± 3.2
59.0 ± 1.7
57.3 ± 2.3
30.0 ± 0.0
48.7 ± 1.2
38.0 ± 2.0
26.5 ± 3.5
45.3 ± 1.2
45.7 ± 1.5
32.7 ± 2.5
45.0 ± 2.6
43.3 ± 0.6
24.3 ± 1.2
37.3 ± 2.1
32.3 ± 0.6
24.7 ± 1.2
24.3 ± 2.1
24.7 ± 0.6
24.5 ± 0.7
18.7 ± 2.1
19.0 ± 0.0
21.7 ± 2.1
18.7 ± 1.5
19.0 ± 1.0
17.3 ± 1.5

b* value

-10.5 ± 0.5
-2.0 ± 2.0
-3.0 ± 3.0
0.7 ± 1.5
-5.0 ± 2.0
-2.7 ± 4.0
-7.3 ± 1.2
-12.0 ± 1.0
1.3 ± 2.9
-9.3 ± 2.5
22.7 ± 1.2
24.3 ± 1.5
25.5 ± 0.7
23.0 ± 1.0
38.7 ± 1.2
27.5 ± 3.5
25.0 ± 4.2
26.0 ± 3.5
30.0 ± 2.0
38.0 ± 1.0
36.5 ± 2.1
44.0 ± 1.0
40.0 ± 1.0
39.0 ± 0.0
55.3 ± 1.2
47.7 ± 2.5
44.0 ± 2.8
58.7 ± 1.5
59.7 ± 2.1
49.3 ± 1.5
60.7 ± 0.6
60.7 ± 1.2
52.0 ± 1.0
46.0 ± 5.2
69.3 ± 0.6
59.0 ± 2.0
62.7 ± 4.0
60.7 ± 2.1
70.5 ± 3.5
68.0 ± 3.5
72.5 ± 0.7
76.0 ± 1.0
75.0 ± 1.0
77.0 ± 1.0
75.3 ± 0.6

Average ∆E
4.1 ± 0.1
8.3 ± 1.3
8.8 ± 0.5
7.7 ± 0.4
7.6 ± 0.5
7.5 ± 1.5
6.0 ± 0.3
4.7 ± 0.5
9.0 ± 1.5
5.9 ± 0.4
21.0 ± 0.3
21.2 ± 1.6
20.6 ± 0.6
20.9 ± 1.0
29.6 ± 1.5
23.0 ± 2.5
21.4 ± 1.4
22.3 ± 1.6
23.8 ± 1.3
26.2 ± 0.5
28.5 ± 0.6
30.7 ± 0.6
29.2 ± 1.0
36.6 ± 0.6
38.7 ± 0.5
38.1 ± 1.0
40.6 ± 2.5
41.4 ± 1.1
41.9 ± 1.5
42.5 ± 1.4
42.6 ± 1.0
43.3 ± 0.5
46.2 ± 0.8
51.0 ± 1.0
51.4 ± 0.5
51.5 ± 0.7
52.8 ± 1.5
51.3 ± 1.6
54.2 ± 1.3
57.4 ± 1.2
57.0 ± 0.0
57.4 ±1.2
58.6 ± 1.3
59.1 ± 0.8
59.4 ± 0.8

Each value is the average of three independent assays. The L*, a*, b* values for the control samples (no
DNA) used to calculate the ∆E values are shown in Table 2.3A (see Appendix II).
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2.2.2 Nucleic Acid Sample Preparation

Stock samples of different monomers of nucleic acids are prepared in 100 mM or 10
mM (purines) quantities in water and stored in the freezer. Stock samples of

different 5-mer ssDNA are prepared in 1mM quantities in water and stored in the
freezer.

2.2.3 Reaction Procedure: Permanganate CIENA Assays

Detection of thymine, cytosine, or guanine was performed using an aqueous solution
of 10 mM NaMnO4 made fresh prior to the time of detection. In the thymine assay

experiments, the final solutions consisted of deionized water, 0.1 M NaCl, 10 mM

phosphate buffer at a pH 7.0, and a total nucleotide DNA concentration of 1 mM 5mer ssDNA at room temperature in disposable cuvettes. In the cytosine assay
experiments, the final solutions consisted of deionized water, 20 mM sodium

cacodylate (NaC2H6AsO2), and 1 M NaCl at a pH of 7.5. In the guanine-permanganate
assay experiments, the samples were first subjected to chemical cleavage protocols
(incubating solutions in 0.1 M HCl, 0.1 M KCl in a 90οC water bath for 18

hours)((27)) then transferred to disposable cuvettes followed by the addition of 1 M
ammonium hydroxide (NH4OH) at room temperature. Once the samples were

prepared, 25 uL of 10 mM NaMnO4 was added to the solutions so that the total

nucleotide concentration of DNA and NaMnO4 were both 1 mM in a final sample
volume of 250 uL in a disposable cuvette. A digital image of each solution was

captured at 5 minutes for the thymine assay, 40 minutes for the cytosine, and at 1

minute for the guanine assay (image capture examples shown in Figure 2.3A, 2.4A,
and 2.10A respectively).

2.2.4 CIENA Procedure

We utilize CIELAB color space (21) and the color difference equation (ΔE) (20) to
colorimetrically quantify the number of thymines, cytosines, and guanines in

monomeric DNA and ssDNA. For this analysis, the permanganate reaction was

allowed to incubate at room temperature for a designated time period (5 minute for
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the thymine assay, 40 minutes for the cytosine assay, and 1 minute for the guanine

assay), at which time a digital image of each solution was captured (example shown
in Figure 2.3A, 2.4A, and 2.10A respectively). These images were captured using a

light-box fitted with a Cannon Power-Shot A620 digital camera set in manual mode.
The camera custom white balance was set using an 18% grey white-balance card.
The light-box was illuminated using three D50 halogen light bulbs (color

temperature ~ 5,000 K which represents horizon light), one on each side on the
sample and one above. An X-Rite M50111 Mini Color Checker chart (Adorama

Camera, Inc., New York, NY) in the light-box was included in the images to calibrate
color across experiments. Images were captured in “camera raw” format and the

color was calibrated using the Color Checker chart image (using a simple computer
script called ACR-Calibrator-L-v31). Adobe Photoshop was then used to compute
the L*, a*, and b* values for each color-calibrated image (L*, a*, b* values with

standard deviation for each 5-mer ssDNA samples measured in three independent
experiments are provided in Tables 2.1, 2.2, and 2.3). These values were then

inserted into the color change (ΔE) equation (Appendix I(20)) to quantify the color
relative to a no-DNA control sample. A control (no DNA) was run for each sample

used to calculate the ΔE values. Thus, the averaged L*, a*, b* values for the controls
from the triplicate experiment are shown in Appendix II, Tables 2.1A-2.3A. The

constants, kL, kC, and kH, in the ΔE equation were set to 2.5, 1.5, and 1.5 respectively.

The values kL, kC, and kH are associated with the lumination, chroma, and hue terms,
respectively, within the ∆E equation. These constants can be set to unity, which is

one, however, by increasing particular constants, we amplify the magnitude of any
one of the parameters. For the permanganate assay, the chroma difference from

sample to sample changes the largest and therefore, we find that setting the values

as mentioned above produces the most sensitivity change in ∆E, (∆∆E). In addition,
all data shown are the compilation of at least three independent experiments.
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2.3

Results and Discussion: Developing Permanganate CIENA Assay for
Thymine Detection

Permanganate at neutral pH reacts specifically with the pyrimidines in monomeric
DNA where thymine is more reactive than cytosine (5’dTMP > 5’dCMP); at 40

minutes numerical ∆Ε values 54.7±07 and 25.7±0.6 respectively for the pyrimidines

(Figure 2.1). The purines are essentially non-reactive (5’dAMP and 5’dGMP), and
therefore, remain the same color as the control and have ∆Ε values less than two.

Analysis of the image captured at 40 minutes indicates numerical ∆Ε values 1.0±0.2

and 1.6±0.6 respectively for the purines (Figure 2.1).
Control

5’

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

40 min
L*

56.0 ± 0.0 57.7 ± 0.6 58.3 ± 1.2 67.0± 0.0 78.0 ± 0.0

a*

86.0 ± 0.0 87.7 ± 1.0 88.0 ± 0.0 60.0 ± 1.0 22.3 ± 1.5

b*

-25.0 ± 0.0 -23.0 ± 0.0 -21.3 ± 1.5 33.0 ± 1.0 65.0 ± 1.0

∆E

1.0 ± 0.2

1.6 ± 0.6 25.7 ± 0.6 54.7 ± 0.7

Figure 2.1. Permanganate specificity for pyrimidines (5’dTMP >
5’dCMP) at neutral pH is indicated by the difference in color
swatches from the samples and the control (∆E value).
This reaction is quite selective over a great period of time for the pyrimidines as
illustrated in Figure 2.2 (i.e. over a time span of 240min). Therefore, this assay is
diagnostic of sequences containing only purines, as the violet color remains for
greater than an hour when no cytosines or thymines are present.
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water , dAMP, dGMP, dCMP, dTMP

1 min
5 min
40 min
60 min
120 min
240 min

Figure 2.2. Permanganate specificity for pyrimidines (dTMP >
dCMP) at neutral pH is indicated by the difference in color swatches
from the sample and control over 120 min.
In addition, the selective color response of thymine toward permanganate to
quantify thymines within 5-mer ssDNA was examined. For each 5-mer ssDNA

sample, the optimized thymine colorimetric assay was performed, sample images

were captured (Figure 2.3A), then color calibrated, quantified, and converted to

color swatches (Figure 2.3B). Next, the color change (ΔE) of each sample relative to
a no-DNA control for each sample was calculated. In the thymine-specific reaction, a
sample with five thymines has a large color change (ΔE =41.0) compared to little or
no color change for a sample with zero thymines (ΔE =2.4). The experimental data
from these thymine-specific assays show a red-orange color change for DNA

polymer samples containing multiple thymines as compared to samples with little to
no thymines present which show a pink-purple color (Figure 2.3B). Thus, as the

number of thymines in the oligomer increases, the change in color of the solution
increases (from violet to orange-yellow), along with an increasing ΔE value. Note
that the negative control (no-DNA) and 5’CGAGC3’ experiments are nearly the same
color because they contain no thymines, which shows the specificity of the overall

reaction for thymines. These trends hold true when all of the 44 5-mer ssDNA

sequences are graphically displayed and fitted with a linear best-fit relationship
(Figure 2.3C). For this graph, each point plotted is the average ΔE value of all the

sequences containing the same number of thymines (Table 2.1). The error is the
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standard error calculated by the square root of the total sum of each standard
deviation squared (i.e. (a2 + b2+ c2)1/2 where a, b, c, etc are the standard deviation in

each triplicate measurement). Irrespective of the positions of the thymines in each

sequence, as well as the identity of the non-thymine DNA, there is a predictable and
unique ΔE value as a function of the thymine frequency in each sequence. These
results demonstrate that the permanganate reagent at pH 7.0 can be used as a

specific colorimetric probe for the identity and the quantification of thymines in
ssDNA oligomers.
A

Thymine Frequency

B

Control

CGAGC

GCTGC

TGTGC

TTTGA

TTGTT

TTTTT

∆E

2.4 ± 0.3

8.4 ± 0.4

13.2 ± 0.5

20.5 ± 0.3

27.9 ± 0.1

41.0 ± 1.1

C
Thymine

70.0
60.0
50.0

y = 7.702x + 1.32
R² = 0.9947

40.0

∆E

30.0
20.0
10.0
0.0
0

1

2

3

4

Thymine Frequency

5

Figure 2.3. Analysis of 5-mer ssDNA at 5 minutes. Panel A: Image
capture of a representative thymine-specific permanganate reaction.
Panel B: Results from thymine-specific permanganate reactions
represented in color swatches. Panel C: Graph illustrating the
correlations of average color change (ΔE) values with thymine
frequency present in the analyzed 5-mer ssDNAs.
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Sodium permanganate, NaMnO4, in a pH 7 buffer, colorimetrically identifies and
quantifies thymines within monomeric and oligomeric 5-mer ssDNA successfully.

Under neutral buffer conditions in the presence of permanganate, the
thymines/thymidines are oxidized at an earlier time point thus resulting in a change

in solution color as compared to the other nucleobases (cytosine, adenine, and
guanine). This change in solution color specific to the number of thymines present

promotes an accurate way of quantifying the number of thymines present within a
5-mer ssDNA. In this user-friendly assay, images are captured at 5 minutes using a
camera and converted to L*, a*, b* values within the CIELAB color space using
Photoshop. These L*, a*, b* values of the sample (contains the 5-mer ssDNA) and the

L*, a*, b* values of the control (no DNA) are both put in the ∆Ε equation (Appendix I

(20)) to produce a single value. This value can be used for y in the thymine best-fit

linear equation in Figure 2.3C (y=7.702x+1.32) to solve for x to estimate the number
of thymines present within the 5-mer ssDNA sample. The linear correlation for the

measured ΔE values corresponding to the frequency of thymines present in over 44

different 5-mer ssDNAs was R2=0.994. This is indicative of a high correlation of the

measured ∆E values to the number of thymines present within the 5-mer ssDNA,

and thus, illustrates the selectivity of this colorimetric thymine-specific CIENA
assay.

2.4

Results and Discussion: Developing Permanganate CIENA Assay for
Cytosine Detection

Permanganate at neutral pH is known to oxidize both thymine and cytosine

although cytosine is oxidized more slowly than thymine (31). Since thymine reacts

with permanganate very early in the assay (within 10 minutes) and cytosine reacts
later (around 40 minutes), time oxidation studies of the pyrimidines were

performed to determine whether permanganate could be used to quantify cytosines
colorimetrically at later time points. In Figure 2.4, panel A shows cuvette images

from a representative experiment, and panels B-E show color swatches generated
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from experiments from 5-mer ssDNA sequences that contain zero, one, two, or three
thymines, respectively. We found that for 5-mer ssDNAs that contain two or fewer

thymines, capturing an image at a later time point (40 min) in a sodium cacadylate
buffer produces a change in color that is proportional to the number of cytosines

present (Figure 2.4). As illustrated in Figure 2.4E, 5-mer ssDNAs containing three or
more thymines have ∆E values that are saturated (∆E ≥ 60) before the 40 minute

time point and therefore cannot colorimetrically measure the number of cytosines
present. Therefore, using NaMnO4 for cytosine colorimetric measurements in the
presence of three or more thymines in a 5-mer ssDNA sequence is unreliable.

However, this permanganate cytosine-specific assay, can accurately measure the

number of cytosines present for 5-mer ssDNAs containing two or fewer thymines.
To perform the permanganate cytosine-specific assay, first the number of thymines
is determined using the permanganate thymine-specific assay discussed in the
previous section. The time point for image capture is at 40 minutes for the

permanganate cytosine-specific assay which is quite later than the five minute

image capture for the thymine. If thymines are present, the ∆E value at 40 minutes

will be larger than if there are no thymines present. Therefore, the ∆E value, which

is a measurement of the color difference between the 5-mer ssDNA sample and the

control sample (no DNA), depends on the number of thymines present (i.e. two
thymines ∆E=44.3, one thymine ∆E=16.9, and zero thymines ∆E=2.2). For this

reason, the number of thymines are first measured in the thymine-specific assay,
then the color difference (∆E value) can readily be correlated to the number of

cytosines present using a linear equation to solve for x (i.e. x is the number of

cytosines based on the measured ∆E value y), (Figure 2.5). The linear equation

chosen to solve for cytosine frequency depends on the number of thymines present.
Figure 2.5 shows three linear equations each depending on the number of thymines
present with correlation values of R2=0.9514, 0.9792, and 0.9771 for two, one, and
zero thymines within 5-mer ssDNAs respectively. The data gathered for the 5-mer
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ssDNA sequences for the cytosine assay are organized depending on the number of
thymines present in Table 2.2, and graphed in Figure 2.5. These trends illustrate
that in 5-mer ssDNAs containing zero, one, or two thymines, there is a linear

correlation with increasing color difference (∆E value) to the number of cytosines
present.

A

Cytosine Frequency

B

Control

GAAAA

AACAG

ACACA

CGCGC

CCGCC

CCCCC

∆E

2.2 ± 0.5

5.8 ± 0.3

11.4 ± 0.3

20.6 ± 1.3

27.9 ± 0.8

37.0 ± 1.6

C
Control

AATAA

AACTG

CATAC

CATCC

CCTCC

∆E

16.9 ± 0.4

26.3 ± 0.1

33.0 ± 1.6

44.2 ± 0.4

49.4 ± 1.0

D

E

Control

TAAAT

TACTG

CACTT

CTCTC

∆E

44.3 ± 3.7

50.4 ± 0.9

54.6 ± 4.6

61.5 ± 0.8

Control

TATCT

ATATT

TTATT

TTCTT

TTTTT

∆E

66.5 ± 1.5

68.1 ± 0.3

66.8 ± 0.3

66.6 ± 0.2

65.4 ± 0.2

Figure 2.4. Analysis of 5-mer ssDNA cytosine-specific permanganate
reactions at 40 minutes. Panel A: Image capture of a representative
reaction. Panel B: Results shown in color swatches from 5-mer ssDNA
containing zero thymines. Panel C: Results shown in color swatches
from 5-mer ssDNA containing one thymine. Panel D: Results shown in
color swatches from 5-mer ssDNA containing two thymines. Panel E:
Results shown in color swatches from 5-mer ssDNA containing three
thymines.
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3
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Figure 2.5. Graphs correlating the average color change (∆E) values with cytosine
frequency in oligomeric 5-mer ssDNA with two, one, and zero thymines
respectively.

We demonstrate that permanganate at neutral pH in sodium cacodylate buffer and
image capture at later time point (40 minutes) can produce a colorimetric changes
that are proportional to the number of cytosines present. If the number of thymines
is accounted for as discussed in section 2.2, then a CIENA assay can accurately

estimate the number of cytosines present within 5-mer ssDNAs containing two or
fewer thymines. For this reason, the number of thymines is first measured in the

thymine-specific assay then linear best-fit curves to predict cytosine content are
generated based on thymine content. Unfortunately, this permanganate CIENA assay

cannot be used to reliably detect cytosine in 5-mer ssDNAs that contain three or
more thymines in the sequence. Therefore, we explored other chromophores and

cytosine-specific cleavage strategies in an attempt to measure cytosine content in
any 5-mer DNA sequence. In chapter 3, we describe a thymine independent

cytosine-specific assay that utilizes cytosine cleavage followed by bicinchoninc

acid/copper colorimetric detection. In chapter 5, we use both permanganate and
bicinchoninic acid/copper cytosine-specific CIENA assays to accurately predict
cytosine content in any 5-mer ssDNA sequence.
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2.5

Results and Discussion: Developing Permanganate CIENA Assay for
Detection of Guanine

Although permanganate has been shown to be more reactive towards the

pyrimidines at physiological pH, cleaved guanines (i.e. a cleaved purine) are more
reactive in reaction conditions using aqueous ammonium hydroxide at pH 11.
Utilizing N-glycosidic bond cleavage reactions like those used in Maxam’s and

Gilbert’s chemical cleavage method (CCM) for sequencing DNA (39) in combination
with permanganate offers a unique colorimetric approach for guanine nucleobase

selectivity. We selectively cleaved purines by incubating ssDNA in hydrochloric acid

(HCl) at 90οC overnight (39) (Scheme 2.2) followed by the addition of permanganate

as a colorimetric probe in ammonium hydroxide buffer (pH 11) to detect and
quantify guanine, as adenine is not reactive toward permanganate.
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Scheme 2.2. Purines are cleaved under acidic conditions such as HCl in a
90oC water bath.
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2.5.1 Discovery of Permanganate CIENA Assay for Guanine Detection

Guanosine (N-heterocyclic nucleobase attached to the deoxyribose) and 5’dGMP
(nucleotide) are both non-reactive in the presence of permanganate (36).

Permanganate, however, will oxidize guanine (nucleobase only) under neutral pH
conditions, (Figure 2.6). Permanganate under neutral conditions also readily

oxidizes the pyrimidine C5-C6 double bond to produce a measureable chromophore.
In this particular result, it was observed that permanganate oxidizes guanine

producing a measured ΔE value of 23.1±5.9 (Figure 2.6). Adenine is not oxidized and
either is dihydrouracil, as would be expected, since dihydrouracil is a saturated
pyrimidine (Figure 2.7). This lack of oxidation is observed by the lack of color

change from the sample and the control (no DNA) giving measured ΔE values of 0.6±
0.2 and 0.5±0.1 for adenine and dihydrouracil, respectively.
Control

Adenine

Guanine Dihydrouracil

L*

60.3 ± 0.6 60.3 ± 0.6 64.0 ± 1.7

59.7± 0.6

a*

91.7 ± 0.6 90.3 ± 0.6 59.7 ± 6.7

89.7 ± 1.2

b*

-34.3 ± 1.5 -32.7 ± 2.1 24.3 ± 10.3 -33.3 ± 1.5

∆E

0.6 ± 0.2 23.1 ± 5.9

0.5 ± 0.1

Figure 2.6. Permanganate oxidizes guanine
however 5’dAMP and dihydrouracil are nonreactive and are therefore the same color as
the control as illustrated in the color

Figure 2.7. Structure of
dihydrouracil. Note the
saturation of the Nheterocyclic ring.

This result led my research to explore colorimetric reaction conditions that could

specifically oxidize guanine if cleaved from the monomeric or oligomeric DNA. The
first approach was to use commercially available guanine to determine what

conditions could oxidize guanine at an earlier time point than the oxidation of

thymine/thymidine derivatives using permanganate. Once these conditions were
discovered, reagents compatible for guanine cleavage conditions with
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permanganate metal were then explored (i.e. not color quenching). It was observed
that within one minute, in ammonium hydroxide buffer (NH4OH), permanganate

starts to oxidize guanine sooner than that for thymine, thymidine, and dTMP (Figure
2.8). This ensuing color change over 5 minutes, from violet to yellow, indicates that
permanganate is reduced from Mn+7 by guanine in ammonium hydroxide buffer.

Initially at 1 minute, guanine is already a greenish color, and at 5 minutes it is
reacted to produce a yellow color. When guanine is covalently bound to the

deoxyribose sugar (dGMP), however, no oxidation occurs, as noted by the lack of

color change from the control (containing only buffer and no nucleic acid material).
The guanine assay using permanganate in ammonium hydroxide (pH 11) gives a
selective colorimetric response for guanine but not dGMP (Figure 2.8).
Control dAMP dGMP
(water)

dTMP dCMP

Control Adenine Guanine Thymine Cytosine

1 min
5 min

Figure 2.8. Results of apurinated DNA using NH4OH buffer and
permanganate. Guanine is oxidized by permanganate at an earlier time
point than it oxidizes thymine and dTMP in NH4OH buffer.

To capitalize on the oxidative selectivity of guanine by permanganate, guanine must

first be cleaved from its corresponding nucleotide. Since purines are easier to cleave
than the pyrimidines, and adenine is non-reactive under these conditions, mild N-

glycosidic bond cleavage reactions were used to generate guanine specific cleavage.
To ensure quantitative purine cleavage, the samples were incubated in a pH 2.0

(KCl/HCl) solution at 90οC water bath overnight before the addition of 1 M NH4OH

and 1 mM NaMnO4. Figure 2.8 illustrates these reactions at 1 minute and 5 minute
intervals.
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The purine cleavage conditions (acid and heat overnight), followed by the addition
of ammonium hydroxide buffer and permanganate, were applied to the oligo-

adenine, oligo-guanine, oligo-cytosine, and oligo-thymine 5-mer ssDNA. The same
reactivity trend observed in the monomeric DNA was observed in the oligomeric
DNA (Figure 2.9). The optimized time point for image capture for this guanine

CIENA assay is at 1 minute to minimized colorimetric interference from the other
nucleobases. Oligo-guanine at 1 minute reacts significantly faster than the other

oligomers, with an observed ΔE value of 52±0.8, followed by oligo-adenine with a ΔE

value of 18.5±1.9, and oligo-cytosine ΔE value 8.9±0.6, and poly-thymine ΔE value
7.1 ±1.8 (Figure 2.9).

Control

AAAAA

GGGGG

CCCCC

TTTTT

1 min
L*

55.7 ± 0.6 62.3 ± 1.5 77.0 ± 1.0 56.3 ± 0.6 60.0 ± 2.0

a*

85.3 ± 1.2 63.0 ± 1.0 18.0 ± 1.0 83.0 ± 1.0 78.7 ± 2.1

b*

-25.0 ± 1.0 20.7 ± 3.8 53.7 ± 3.1 0.7 ± 1.5 -4.7 ± 4.6

∆E

18.5 ± 1.9 52.0 ± 0.8 8.9 ± 0.6 7.1 ± 1.8

Figure 2.9. Color swatches and L*, a*, b*, ∆E values illustrating
how permanganate oxidizes oligo-guanine 5-mer ssDNA at an
earlier time point than it oxidizes oligo-thymine 5-mer ssDNA in
ammonium hydroxide buffer (NH4OH) after pre-treatment with
acid and heat overnight to cleave purines.
This optimized assay was then applied to non-homogenous 5-mer ssDNA oligomers

(Table 2.3). Each sample image (example shown in Figure 2.10A) was then color
calibrated, quantified, and converted to color swatches (Figure 2.10B). Next, the
color change (ΔE) of each sample relative to a no-DNA control for each sample was

calculated. A larger color change for 5-mer ssDNA samples occurs as the guanine

frequency increases (Figure 2.10B). This indicates that as the number of guanines in
the 5-mer ssDNA increases, the change in color of the solution progresses (from red
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to yellow), as an increasing ΔE value. Note that the no-DNA and 5’TACAC3’
experiments have a pink-red color because they contain no guanines although there

is a color difference (ΔE) of 12.5±0.7. This small color difference is likely due to
interfering reactions within the sample; however, the magnitude of the ∆E value

significantly increases as the guanine frequency increases. Thus, the assay is a

predictor of the number of guanines present. These trends hold true when all of the
46 different 5-mer ssDNA sequences were analyzed and compiled (Table 2.3). The

average ∆E values for these sequences relative to the guanine frequency, is
graphically displayed most accurately with a polynomial best-fit curve (Figure

2.10C). The points plotted and standard error was calculated as described in section
2.3 (thymine-specific permanganate assay). Irrespective of the positions of the
guanines in each sequence, as well as the identity of the non-guanine DNA, there is a
predictable and unique ΔE value as a function of guanine frequency in each

sequence. These results demonstrate that the permanganate reagent in NH4OH
buffer at pH 11.0 after acidic purine cleavage conditions can be used as a specific
colorimetric probe for the identity and number of guanines in monomeric DNA and
in 5-mer ssDNA.
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A

Guanine Frequency

B

Control

TACAC

TTGAA

AGAGC

∆E

12.5 ± 0.7

30.7 ± 0.6

41.9 ± 1.5

C

GTGGC

GCGGG

51.4 ± 0.5 57.4 ± 1.2

GGGGG
59.4 ± 0.8

Guanine (Permanganate)

70.0
60.0
50.0

∆E

40.0
30.0
20.0

y = -1.554x 2 + 16.676x + 15.383
R² = 0.9986

10.0
0.0
0

1

2

3

4

Guanine Frequency

5

Figure 2.10. Analysis of 5-mer ssDNA in the guaninespecific permanganate reaction at 1 minute. Panel A: Image
capture of a representative reaction. Panel B: Results
illustrated in color swatches from a 5-mer ssDNA reaction.
Panel C: Graph illustrating the correlation of average ΔE
values with the number of guanines present in 5-mer ssDNAs.
2.5.2 Conclusions for Permanganate CIENA Assay for Guanine Detection

A CIENA assay was developed to attempt to quantify the number of guanines

present within a 5-mer ssDNA using permanganate in NH4OH solution after acidic

purine cleavage. Similar to other CIENA assay protocols, an image is captured for
each sample using the permanganate assay at 1 minute and processed into L*, a*, b*
values from the images for each 5-mer ssDNA unknown samples (Table 2.3) and L*,

a*, b* values for the control (no DNA), then entered into the ∆Ε equation (Appendix
I (20)) to produce a single value. This ∆Ε value is then put into a guanine best-fit
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polynomial equation (Figure 2.10C; y=-1.554x2+16.676x+15.383) and solved for x.

This equation will estimate the number of guanines present within the 5-mer

ssDNA. The high correlation value of the curve fit, R2=0.9986, indicates that the

measured color difference (∆E) between the sample and control (no DNA) is
predictive of the guanine frequency within 5-mer ssDNAs.
2.6

Conclusions for All Permanganate CIENA Assays (Thymine, Cytosine,
and Guanine Detection)

In this chapter, we have developed several CIENA assays that utilize permanganate

chromophore to selectively detect thymine, cytosine, or guanine. Permanganate is
an excellent colorimetric probe for thymine in aqueous solution at neutral pH. We

were able to detect cytosine colorimetrically in aqueous solution at neutral pH at a
longer time point (40 minutes), however, the cytosine-specific permanganate
detection is limited to 5-mer ssDNA oligomers having only zero to two thymines

present. Due to this limitation, other cytosine-specific colorimetric reactions were
investigated. The next chapter proposes a cytosine-specific colorimetric assay that is
independent of thymines, using a nucleobase-specific cleavage strategy, followed by

the addition of a chromophore. This strategy was first introduced in this chapter by

cleaving guanine from the DNA oligomer, followed by the addition of permanganate,
to provide a colorimetric guanine-specific CIENA assay. This reaction works well for

detecting guanine in the presence of the other nucleobases at 1 minute, however,

the nucleobases are still quite reactive with permanganate and therefore, this assay
is limited by colorimetric interference at longer time points. For this reason, the
next chapter also investigates another guanine-specific colorimetric reaction using

bicinchoninic acid as the chromophore after guanine-selective cleavage.
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Chapter 3
3.1

Developing the Bicinchoninic Acid/Copper CIENA Assays for

Detection of Adenosine, Guanosine, Cytidine, and Total Purine
Introduction to Bicinchoninic Acid/Copper

This chapter discusses the development of CIENA assays using bicinchoninic acid

(BCA) and copper to selectively quantify adenosine, guanosine, cytidine, and total
purine within monomeric DNA and 5-mer ssDNA. These assays use selective

cleavage reactions followed by BCA/copper chromophore for detection of the

resulting deoxyribose sugar, which directly correlates with specific nucleobase

composition in 5-mer DNA sequences. Moreover, because the BCA/copper reagent
detects the resulting deoxribose sugar, these colorimetric assays are effectively
detecting abasic sites in DNA oligomers, which are known to occur after DNA
damage (40,41).

BCA/copper is a common reagent for the determination of protein concentrations
(29). BCA/copper has also been used for the colorimetric determination of

aldehydes (reducing sugars) (42). Since nucleotide-specific chemical cleavage

methods produce reducing sugars, BCA/copper could also provide for a useful

method of identifying nucleotides. In this method, the N-glycosidic bond of a given
nucleotide is first be hydrolyzed, thus producing a deoxyribose cleavage product.

The resulting 2-deoxy-D-ribose derivative (4-keto-pent-2,3-enal, I) then reduces

Cu2+ to Cu1+ in solution. Once Cu1+ is generated, the aqueous soluble bicinchoninic

acid ligand (BCA, II) chelates the copper to form a violet chromogen [(BCA)2-Cu, III]

in amounts proportional to the cleaved product (Scheme 3.1). In this way, and

depending on the selective nucleobase cleavage reaction employed, the identity of
the nucleotide can be colorimetrically determined in a CIENA assay.
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3.1.1 Problem: Uniquely Detect Adenine and/or Guanine Colorimetically

(I)
4-keto-pent-2,3-enal

(II)
bicinchoninic acid (BCA)

(III)
(BCA)2-Cu

Scheme 3.1. Fragmented 2-deoxy-D-ribose derivative (1) reduces Cu2+ to Cu1+.
Cu1+ chelates with bicinchoninic acid (II) to form the (BCA)2-Cu1+ violet
chromagen (III).
One long-standing, fundamental problem with regard to the colorimetric analyses of
deoxyribonucleic acids, however, is methods to uniquely detect pyrimidines

cytosine and thymine (24) and the purines adenine and guanine (28). For example,
osmium tetroxide (43) and potassium permanganate (24) can each be utilized as

probes for ssDNA pyrimidines, and can even be used to distinguish between the two
pyrimidines - cytosine and thymine (24). This characteristic has been cleverly

exploited for the colorimetric detection of DNA mismatches in long double-stranded
DNA polymers (36). However, these reactions are not ideal for identifying purines,
especially when pyrimidines are also present.

For purine detection, diphenylamine can be used to colorimetrically quantify both

adenine and guanine as a measure of total purine within DNA (25). Diphenylamine,
however, cannot be used to uniquely detect adenine and guanine. Sodium

hexachloroiridate reactions could possibly be used to identify guanine (44),

however we find this reaction to be nonstoichiometric and unreliable, as well as not
useful for identifying adenine. Diethylpyrocarbonate (DEPC) is a robust probe for

detecting adenine in strand separation and structural distortions in DNA, however
DEPC is not a colorimetric probe for adenine (45). Therefore, we know of no
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chemical colorimetric probes that can be used to readily distinguish adenine from
guanine. This lack of specificity limits the applicability of colorimetry in the
biochemical analyses of nucleic acid samples.

3.1.1 Developing Bicinchoninic Acid/Copper CIENA Assay for Adenosine
Detection

In the two-step reaction strategy, adenosines are first sequence-selectively cleaved

using previously reported methods (Scheme 3.2 adenine-specific sodium hydroxide
(NaOH) cleavage (27), and Scheme 3.3 adenosine-specific diethylpyrocarbonate
(DEPC) cleavage (45). The resulting abasic backbone sugars react with a

BCA/copper reagent to produce a violet color. For the first step, we use NaOH or
DEPC as selective cleaving agents. Note that these agents alone, while known to

result in cleavage (for example in secondary structure probing of radiolabeled RNAs
(46)), have not previously been coupled with chemical probes for colorimetric
detection. In our method, under reaction conditions optimized for adenosine

detection, the pyrimidine positions remain unreactive, providing for the specific
identification of each of the adenosines.
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Scheme 3.2. Adenosines are cleaved under basic conditions such as
NaOH in a 90oC water bath(27).
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Scheme 3.3. Purines (adenine >> guanine) are cleaved using diethyl
pyrocarbonate (DEPC) (45).
3.1.2 Developing Bicinchoninic Acid/Copper CIENA Assay for Guanosine
Detection

In the two-step reaction strategy, guanines are first sequence-selectively cleaved

using modified reported methods (dimethylsulfate (DMS) at room temperature for

15 minutes followed by hydrochloric acid/potassium chloride (HCl/KCl) buffer pH 2
at 0οC for 18 hours (39)). The resulting abasic backbone sugars react with a
BCA/copper reagent to produce a violet color.

Guanosine-specific cleavage was achieved by using DMS to methylate guanine at the
N7 position (39). Because this occurs five-fold faster than methylation of the N3

position of adenine (39), we were able to optimize reaction conditions that were

specific for guanosine. The cleavage reaction occurs overnight, and the subsequent

detection of guanosine-specific cleavage using BCA/copper takes approximately 18

hours. It is possible that the chromophore formation for guanine takes much longer
than that for adenosine because the cleavage of the guanosine sugar from the

corresponding phosphate group occurs more slowly with the BCA/copper reagent
under alkaline conditions (pH 11).

42

3.1.3 Developing Bicinchoninic Acid/Copper CIENA Assay for Cytidine
Detection

In the two-step reaction strategy, cytidines are first sequence-selectively cleaved
according to an established method incubating DNA in hydroxylamine (NH2OH)

(Scheme 3.4)(47). The resulting abasic backbone sugars react with a BCA/copper
reagent to produce a violet color. In this reaction, all other nucleobases remain

unreactive, thus allowing for the linear colorimetric quantification of cytidines. This
represents an important step in overcoming the barriers towards using simple
color-changing chemical reactions to uniquely identify all four nucleotides in
oligonucleotides.

NHOH
NH2

NHOH
NH2OH

N
N
HO

O

OH

O

Me2NH

HOHN
N
HO
O

N
Base

N

HOHN
+

O
HO

O

OH

N
H
HO

O

OH O
H

OH

OH

OH

Scheme 3.4. Cytidines are cleaved using hydroxylamine (NH2OH) in base
(dimethylamine) (47).
A cyidine-specific cleavage method was developed by modifying cleavage conditions
used in R.G. Cotton’s chemical cleavage detection of mis-matched cytosine in double
stranded DNA (47). In this specific cleavage, NH2OH is used to modify the

mismatched cytidine, thus, generating a fragmented DNA that is radiolabeled and
isolated using gel electrophoresis. Our assays require quantitative cleavage of
cytidines so we employ longer incubation times, up to three hours at 50οC.

Additionally, these conditions promote the cleavage of the deoxyribose sugar from
the DNA phosphate backbone, thus, generating the required substrate to reduce

copper. Therefore, after removing the excess NH2OH by using low molecular weight
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cut off (MWCO) dialysis tubing and ion-exchange buffer, this led to the immediate

generation of the violet chromophore upon addition of the BCA/copper solution for
rapid analysis of samples.

3.1.4 Developing Bicinchoninic Acid/Copper CIENA Assay for Total Purine
Detection

Purines are cleaved according to the established method using dimethylsulfate

(DMS) (27), Scheme 3.2, resulting in abasic backbone deoxyribose sugars that react

with BCA/copper to produce a violet color. Under reaction conditions optimized for
total purine-specific cleavage, total purines can be detected and quantified in an
alkaline solution. This is an alternative to the acidic diphenylamine assay.
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Scheme 3.5. Purines are cleaved under alkylating condition, such as
with dimethylsulfate (DMS) (27).
For cleavage of both purines, the DNA was first treated with dimethylsulfate for an

hour at 90οC to cleave the N-glycosidic bond in guanosine, followed by incubation in
sodium hydroxide for an additional hour to cleave the N-glycosidic bond in

adenosine. This is a modified approach to the Maxam Gilbert chemical cleavage
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method used for strong guanine/weak adenine cleavage (27). The BCA/copper

solution is then added and incubated at room temperature for 4 hours to obtain the
violet chomophore. The shorter time for chromagen formation as compared to the
guanosine-specific assay is likely due to the fact that the purine reaction have

incubated for one hour under alkaline conditions at higher temperatures prior to

the addition of BCA/copper. Thus, this chapter describes the development of a panel
of CIENA assays using bicinchoninic acid (BCA) and copper to selectively detect and
quantify adenosine, guanosine, cytidine, and total purine within monomeric DNA
and 5-mer ssDNA.
3.2

Materials and Methods: Bicinchoninic Acid/Copper CIENA Assays

This section of the chapter includes all the chemicals, sample preparations,

procedures for each reaction, and optimized image capture times and constant

values (kL, kC, and kH) required for the ∆E equation located in Appendix I (20). For

more detailed CIENA protocols, refer to section 2.2.4 of this dissertation.
3.2.1 Materials

All chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise

specified. This includes: 5’-monophosphodeoxyguanosine (dGMP, 5’-

monophosphodeoxyadenosine (dAMP), 5’-monophosphodeoxycytidine (dCMP), 5’monophosphodeoxythymine (dTMP), dimethylsulfate (DMS), hydrochloric acid

(HCl), potassium chloride (KCl), diethylpyrocarbonate (DEPC), sodium phosphate
dibasic (Na2HPO4), sodium phosphate monobasic (NaH2PO4) sodium hydroxide
(NaOH), ethanol, hydroxylamine hydrochloride (NH2OH-HCl), dimethylamine

(Me2NH), Biotech CE Tubing MWCO 100-500Da Catalog #131048 (Spectrum

Laboratories; Rancho Dominguez, CA) and PierceTM BCA Protein Assay Kit (Reagent
A, 23225; Reagent B, 23227). Oligomeric 5-mer ssDNA was randomly selected and

purchased from Integrated DNA Technologies (Coralville, IO). See Tables 3.1- 3.5 for
sequences.
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Table 3.1. Average L*, a*, b*, and ∆E values for adenosine-specific cleavage of 5mer DNAs using NaOH as the cleaving agent.
# Adenosines
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
3
3
3
4
4
5

Sequences
TTTTT
TTCTT
CTCTC
CCTCC
CGTCC
CGCGC
CCGCC
CCCCC
TTGTT
GGGGG
GCGGG
GTGGC
TGGTG
GCTGC
CGGCG
AGGGG
GGGGA
ATGTT
GGAGG
GTGGA
TTATT
TATCT
TACTG
CACTT
CGAGT
CATGC
CACCC
AGAGC
GAGAC
ATATT
AGTAT
TACTA
GAGTA
AACTG
GAGTA
TAAAT
AACAG
ACACA
GAAAA
AATAA
AAAAA

L* value

100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
99.7 ± 0.6
100 ± 0.0
98.7 ± 0.6
100 ± 0.0
100 ± 0.0
91.0 ± 0.0
91.5 ± 0.7
91.0 ± 2.0
90.0 ± 1.0
90.0 ± 1.4
79.7 ± 2.1
79.7 ± 0.6
81.0 ± 2.0
77.3 ± 2.1
75.7 ± 3.8
70.3 ± 2.3
77.0 ± 6.6
73.3 ± 1.5
74.0 ± 6.1
71.3 ± 9.9
73.0 ±4.4
63.7 ± 1.5
50.3 ± 0.6
42.7 ± 1.5
47.7 ± 2.3
43.3 ± 1.2
39.3 ± 1.5
44.7 ± 2.5
42.3 ± 2.5
43.0 ± 7.8
26.0 ± 1.0
29.3 ± 1.5
32.7 ± 1.2
24.0 ± 0.0
26.0 ± 1.0
22.0 ± 1.0

a* value

0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
1.0 ± 1.7
0.3 ±0.6
3.3 ± 2.3
0.0 ± 0.0
0.0 ± 0.0
-1.0 ± 1.4
-1.0 ± 2.8
-1.0 ± 1.0
-2.3 ± 0.6
-1.0 ± 1.4
12.7 ± 2.5
7.0 ± 1.0
10.3 ± 2.3
14.3 ± 3.2
15.7 ± 4.5
42.3 ± 2.1
35.3 ± 9.3
40.3± 1.5
39.7± 7.4
42.0± 10.4
40.3 ± 4.6
50.3 ± 1.5
36.3 ± 7.5
45.3 ± 2.1
60.3 ± 1.2
61.7 ± 0.6
61.3 ± 1.2
61.3 ± 0.6
60.3 ± 0.6
59.3 ± 1.5
20.0 ± 3.5
42.7 ± 5.1
48.0 ± 3.6
19.3 ± 4.0
16.7 ± 7.4
14.7 ± 3.8

b* value

0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
-0.3 ± 0.6
-0.3 ± 0.6
-2.0 ± 1.0
0.0 ± 0.0
0.0 ± 0.0
-5.0 ± 0.0
-5.0 ± 1.4
-2.3 ± 0.6
-2.0 ± 1.0
-4.0 ± 2.8
-14.3 ± 2.1
-9.7 ± 0.6
-10.7 ± 3.1
-14.3 ± 3.1
-14.3 ± 4.5
-35.0 ± 1.0
-28.7 ± 7.5
-32.3 ±1.5
-32.7 ±5.7
-36.0 ±7.0
-34.7 ± 3.2
-39.3 ± 0.6
-32.3 ± 5.0
-34.3 ± 1.5
-49.0 ± 1.7
-50.3 ± 0.6
-49.7 ± 1.2
-50.3 ± 1.2
-48.7 ± 0.6
-47.0 ± 2.0
-22.7 ± 2.1
-38.7 ± 2.5
-39.7 ± 1.5
-21.3 ± 2.3
-19.3 ± 7.1
-16.7 ± 3.8

Average ∆E
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.9 ± 1.6
0.4 ± 0.7
3.2 ± 1.8
0.0 ± 0.0
0.0 ± 0.0
1.7 ± 1.4
3.0 ± 2.0
2.2 ± 1.3
1.9 ± 0.5
2.8 ± 0.8
14.9 ± 2.1
12.9 ± 0.7
13.5 ± 2.3
17.5 ± 2.1
19.1 ± 2.8
25.8 ± 1.4
21.6 ± 4.1
23.9 ± 0.9
23.6 ± 3.9
20.2 ± 2.9
17.1 ± 2.6
30.3 ± 1.1
37.5 ± 0.4
40.2 ± 2.3
43.1 ± 2.1
47.0 ±1.0
50.8 ± 1.5
45.8 ± 2.3
47.9 ± 2.4
51.6 ± 0.6
63.9 ± 1.3
60.8 ± 1.6
57.2 ± 1.2
65.2 ± 0.3
63.6 ± 0.8
68.0 ± 0.2

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 3.1A (see Appendix II). Furthermore,
when the L*, a*, and b* values are 100, 0, and 0, respectively, the solution is clear.
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Table 3.2. Average L*, a*, b*, and ∆E values for adenosine-specific cleavage of 5mer DNAs using DEPC as the cleaving agent.
# Adenosines

Sequences

L* value

0

CGTCC

84.3 ± 2.5

0
0

CTCTC
CCTCC

0

GTGGC

0

GGGGG

1

AGGGG

0
0
1
1
1
1
1

CCCCC

TTGTT
CGATC

GGAGG
ATGTT
CATGC
CACCC

2

GAGGA

3

AACAG

2
2
3

AGAGC

GAGAC

CAAGA

3

GGAAA

4

ACAAA

3
4
4
4
4
5

ATAAG

AAATA
AACAA

GAAAA
AATAA

AAAAA

90.0 ± 1.7

a* value

b* value

Average ΔE

-5.0 ± 4.6

-0.7 ± 2.1

9.3 ± 2.5

-6.3 ± 1.2

2.0 ± 2.0

-9.7 ± 1.2

89.3 ± 2.1

-10.3 ± 0.6

88.3 ± 0.6

-7.7 ± 1.5

84.7 ± 0.6

-3.7 ± 0.6

88.7 ± 1.2
83.7 ± 0.6

-1.3 ± 0.6

81.7 ± 1.2
83.3 ± 2.1
80.0 ± 2.0

-2.7 ± 2.1
-2.7 ± 1.5
-5.0 ± 1.7
-3.7 ± 1.2
-7.3 ± 1.5
-8.0 ± 2.6

75.0 ± 0.0

13.7 ± 0.6

-11.3 ± 1.5

71.0 ± 3.0

25.0 ± 3.0

-17.7 ± 3.1

19.7 ± 1.2

71.7 ± 1.2

17.7 ± 0.6

78.3 ± 2.9

10.3 ± 1.5

66.0 ± 1.0

27.7 ± 2.5

55.7 ± 2.1

39.7 ± 2.5

60.7 ± 1.5

33.7 ± 1.5

62.3 ± 1.5

32.7 ± 2.1

68.0 ± 1.7

21.3 ± 2.3

57.3 ± 1.5

7.3 ± 1.2

18.3 ± 4.2

9.0 ± 2.6

72.0 ± 1.0

4.3 ± 0.9

-4.0 ± 3.0

9.0 ± 1.0

78.7 ± 0.6

0.3 ± 0.6

1.0 ± 0.9

3.3 ± 3.2
2.3 ± 1.2

77.0 ± 1.0

5.3 ± 0.6

7.3 ± 0.2

19.7 ± 1.8

4.3 ± 1.2

82.3 ± 0.6

1.3 ± 1.2

1.9 ± 0.5

-4.3 ± 2.1

1.7 ± 0.6

81.7 ± 2.5

4.3 ± 1.5

1.6 ± 0.3

4.0 ± 1.0
0.3 ± 1.5

81.7 ± 0.6

5.0 ± 2.0

35.3 ± 1.5

-14.7 ± 0.6
-9.0 ± 6.1
-5.3 ± 3.5

-19.0 ± 1.0
-26.0 ± 1.0
-24.0 ± 2.0
-23.0 ± 1.7
-14.3 ± 1.2
-23.7 ± 1.5

13.3 ± 3.8
15.4 ± 1.1
15.0 ± 4.5
17.1 ± 1.9
26.4 ± 0.6
25.3 ± 1.9
23.0 ± 3.4
32.9 ± 0.5
34.5 ± 2.3
33.4 ± 0.9
28.5 ± 2.3
35.3 ± 0.3
40.5 ± 2.2
38.4 ± 0.8
37.2 ± 0.7
36.8 ± 4.5
40.5 ± 3.7

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 3.2A (see Appendix II).
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Table 3.3. Average L*, a*, b*, and ∆E values for guanosine-specific cleavage of 5mer DNA.
# Guanosines
0
0
0
1
1

Sequences

84.7 ± 0.0

TTGTT

78.0 ± 0.0

CCCCC

TTTTT
CCGCC

1

ATGTT

2

AGAGC

2
2

CGAGT
GCTGC

3

GTGGA

4

GGAGG

3
4
5

L* value

CTCTC

TGGTG

AGGGG
GGGGG

84.0 ± 0.0

a* value

-0.7 ± 1.5

-7.3 ± 1.5

16.0 ± 2.1

-11.0 ± 0.0

21.9 ± 0.2

-9.5 ± 0.7

-22.5 ± 2.1

78.0 ± 0.0

-12.0 ± 1.4

70.0 ± 1.4

4.0 ± 1.4

70.0 ± 0.0
71.0 ± 0.0

0.7 ± 0.6

-2.0 ± 0.0
-0.5 ± 0.7

54.0 ± 1.0

32.3 ± 1.5

49.7 ± 1.5

26.3 ± 2.5

58.3 ± 2.5
53.0 ± 3.5
40.7 ± 1.2

Average ∆E

-0.3 ± 0.6

86.0 ± 0.0
77.3 ± 0.6

b* value

-9.7 ± 0.6

-1.5 ± 0.7
3.0 ± 1.4

-7.3 ± 0.6
-3.5 ± 0.7

-12.5 ± 0.7
-17.0 ± 1.4
-30.3 ± 1.5

15.7 ± 1.5

-23.7 ± 10.6

31.7 ± 1.5

-32.0 ± 1.0

31.7 ± 4.6

-30.0 ± 2.6
-31.3 ± 1.5

4.9 ± 0.6
4.8 ± 0.6
0.9 ± 0.2

17.4 ± 0.8
9.0 ± 0.8

25.9 ± 0.7
29.5 ± 0.6
40.5 ± 1.8
39.5 ± 1.2
41.1 ± 1.3
46.8 ± 2.0
48.5 ± 2.7

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 3.3A (see Appendix II).
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Table 3.4. Average L*, a*, b*, and ∆E values for purine-specific cleavage of 5-mers
DNA.
# Purines

Sequences
CTCTC

90.0 ± 0.6

0

CCCCC

93.0 ± 0.0

0
0

CCTCC

0

TTTTT

1

CGTCC

1

TTGTT

2

CATGC

1
1
1

CACCC
CCGCC

TATCT

2

TACTA

2

ATGTT

3

GTGGC

2
2

CGAGT

AGTAT

4

GAGTA

4

AACAG

GAGAC

4

GTGGA

5

GGAGG

5

AGGGG

5

AGAGC

GGGGA

5

GAAAA

5
5

GGGGG
AAAGA

5

AAAAA

-0.7 ± 0.6

b* value

-4.7 ± 0.6

Average ∆E

-0.3 ± 0.6

-1.3 ± 1.5

6.8 ± 1.8

a* value

-2.0 ± 1.0
-1.3 ± 0.6
0.0 ± 1.0

-3.7 ± 0.6
-1.0 ± 0.0

13.8 ± 0.9

19.3 ± 4.2

-16.0 ± 2.6

67.7 ± 0.6

24.0 ± 2.0

-23.0 ± 1.7

78.0 ± 1.7
71.3± 2.5

66.7 ± 1.2

13.3 ± 3.8
20.0 ± 3.6
22.7± 2.9
7.7 ± 2.1
9.0 ± 1.0

55.0 ± 1.0

21.7 ± 1.5

56.5 ± 2.1

39.0 ± 4.2

52.7 ± 0.6

60.7 ± 3.1
61.0 ± 5.2
50.7 ± 4.0
54.0 ± 1.7
56.3 ± 3.5
48.3 ± 1.2
49.0 ± 1.0
41.7 ± 0.6
40.0 ± 1.0

23.3 ± 0.6

-19.3 ± 2.5
-22.0 ± 2.6
-12.0 ± 2.6
-13.3 ± 1.5
-21.3 ± 0.6
-22.7 ± 0.6
-34.0 ±2.8

42.3 ± 1.5

-35.7 ± 2.1

49.3 ± 2.1
38.3 ± 2.3
31.3 ± 6.7
28.7 ± 2.5
22.3 ± 1.5
8.7 ± 1.2

10.0 ± 2.6

40.0 ± 9.0

48.0 ± 3.6

33.3 ± 5.9
39.7 ± 3.1

-13.3 ± 2.1

-28.0 ± 2.0

43.7 ± 1.5
49.3± 5.9

-6.3 ± 1.2

34.0 ± 2.6
32.3 ± 1.2

43.3 ± 0.6
47.3 ± 1.5
48.7 ± 1.2

5.3 ± 0.8

-4.0 ± 1.4

79.0 ± 3.6

-2.5 ± 0.7

9.2 ± 0.9

16.2 ± 0.1

-0.3 ± 0.6

73.0 ± 0.0

10.9 ± 0.8

-1.3 ± 2.9

71.3 ± 0.6

63.7 ± 1.5

AACTG

4

71.0 ± 1.0

GCTGC

3
4

94.0 ± 1.0

69.3 ± 2.1

TGGTG

3

89.7 ± 1.5

TACTG

3
3

L* value

-29.7 ± 0.6
-35.3 ± 1.2
-32.7 ± 1.2
-28.3 ± 4.9
-27.3 ± 3.5
-22.0 ± 1.7

-13.3 ± 1.2
-12.3 ± 1.5
-36.3 ± 0.6
-39.3 ± 3.8
-38.3 ± 0.6
-40.0 ± 1.0

18.4 ± 1.0
26.1 ± 1.4
26.7 ± 1.9
32.7 ± 0.2
29.8 ± 2.1
31.9 ± 1.0
28.0 ± 2.1
30.5 ± 0.3
30.5 ± 0.3
38.4 ± 1.8
40.7 ± 1.1
34.2 ± 0.5
37.4 ± 2.5
44.4 ± 2.8

39.0 ± 1.5
40.3 ± 1.5
43.1 ± 2.4
41.9 ± 0.9
47.3 ± 1.7
46.2 ± 0.6
43.0 ± 2.1
45.4 ± 3.7
47.1 ± 3.5
51.7 ± 2.4
53.4 ± 2.7

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 3.4A (see Appendix II).
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Table 3.5. Average L*, a*, b*, and ∆E values for cytidine-specific cleavage of 5-mer
DNA.
# Cytidines
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
2
2
2
2
2
3
3
3
3
4
4
4
5

Sequences
GGAGG
GAAAA
ATGTT
AGTAT
AGGGG
GTGGA
TTGTT
AAAAA
GGGGG
TTTTT
CGAGT
GTGGC
GAGAC
AGAGC
AACAG
CATGC
TGCAC
CGATC
CCATT
CTCTT
CTCTC
CGTCC
ATCCC
CATCC
CGCCC
CCTCC
CACCC
CCCCC

L* value

95.3 ± 0.6
94.7 ± 1.5
95.0 ± 1.0
94.3 ± 1.5

93.0 ± 0.0
89.7 ± 1.2
92.7 ± 0.6
96.0 ± 0.0
92.0 ± 0.6
95.7 ± 0.6
85.3 ± 0.6
84.0 ± 3.0
83.7 ± 0.6
81.3 ± 1.2
81.7 ± 2.9
76.3 ± 0.6
78.7 ± 7.4
76.0 ± 1.0
81.0 ± 2.0
77.3 ± 1.2
72.3 ± 0.6
66.3 ± 4.9
69.7 ± 2.1
68.0 ± 1.0
54.7 ± 11.0
59.7 ± 8.0
54.7 ± 6.8
66.3 ± 5.5

a* value

-11.0 ± 1.0
-8.3 ± 0.6
-9.0 ± 0.0
-9.3 ± 0.6
-11.3 ± 0.6
-5.7 ± 2.1
-10.3 ± 1.5
-9.7 ±0.0
-4.7 ± 8.4
-10.3 ± 0.6
3.7 ± 1.2
5.7 ± 4.7
5.3 ± 2.5
4.3 ± 2.5
4.0 ± 1.7
13.3 ± 2.5
17.0 ± 6.9
12.3 ± 1.2
10.3 ± 2.3
14.3 ± 3.5
22.7 ± 1.2
28.3 ± 2.9
23.0 ± 3.0
22.7 ± 1.5
40.3 ± 8.4
35.0 ± 8.5
41.0 ± 5.6
28.0 ± 5.0

b* value

8.7 ± 2.1
7.7 ± 1.5
6.7 ± 1.2
7.3 ± 0.6
8.0 ± 1.0
4.0 ± 1.7
9.3 ± 0.6
7.3 ± 0.6
3.0 ± 6.1
7.0 ± 1.0
-3.3 ± 0.6
-2.7 ± 5.5
-3.0 ± 2.0
-2.0 ± 1.0
-1.7 ± 2.1
-8.3 ± 4.2
-10.7 ± 6.1
-9.0 ± 1.7
-10.7 ± 3.1
-8.7 ± 1.2
-16.0 ± 0.0
-19.3 ± 3.1
-13.7 ± 1.5
-13.0 ±1.0
-28.7 ±5.5
-24.7 ±5.1
-29.7 ± 4.7
-20.3 ± 3.5

Average ∆E
1.3 ± 0.6
1.8 ± 0.4
2.0 ± 0.5
2.2 ± 0.7
3.0 ± 0.4
4.7 ± 1.3
3.2 ± 1.8
1.8 ± 0.4
2.5 ± 0.6
2.5 ± 1.0
18.1 ± 2.7
20.7 ± 7.4
21.3 ± 3.8
21.0 ± 3.4
20.3 ± 4.0
32.0 ± 2.0
32.6 ± 6.1
32.8 ± 1.3
34.2 ± 0.6
32.6 ± 1.6
40.1 ± 0.2
42.5 ± 2.5
40.7 ± 1.0
40.9 ± 0.8
50.0 ± 10.5
46.2 ± 6.9
47.4 ± 9.6
41.2 ± 2.8

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 3.5A (see Appendix II).

3.2.2 Chemical Cleavage Reactions

Selective cleavage methods for generating deoxyribose sugars were first developed
using aqueous monomeric DNA solutions: 1mM of deoxyadenosine 5’-

monophosphate (5’dAMP), deoxyguanosine 5’-monophosphate (5’dGMP),

deoxycytidine 5’-monophosphate (5’dCMP), and deoxythymidine 5’-monophosphate
(5’dTMP). Two selective adenosine cleavage approaches were successful. The first
adenosine cleavage requires incubating solutions in 1.5 M NaOH in a 90οC water
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bath for 3 hours (39). The second adenosine cleavage requires incubating solutions
in 50 mM DEPC in a 37οC water bath for 90 minutes (45). In addition, selective

guanosine cleavage is a methylation reaction promoted by incubating solutions in

0.42 M dimethylsulfate, DMS, followed by cleavage with 0.1 M HCl and 0.1 M KCl at
0οC overnight (39). Chemical cleavage of both purines together is accomplished by

incubating the solutions at 90οC with 0.42 M DMS for 60 minutes followed by the

addition of 0.25 M NaOH for 60 minutes (39). The same cleavage methods as listed

above for the monomer DNA were used for selective cleavage of solutions consisting
of 1mM 5-mer ssDNA. Cytidine-specific cleavage was achieved by incubating

solutions of 1 mM 5-mer ssDNA in 5.2 mM NH2OH/Me2NH (aqueous solutions at pH
6.0) in a 50οC water bath for 3 hours (47). To remove excess NH2OH, dialysis was

performed using low molecular weight cut off (MWCO) cellulose tubing (Biotech CE
Tubing MWCO 100-500D Catalog #131048). Serial dialysis was performed over

three days for complete removal of hydroxylamine. Shorter serial dialysis times

were evaluated, but were unsuccessful. On day one, the samples were dialyzed in 0.3
M sodium phosphate buffer at pH 7.0, followed by day two in 0.2 M sodium

phosphate buffer at pH 7.0, and then finally on day three in 0.1 M sodium phosphate
buffer at pH 7.0. A serial dialysis in decreasing amounts of buffer concentration of
salts was required to prevent the osmotic pressure from swelling the membrane.
3.2.3 Bicinchoninic Acid/Copper Reactions

Detection of deoxyribose sugars selectively cleaved at adenine, guanine, all purines,

and cytosine was performed using the BCA working reagent (PierceTM BCA Protein
Assay Kit). The BCA working reagent is prepared by mixing reagent A (sodium

carbonate, sodium bicarbonate, bicinichoninic acid and sodium tartrate in 0.1 M

NaOH) and reagent B (4% cupric sulfate aqueous) prior to the time of detection. The
total volume of the BCA working reagent added to the samples varied so as to

provide a final solution volume of 250 µL in each reaction. The adenosine, purine,

and cytidine selective assays utilized a BCA working reagent ratio of 50:1 of solution
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A relative to solution B. The adenosine, purine, and cytidine reactions incubated for
1 minute for the adenosine-specific NaOH cleavage product, 20 minutes for the

adenosine-specific DEPC cleavage product, 4 hours for the purine cleavage product,
and 3 minutes for the cytidine cleavage product prior to image capture. The

guanosine-selective reaction utilized a BCA working reagent ratio of 25:1 and

incubated for 18 hours prior to image capture. The increased Cu2+ concentration

required in the guanine-specific reaction may be indicative of Cu2+ participation in
the selective guanine cleavage mechanism.

3.2.4 CIENA Procedure: Bicinchoninic Acid/Copper CIENA Assays

For this analysis, the BCA reaction was allowed to incubate at room temperature for
a designated time period (1 minute for the adenine NaOH cleavage assay, 20

minutes for the adenine DEPC cleavage assay, 18 hours for the guanine assay, 4

hours for the purine assay, and 3 minutes for the cytosine assay), at which time a

digital image of each solution was captured (example shown in Figure 3.1A). A more
detailed CIENA procedure is presented in section 2.2.4 of this dissertation.

Adobe Photoshop was then used to compute the L*, a*, and b* values for each colorcalibrated image (Tables 3.1-3.5). These values were then inserted into the color

change (ΔE) equation (Appendix I(20)) to quantify the color relative to a no-DNA
control sample. Thus, the averaged L*, a*, b* values for the controls from the

triplicate experiment are shown in the Appendix Tables 3.1A-3.5A. The constants,

kL, kC, and kH, in the ΔE equation (Appendix I) were set to 1, 1.5, and 1, respectively.

All data shown are the compilation of at least three independent experiments. For
the data in the graphs in Figure 3.3, standard error was used, which calculates the
square root of the total sum of each standard deviation squared [i.e. (a2+b2+c2)1/2

where a, b, and c are the standard deviations in each triplicate measurement].
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3.3

Results: Bicinchoninic Acid/Copper CIENA Assay for Detection of
Adenosine, Guanosine, and Purines in Monomeric DNA

DNA in monomeric form (i.e. nucleotides) were used to optimize the specificity of
our cleavage reactions, as well as to optimize color production in the subsequent
BCA/copper reactions. The final optimized conditions for the adenosine-specific,

guanosine-specific, cytidine-specific, and purine-specific assays are described above.
A typical result from an optimized NaOH adenine-specific cleavage assay is shown in

Figure 3.1A. A large color change for AMP (ΔE=29.4) and no color change (ΔE=0) for
the control (no-DNA sample), GMP, CMP, and TMP were observed (Figure 3.1B),
indicating a strong sequence specificity of this assay for AMP. Color swatch

representations of this reaction, along with calculated ΔE values, are shown in

Figure 3.1B. Color swatch representations from optimized DEPC adenosine-specific
cleavage reactions are shown in Figure 3.1C. In this assay, a large color change

occurred for AMP (ΔE=34.9) while the control, GMP, CMP, and TMP samples showed
relative small changes in color (ΔE<14). Therefore, this reaction is fairly specific for

AMP. Color swatch representations from optimized guanosine-specific reactions are
shown in Figure 3.1D. In this assay, a large color change occurred for GMP

(ΔE=27.2) while the control, AMP, CMP, and TMP samples showed relatively small
changes in color (ΔE<9). Therefore, this reaction is fairly specific for GMP. Color

swatch representations from optimized purine-specific reactions are shown Figure
3.1E which illustrate a large color change for purines, AMP and GMP, (ΔE>58) but

little color change for pyrimidines CMP and TMP (ΔE<5). Therefore, this reaction is
specific for the purines. Taken together, these results show that by changing

reaction conditions, the sequence-specificity of this colorimetric assay can be

controlled. Furthermore, these results validate the specificity of our chemical

cleavage methods and demonstrate that the BCA/copper reagent can be effective at

creating colorimetric differences between cleaved and uncleaved nucleotides. These
results also demonstrate that the difference in color change between reacted and
unreacted samples is large enough to be visualized with the unaided eye.
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A

B

Control
∆E

C

Control
∆E

D

Control
∆E

E

Control
∆E

5’

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

29.4 ± 0.5 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
5'

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

34.9 ± 1.1 13.4 ± 4.8 0.8 ± 0.2 1.1 ± 0.7
5'

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

6.6 ± 2.8 27.2 ± 2.3 8.1 ± 0.8 1.4 ± 0.8
5'

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

58.4 ± 1.0 59.2 ± 0.2 4.0 ± 0.2 1.9 ± 0.3

Figure 3.1. Analysis of monomeric DNA samples illustrated
in color swatches in Panels B-E. Panel A: Image capture of a
typical adenine-specific BCA reaction at 1 minute. Panel B:
Results from NaOH cleavage adenine-specific BCA reactions
at 1 minute. Panel C: Results from DEPC cleavage adeninespecific BCA reactions at 10 minutes. Panel D: Results from
guanine-specific BCA reactions at 18 hours. Panel E: Results
from purine-specific BCA reactions at 4 hours. Average ΔE
values are from three independent experiments. The control
samples do not contain DNA.
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3.4

Results: Bicinchoninic Acid/Copper CIENA Assay for Detection of
Adenosine, Guanosine, Cytidine, and Purines in 5-mer ssDNA

To determine if the above conditions and methods for the monomeric DNA are

amendable to quantifying nucleobases within polymers, we used 5-mer ssDNA

sequences as substrates in each of the previously described assays. Testing and

analyzing polymers is more complex than monomers because each sequence tested
can have from zero to five nucleobases, in any combination. Therefore, the

sequences of polymers were carefully chosen to include multiple instances of each
possible nucleobase composition. For example, in the NaOH adenosine-specific

cleavage assay, we analyzed twelve different sequences with one adenine, eight
different sequences with two adenines, and so forth. The sequences and their

results, from triplicate experiments, are shown in Figures 3.2 and 3.3, and in Table
3.1 for the adenosine-specific NaOH cleavage assay, Table 3.2 for the adenosine-

specific DEPC cleavage assay, Table 3.3 for the guanosine-specific cleavage assay,
Table 3.4 for the purine-specific cleavage assay, and Table 3.5 for the cytidinespecific cleavage assay.
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A

B

C

D

E

Control

CGTCC

CGAGT

AACTG

AACAG

GAAAA

AAAAA

∆E

0.0 ± 0.0

20.2 ± 2.9

47.9 ± 2.4

60.8 ± 1.6

65.2 ± 0.3

68.0 ± 0.2

Control

TTGTT

ATGTT

AGAGC

AACAG

GAAAA

AAAAA

∆E

1.0 ± 0.8

18.3 ± 4.2

25.3 ± 1.9

27.6 ± 4.0

31.4 ± 2.5

40.5 ± 3.7

Control

TTTTT

ATGTT

CGAGT

TGGTG

GGAGG

GGGGG

∆E

0.9 ± 0.2

9.0 ± 0.8

21.9 ± 0.2

39.5 ± 1.2

46.8 ± 2.0

48.5 ± 2.7

Control

CCTCC

TATCT

TACTG

AGTAT

GAGAC

AAAGA

∆E

9.2 ± 0.9

26.7 ± 1.9

31.9 ± 1.0

37.4 ± 2.5

39.0 ± 1.5

53.4 ± 2.7

Control

TTTTT

GAGAC

CGATC

CATCC

CACCC

CCCCC

∆E

2.5 ± 1.0

18.6 ± 7.8

32.8 ± 1.3

40.9 ± 0.8

47.4 ± 9.6

41.2 ± 2.8

Figure 3.2. Analysis of 5-mer ssDNA illustrated in color swatches above.
Panel A: Results from adenine-specific NaOH cleavage BCA reactions at 1
minute. Panel B: Results from adenine-specific DEPC cleavage BCA reactions
at 20 minutes. Panel C: Results from guanine-specific BCA reactions at 18
hours. Panel D: Results from purine–specific BCA reactions at 4 hours. Panel
E: Results from cytosine-specific BCA reactions at 3 minutes. Average ΔE
values are from three independent experiments. The control samples do not
contain DNA.
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A

60.0
50.0
∆E

B

Adenosine (NaOH Cleavage)
70.0

40.0
30.0
20.0
10.0
0.0
0

1

Adenosine (DEPC Cleavage)

70.0
60.0
50.0
40.0
y = -3.4861x 2 + 31.336x - ∆E
30.0
2.6635
20.0
R² = 0.9968
10.0
0.0
2
3
4
5
0

y=

1

y = -1.089x 2 + 14.831x + 2.2185
R² = 0.9887

50.0
40.0
30.0
20.0
10.0
0.0

1

2

3

4

0

5

1

2

3

Purine Frequency

4

3

4

5

Cytosine

E
70.0
60.0
50.0
40.0
∆E
30.0
20.0
10.0
0.0

y = -2.593x 2 + 21.093x + 1.9936
R² = 0.9908
0

5

2

Guanosine Frequency

Adenosine Frequency

y = -0.9997x 2 + 12.348x + 10.626
R² = 0.9612
0

60.0

R² = 0.9995

Purine (Bicinchoninic Acid/Copper)

70.0
60.0
50.0
40.0
ΔE
30.0
20.0
10.0
0.0

70.0

-1.0615x 2 + 12.518x + 4.4417

∆E

Adenosine Frequency
D

Guanosine

C

1

2

3

4

5

Cytosine Frequency

Figure 3.3. Graphs correlating the average color change (ΔE) values with the
frequency of adenosines in the NaOH cleavage assay (Graph A), the frequency of
adenosines in the DEPC cleavage assay (Graph B), the frequency of guanosines
(Graph C), frequency of purines (Graph D), and frequency of cytidines (Graph E)
present in the analyzed 5-mer single-stranded DNAs.
3.4.1 Discussion: Bicinchoninic Acid/Copper CIENA Assay for Adenosine
Detection

Representative experimental data from the adenine-specific assays are shown in
Figure 3.2A (NaOH cleavage) and Figure 3.2B (DEPC cleavage). As the number of

adenosines in the oligomer increase, the difference in the change in color from the
control and sample solution increases [from clear (NaOH) or teal (DEPC) to dark
violet], as demonstrated by an increasing ΔE value. Note that the no-DNA and

5’CGTCC3’ and 5’TTGTT3’ experiments are transparent or teal in color because they
contain no adenosines, which shows the specificity of the overall reaction for

adenosines. These trends hold true when all of the 41 adenosine-specific assays
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(Table 3.1 NaOH cleavage and Table 3.2 DEPC cleavage) are graphically displayed

and fitted with a polynomial best-fit relationship (Figure 3.3A NaOH cleavage and

Figure 3.3B DEPC cleavage). Irrespective of the positions of the adenosines in each
sequence, as well as the identity of the non-adenosine bases, there is a predictable

and unique ΔE value as a function of the frequency of adenosines in each sequence.

These results demonstrate that the BCA/copper reagent, combined with adenosinespecific cleavage methods, can be used as a specific colorimetric probe for the
identity and estimation of adenosine frequency in 5-mer ssDNA.

3.4.2 Discussion: Bicinchoninic Acid/Copper CIENA Assay for Guanosine
Detection

Representative experimental data for 5-mer ssDNA in the guanosine-specific assay

are shown in Figure 3.2C. The results demonstrate that as guanosine frequency in
the oligomer increase, the change in color of the solution changes (from teal to

violet), as demonstrated by an increasing magnitude in the ΔE value. In contrast, we
observe only a very little of color change (ΔE=0.9) when no guanosines are present.
This illustrates the specificity of this reaction for guanosines. For the compiled

dataset with 14 different sequences (Table 3.3), the ΔE increases in a polynomial

best-fit relationship as a function of increasing guanosine frequency (Figure 3.3C).

These results demonstrate that the BCA/copper reagent, combined with guanosinespecific cleavage methods, can be used as a specific colorimetric probe for the
identity and estimation of the number of guanosines in 5-mer ssDNA.

3.4.3 Discussion: Bicinchoninic Acid/Copper CIENA Assay for Total Purine
Detection

Representative experimental data for ssDNA polymers used in the purine-specific

assay are shown in Figure 3.2D, and the compiled data from 31 different sequences

are shown in Table 3.4. This data shows that as the number of purines increases, the
BCA/copper reagent changes color to darker hues of violet, and the ΔE values

progressively increase. This change in ΔE is graphically shown in Figure 3.3D as a
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polynomial increase in ΔE as the number of purines in the oligomer increase. This
data illustrates that the BCA/copper reagent combined with purine-specific

cleavage method can be used as a specific colorimetric probe for the identity and
estimation of purine frequency in 5-mer ssDNA. In this purine-specific assay, the

sequences without purines do show some color change. However, the color change

is significantly less than sequences that have at least one purine and therefore does
not affect the assay. These results demonstrate that the BCA/copper reagent,
combined with purine-specific cleavage methods, can be used as a specific

colorimetric probe for the identity and estimation of the number of purines in 5-mer

ssDNA .

3.4.4 Discussion: Bicinchoninic Acid/Copper CIENA Assay for Cytosine
Detection

Representative experimental data for ssDNA polymers used in the cytidine-specific
assay are shown in Figure 3.2E, and the compiled data from 28 different sequences

are shown in Table 3.5. This data shows that as the cytidine frequency increases, the
BCA/copper reagent changes color to darker hues of violet, and the magnitude in ΔE
values progressively increase. This change in ΔE is graphically shown in Figure 3.3E
as a linear increase in ΔE. However, there are a few issues that deserve note when
analyzing 5-mers with the larger number of cytidines present. For one, there is a

larger error associated with this assay than the other assays where the largest error

is in the 5-mer ssDNA oligomers containing four cytidines. The oligo-cytidine 5-mer
ssDNA (5’-CCCCC-3’) ΔE value is less than the ssDNAs containing four cytidines (see
Figure 3.2 Panel E with 5’-CCCCC-3’ having a ΔE value of 41.2 ± 2.8 compared to 5’-

CACCC-3’ having a ΔE value of 47.4 ± 9.6). The higher error in this assay is likely due
to the buffer exchange procedure required to remove the excess NH2OH.

Unfortunately, even the lowest molecular weight cut off (MWCO) dialysis tubing

available (100-500Da) is insufficient to retain the cleaved fragmented ssDNA in its

entirety. In this cytidine-specific assay, the sequences without cytidines do not show
color change. These results demonstrate that the BCA/copper reagent, combined
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with cytidine-specific cleavage methods, can be used as a specific colorimetric probe
for the identity and estimation of the number of cytidines in 5-mer ssDNA.
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Chapter 4

Using the Established Diphenylamine Assay for Detection of Total
Purines in a CIENA Assay

4.1

Introduction to Diphenylamine

Dr. K. Burton demonstrated in the 1960’s that diphenylamine in acidic conditions

(acetic acid and sulfuric acid) generates a blue chromophore that can be measured
to quantify the amount of DNA within cell lysate samples (25). Mechanistically the

purines are cleaved (N-glycosidic bond is hydrolyzed) under the acidic conditions to
produce an apurinic (AP) site (Scheme 4.1) (48). These apurinic sites produce a

deoxyribose sugar that can be in equilibrium with its open conformation (aldehyde)
and closed conformation (acetal). The open conformation becomes trapped by the
diphenylamine through a Schiff base reaction, thus producing a blue chromophore
(Scheme 4.2) (25). We examined, using diphenylamine in our CIENA method, that
this assay was sensitive enough to colorimetrically measure different numbers of
purines present within 5-mer ssDNA oligomers.
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Scheme 4.1. Purines cleave readily in acidic conditions (HCl and 90οC) to
produce apurinic sites. These apurinic sites shown here shows the acetal
conformation of the deoxyribose sugar.
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Scheme 4.2. Diphenylamine under acidic conditions produces a Schiff
base with apurinc site.
4.2

Materials and Methods: Diphenylamine CIENA Assay

This section of the chapter includes all the chemicals, sample preparations,

procedures for each reaction, and optimized image capture times. This section also

describes the constant values (kL, kC, and kH) we used for the ∆E equation (located in
Appendix I). For more detailed CIENA protocols, refer to section 2.2.4 of this
dissertation.

4.2.1 Chemicals: Diphenylamine CIENA Assay

All chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise
specified. This includes: 5’-monophosphodeoxyguanosine (dGMP, 5’-

monophosphodeoxyadenosine (dAMP), 5’-monophosphodeoxycytidine (dCMP), 5’monophosphodeoxythymine (dTMP), sodium phosphate (Na2HPO4), sodium

chloride (NaCl), acetic acid, diphenylamine, sulfuric acid, and acetylaldehyde.
Oligomeric 5-mer ssDNA was purchased from Integrated DNA Technologies
(Coralville, IO). See Table 4.1 for sequences.
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Table 4.1. Average L*, a*, b*, and ∆E values for purine-specific (DPA) 5-mer DNA.
# Purines

Sequences

0

TTTCT

0

L* value

a* value

b* value

Average ∆E

100.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.6 ± 0.5

TCTTC

100.0 ± 0.0

0

TTTTT

100.0 ± 0.0

-0.3 ± 0.6

1

TCCTG

79.7 ± 0.6

-7.3 ± 0.6

0
1
1
1
1

CTTTT

TCTGT

TATCT
ATTTC
TACCT

2

GTTTA

2

TCGAC

2
2
2

CGTAT
TACAC
GACTC

3

CGAAT

3

GCCGG

3
3
4
4
4
4
5
5
5

GCATG

TGGTG

GCGAG

AGTGA

AGAAC
GCGGG

GGAGG

AAAGA
AAAGG

100.0 ± 0.0
79.0 ± 1.0
80.3 ± 1.5
83.0 ± 1.0
85.0 ± 2.0
77.0 ± 0.0
78.7 ± 2.1

0.0 ± 0.0
0.0 ± 0.0

68.0 ± 3.5
60.7 ± 0.6
62.3±2.1

72.5 ± 2.1
64.3 ± 2.5
57.3 ± 5.0
57.0 ± 5.6
55.7 ± 5.0

1.0 ± 1.1

-6.0 ± 0.0

-5.3 ± 1.5

12.0 ± 0.7

-8.7 ± 0.6
-5.0 ± 0.0

-6.7 ± 1.5
2.0± 1.0

-8.3 ± 1.5
6.0 ± 0.0

-7.3 ± 0.6

-16.7 ± 1.5

-6.0 ± 0.0

-1.3 ± 1.5

-4.3 ± 0.6

72.3 ± 1.2

0.6 ± 0.5

15.3 ± 1.0

66.3 ± 3.2
69.0 ± 3.6

1.3 ± 2.3

0.0 ± 0.0

-6.0 ± 1.0

-8.3 ± 0.6

-11.7 ± 2.1

76.0 ± 3.0

0.0 ± 0.0

-9.0 ± 0.0

77.3 ± 2.5
70.3 ± 1.2

0.0 ± 0.0

-7.3 ± 1.2
-5.3 ± 0.6
-7.7 ± 0.6
-6.3 ± 1.5
-2.7 ± 1.2
-2.7 ± 1.2

-13.3 ± 2.3
-2.3 ± 0.6
-0.7 ± 1.5
3.7 ± 2.1
3.0 ± 1.0
3.0 ± 1.7
0.7 ± 0.6
2.7 ± 1.5

-6.5 ± 0.7

-16.5 ± 2.1

-4.7 ± 1.5

6.0 ± 2.6

-8.7 ± 1.5
-5.7 ± 0.6
-3.7 ± 4.0

-15.3 ± 3.1
4.0 ± 4.0

-0.3 ± 2.9

14.3 ± 1.2
13.9 ± 0.5
12.0 ± 1.4
15.2 ± 0.0
16.3 ± 1.4
17.4 ± 2.0
20.5 ± 0.9
16.2 ± 2.1
23.0 ± 2.5
21.0 ± 2.8

19.0 ± 0.8
22.0 ± 2.9
27.3 ± 0.5
25.9 ± 1.6
20.0 ± 1.8
25.9 ± 2.3
30.5 ± 4.2
30.8 ± 4.7
31.8 ± 4.4

Each value is the average of three independent assays. The L*, a*, b* values for the control samples
(no DNA) used to calculate the ∆E values are shown in Table 4.1A (see Appendix II). Furthermore,
when the L*, a*, and b* values are 100, 0, and 0, respectively, the solution is clear.

4.2.2 Diphenylamine Working Solution

Preparation of the diphenylamine working solution must be made fresh prior to use
and contains the following: 62 mM diphenylamine, 2.5 mM sulfuric acid, and 2.9
mM acetyladehyde in a total volume of 50 uL of acetic acid (25).
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4.2.3 Samples and Reaction Procedures

Samples of the nucleic acid monomers (A, C, T, G) were prepared in 100 mM

quantities in water and stored in the freezer. Samples of the 5-mer ssDNA oligomers
were prepared in 1 mM quantities in water and stored in the freezer.

Sample preparation of monomers, for the diphenylamine reactions include the

addition of 5 uL of 100 mM DNA nucleotides with 50 uL of diphenylamine working

solution at 37οC in a water bath for 4 hours. The samples are then transferred from

the eppendorf tubes to disposable cuvettes and acetic acid is added to make a final
volume of 250 uL.

Sample preparation of oligomeric 5-mer ssDNA for the diphenylamine reaction used
0.5 mM 5-mer ssDNA oligomer and 50uL of diphenylamine working solution at 37οC

water bath for 4 hours. The samples were then transferred from the eppendorf

tubes to disposable cuvettes and acetic acid is added to make a final volume of 250
uL.

4.2.4 CIENA Procedure: Diphenylamine CIENA Assay

For this analysis, a digital image of each solution was captured immediately

following transferring the samples and addition of acetic acid to the disposable
cuvettes (example shown in Figure 4.2A). A more detailed CIENA procedure is

presented in section 2.2.4 of this dissertation. Adobe Photoshop was then used to
compute the L*, a*, and b* values for each sample in the color-calibrated image

shown in Table 4.1. These values were then inserted into the color change (ΔE)

equation (Appendix I(20)) to quantify the color change relative to the color change
of a no-DNA negative control. A control was run for every assay, and the L*, a*, b*

values of the controls are listed in Table 4.2A, Appendix II. The constants, kL, kC, and
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kH, in the ΔE equation (Appendix I) were set to 1, 1.5, and 1, respectively. All data
shown are the compilation of at least three independent experiments.
4.3

Results: Diphenylamine CIENA Assay for Purine Quantification in
Monomeric and 5-mer Single Stranded DNA

Analysis of the monomeric DNA results in measurable ∆Ε values of 72.6±1.1 and

67.3±0.1 for the purines adenine and guanine, respectively (Figure 4.1). The
pyrimidines (5’dTMP and 5’dCMP) are essentially non-reactive and therefore,

remain clear as does the negative control that contains no DNA. For the purines
(5’dAMP and 5’dGMP), this reaction takes 4 hours for the blue chromophore to

develop This slow reaction is perhaps due to the equilibrium between the aldehyde
to the acetal (mutarotation) form of the deoxyribose sugar. The positive control for
this reaction is 1 mM deoxyribose sugar and it takes a minimum of 4 hours at 37oC

to produce the blue chromophore. Once the blue chromophore is produced, it is
quite stable for weeks, although it does tend to darken over time (data not shown).

- Control + Control

5’

dAMP

5'

dGMP

5'

dCMP

5‘

dTMP

4 hours
L

96.5 ± 3.5 23.0 ± 4.2 20.0 ± 1.4 24.5 ± 0.7 97.0 ± 2.8 97.0 ± 2.8

A

-1.0 ± 0.0 15.5 ± 2.1 12.0 ± 1.4 17.5 ± 0.7 -0.5 ± 0.7 -0.5 ± 0.7

B

2.5 ± 0.7 -59.5 ± 6.4 -50.5 ± 0.7 -62.5 ± 2.1 1.0 ± 0.0 1.0 ± 0.0

∆E

69.2 ± 4.2 72.6 ± 1.1 67.3 ± 0.1 1.5 ± 0.2 1.3 ± 0.7

Figure 4.1. Diphenylamine in acetic acid produces a measurable
chromophore for the deoxyribose, 5’dAMP and 5’dGMP. The color
swatches of these 3 samples show substantially different colors
than their no-DNA controls, calculated as ∆E.
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A

Purine Frequency

B

Control

TCTTC

TATCT

CGTAT

GCATG

AGTGA

AAAGG

∆E

0.0 ± 0.0

14.3 ± 1.2

16.3 ± 1.4

21.0 ± 2.8

25.9 ± 1.6

31.8 ± 4.4

50.0

Purine (Diphenylamine)

C

40.0
30.0
∆E

20.0
10.0

y = -0.6043x 2 + 8.4605x + 2.4259
R² = 0.9629

0.0
0

1

2
3
4
Purine Frequency

5

Figure 4.2. Analysis of 5-mer ssDNA purine-specific diphenylamine
reaction at 4 hours. Panel A: Image capture of a typical reaction. Panel
B: Results from the reactions shown in Panel A are illustrated as color
swatches. Panel C: Graph illustrating the correlations of average color
change (ΔE) values with the number of purines present in the analyzed
5-mer ssDNAs.
Over 25 different 5-mer ssDNA sequences (Table 4.1) were subjected to the

diphenylamine purine CIENA reaction as described in the methods section. In these
assays, as the number of purines increase in each oligomer, the solution changes

from a clear solution to a light blue then dark grey upon saturation (Figure 4.2). A
sample with more purines gives a larger color difference dependent upon the
number of purines present (i.e. two purines ΔE= 16.3, five purines ΔE=31.8). When

no purines are present, the solution is clear and gives no difference in the measured
change of color from a no-DNA sample (ΔE=0). The change in color in the samples,
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as a function of purine frequency, is shown in Table 4.2 and graphed in Figure 4.2C.

Curve fitting of the resultant data points demonstrates a moderate polynomial

correlation. Note that this assay results in substantially closer ∆E values, as well as

higher general error, when compared to the BCA/copper assay for purine frequency
(Figure 3.3D). Therefore, it appears that the BCA/copper assay might produce more

usable data than the diphenylamine assay. Moreover, it should be noted that the
color of the reaction depends on the amount of acetylaldehyde present (25).

However, acetylaldehyde is volatile and is difficult to measure into solution at a

consistent concentration. Therefore, it is recommended that this assay be calibrated
against several known purine 5-mer ssDNA each time the assay is performed.
4.4

Conclusions of Diphenylamine in the CIENA Assays for Purine
Quantification

The results show that purines can be colorimetrically identified and their frequency

estimated within monomeric and oligomeric 5-mer ssDNA using diphenylamine.

Since the purines are cleaved by hydrolysis of their N-glycosidic bonds more readily

than the pyrimidines, the colorimetric reagents can be optimized to selectively

cleave and quantify the purines, even in the presence of the pyrimidines. This assay

can effectively determine if purines are present within a sample since the ∆E
difference between one purine and zero purines is 14 ∆E units. However, this
method has a limited working range of ∆E values relative to purine frequency. The

frequency of purines can only be roughly estimated (likely between two purines

rather than single purine values) due to the large error overlap in 5-mer ssDNA

containing three or more purines. For this reason, the purine-specific BCA/copper

assay discussed in Chapter 3 is used in the next chapter, which introduces an
application of these colorimetric assays combined with CIENA analysis to estimate
base composition within 5-mer ssDNA.
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Chapter 5
5.1

Application of CIENA to Estimate Base Composition of 5-mer Single

Stranded DNA

Introduction: CIENA Assays Applied to Base Composition Analysis of
5-mer Single Stranded DNA

In this chapter, we describe the application of Colorimetric Identification of Exposed

Nucleic Acids (CIENA) for measuring the frequency of each nucleotide within nucleic
acid oligomers. We have developed seven nucleobase-specific assays (described in
Chapters 2 and 3). The panel of seven colorimetric reactions utilize a chromogen,
either sodium permanganate (NaMnO4) (Chapter 2) or bicinchoninic acid (BCA)
with copper (Chapter 3), to produce color changes proportional to nucleobase

content. These assays were optimized in such a way that the color change (∆E) can
be visualized with the eye or captured with a camera and analyzed using CIELAB

color space (21). Color change (∆E) (23) within the digital images can be quantified
to estimate base composition within 5-mer ssDNA.

Thymine, cytosine, and guanine nucleobases can be selectively quantified using

NaMnO4 under varying assay conditions. At neutral pH (24), sodium permanganate

oxidizes the pyrimidine bases within 5-mer ssDNA to produce a color change, with a

preference for thymine. This color change for NaMnO4 starts out as a violet solution,
which turns yellow, and eventually clear with a brown precipitate (MnO2) upon
reacting with thymine (Chapter 2, Scheme 2.1) (24). At a later time point (40

minutes), 5-mer ssDNA’s containing two or fewer thymines, show a color change
predictive of the frequency of cytosines present using NaMnO4, thus offering a

cytosine-specific colorimetric assay (Chapter 2, Figure 2.4). Under alkaline

ammonium hydroxide conditions, guanine frequency can also be determined using

NaMnO4 (Chapter 2, Figure 2.10). In all three of these NaMnO4 assays, the degree of

color change is quantified as the ∆E value, for which its magnitude increases
proportionally to the nucleobase frequency (Chapter 2).
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The BCA with copper assay has traditionally been used for the determination of

protein concentrations (29), but it can also be used for identification of aldehydes
(reducing sugars) (42), as demonstrated in Chapter 3. Our lab developed a

BCA/copper assay that can be used to identify and quantify each of the four

nucleobases within 5-mer ssDNAs (27). Selective cleavage of cytidine, adenosine or
both purines together generates a reducing sugar (2-deoxyribose) fragment from
the N-glycosidic bond cleavage, which is then capable of reducing Cu2+ to Cu1+

(Chapter 3, Scheme 3.1). This reducing sugar, when exposed to the BCA/copper
reagent, results in a solution color change from teal to dark violet, which is

proportional to the frequency of cytidine, adenosine or purines in the DNA oligomer
(Chapter 3). The magnitude of the color difference from the sample relative to the

control (no DNA), quantified as ∆E, can be used to determine the content of cytidine,
adenosine or purines in 5-mer ssDNA. In this chapter, we use these seven

colorimetric techniques to quantify thymine, cytosine, guanine, adenine, and total
purine content in 5-mer ssDNA.
5.2

Materials and Methods: CIENA Assays for Base Composition Analysis
of 5-mer Single Stranded DNA

The materials and methods for the seven CIENA assays used for base composition
analyses have been described in Chapter 2 and 3. These assays include the

following: thymine-permanganate assay (Section 2.3), cytosine-permanganate

assay (Section 2.4), guanine-permanganate assay (Section 2.5), adenosine assay

with NaOH cleavage (Section 3.4), adenosine assay with DEPC cleavage (Section
3.4), cytidine-bicinchoninic acid/copper assay (Section 3.4), and total purine-

bicinchoninic acid/copper assay (Section 3.4). The 5-mer ssDNA sequences used in
the study were purchased from Integrated DNA Technologies (Coralville, IA) and
can be found in Tables 5.1 and 5.2.
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Table 5.1. Predicted number of pyrimidines using thymine and cytosine
permanganate assays, and the cytidine bicinchoninic acid/copper assay.
Sequences

∆E Thymine

AGAGC

0.8 ± 0.3

AACAG

TP

∆E Cytosine
MnO4

0.0

13.5 ± 0.7

1.6 ± 0.5

0.0

ATGTT

19.0 ± 0.4

2.3

CATGC

9.4 ± 2.1

AGGGG
CACCC
CCCCC

CCTCC

CGAGT

1.6 ± 0.5

4.5 ± 1.6
5.4 ± 1.6
9.7 ± 0.6
9.9 ± 0.2

CGTCC

11.2 ± 1.0

GAAAA

1.9 ± 1.4

CTCTC

GAGAC

GGAGG
GTGGC
TTGTT
TTTTT

16.2 ± 0.3
2.3 ± 0.4
1.1 ± 0.2

7.8 ± 0.4

27.9 ± 0.1
41.0 ± 1.1

0.1

5.8 ± 0.3
1.8 ± 0.5

CP

∆E Cytosine
BCA

1.8

21.3 ± 3.8

0.7
0.1

20.3 ± 4.0

3.7

2.0 ± 0.5

3.7

47.4 ± 9.6

0.6

37.0 ± 1.6

5.1

41.2 ± 2.8

1.1
1.2
1.3
2.0
0.1

49.4 ± 1.0
22.7 ± 0.6
43.5 ± 0.7
61.5 ± 0.8
2.2 ± 0.5

0.2

10.5 ± 0.3

0.9

24.6 ± 0.6

0.0
3.4

2.1 ± 0.1

5.2

1.5
4.0
0.5
3.2
3.2
0.2

32.0 ± 2.0
46.2 ± 6.9
18.1 ± 2.7
42.5 ± 2.5
40.1 ± 0.2

-0.4
2.3
3.2
3.6
1.1
3.3
3.1

1.8 ± 0.4

-0.4

1.3 ± 0.6

-0.4

3.2 ± 1.8

-0.3

1.4

21.3 ± 3.8

3.7

14.6 ± 1.2

0.2

1.4

-0.3

27.2 ± 0.7
30.4 ± 1.4

1.3

3.0 ± 0.4

0.5
1.1

CB

2.5 ± 1.0

1.4
0.8

-0.3

TP is the predicted thymine frequency calculated from the best-fit linear equation from Chapter 2,
Figure 2.3C. Predicted frequency (x) is solved for using x = (y - 1.32)/7.702). CP is the predicted
cytosine frequency calculated from the best-fit linear equations from Chapter 2, Figure 2.5. Where
sequences with zero T are solved for using x = (y – 0.8714)/7.0214), sequences with one T are
solved for using x = (y – 19.16)/7.575), and sequences with two T are solved for using x = (y –
44.98)/5.155). Sequences with more than two T were not calculated for the permanganate cytosine
assay. CB is the predicted cytosine frequency from the best fit polynomial equation from Chapter 3
Figure 3.3E. Predicted frequency (x) is solved for using x = [-21.093 + SQRT{(21.093*21.093) – (4* 2.593*(1.9936–y))}]/(2*-2.593). ∆E is the ∆E value measured in triplicate experiments for that
particular assay. For all predicted frequency calculations, y = the average ∆E value measured for
each sequence. All values are rounded to the nearest 10th.
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Table 5.2. Predicted number of purines using the guanine-permanganate assay,
adenosine assay with NaOH cleavage, adenosine assay with DEPC cleavage, and total
purines bicinchoninic/copper assay.
Sequences

∆E
Guanine

GP

∆E Adenine
NaOH

AB-N

∆E Adenine
DEPC

AB-D

∆E Purine

1.9

37.5 ± 0.4

1.5

25.3 ± 1.9

2.0

41.9 ± 0.9

AACAG

20.9 ± 1.0

0.3

ATGTT

23.0 ± 2.5

0.5

CATGC

21.2 ± 1.6

CCTCC

4.7 ± 0.5

AGAGC

AGGGG
CACCC

41.9 ± 1.5
57.4 ±1.2

4.0

60.8 ± 1.6
14.9 ± 2.1
13.5 ± 2.3

6.0 ± 0.3

-0.5

8.8 ± 0.5

-0.4

CGAGT

40.6 ± 2.5

1.8

20.2 ± 2.9

CTCTC

4.1 ± 0.1

-0.6

0.0 ± 0.0

42.6 ± 1.0

2.0

CCCCC

CGTCC

23.8 ± 1.3

GAAAA

21.0 ± 0.3

GGAGG

58.6 ± 1.3

GAGAC
GTGGC
TTGTT
TTTTT

51.4 ± 0.5
28.5 ± 0.6
5.9 ± 0.4

0.4

-0.6
0.5

30.3 ± 1.1
17.1 ± 2.6
3.2 ± 1.8
0.0 ± 0.0
0.0 ± 0.0

0.3

65.2 ± 0.3

4.4

17.5 ± 2.1

3.0
0.9

-0.5

40.2 ± 2.3
3.0 ± 2.0
0.0 ± 0.0
0.0 ± 0.0

3.1
0.6
0.5
1.2
0.7
0.2

32.9 ± 0.5
15.4 ± 1.1
18.3 ± 4.2
17.1 ± 1.9
15.0 ± 4.5

3.1

1.0
1.2
1.1
0.9

1.0 ± 0.9

-0.3

0.8

19.7 ± 1.8

0.1

0.1
0.1

1.6

16.2 ± 0.1
32.7 ± 0.2

3.8
0.5
2.2

40.7 ± 1.1

3.3

1.6 ± 0.3

-0.2

10.9 ± 0.8

23.0 ± 3.4

1.7

9.3 ± 2.5

13.3 ± 3.8

0.1

28.0 ± 2.1

43.0 ± 2.1

3.6

1.4

1.9 ± 0.5

0.7
0.1

3.3

-0.3

36.6 ± 1.2

0.2

40.3 ± 1.5

6.8 ± 1.8

3.6
1.7

PB

7.3 ± 0.2
4.3 ± 0.9
1.0 ± 0.8

-0.2
0.4
3.8
0.8
0.2
0.0

-0.3

9.2 ± 0.9

18.4 ± 1.0
45.4 ± 3.7
39.0 ± 1.5
47.3 ± 1.7
30.5 ± 0.3
26.1 ± 1.4
5.3 ± 0.8

-0.1
0.7
0.0
4.3
3.1
5.0
1.9
1.4

-0.4

GP is the predicted guanine frequency calculated from the best-fit quadratic equation from Chapter 2
Figure 2.10C. Predicted frequency (x) is solved for using x = [-16.676 + SQRT{(16.676*16.676) – (4* 1.554*(15.383–y))}]/(2*-1.554). AB-N is the predicted adenine frequency calculated from the best-fit
quadratic equation from Chapter 3 Figure 3.3A, where x = [-31.336 + SQRT{(31.336*31.336) – (4*3.4861*(-2.6635–y))}]/(2*-3.4861). AB-D is the predicted adenine frequency is calculated from the
best-fit quadratic equation from Chapter 3 Figure 3.3B, where x = [-12.518 + SQRT{(12.518*12.518)
– (4*-1.0615*(4.4417–y))}]/(2*-1.0615). PB is the predicted purine frequency calculated from the
best-fit quadratic equation from Chapter 3 Figure 3.3D, where x = [-12.348 + SQRT{(12.348*12.348)
– (4*-0.9997*(10.626–y))}]/(2*-0.9997). ∆E is the ∆E value measured in triplicate experiments for
that particular assay. For all predicted frequency calculations, y = the average ∆E value measured for
each sequence. All values are rounded to the nearest 10th.

5.3

Results and Discussion for Estimating Base Composition of 5-mer

ssDNA Oligomers using CIENA Assays

We used 5-mer oligomeric DNA sequences to develop and optimize our CIENA
assays. The sequences of oligomers were carefully chosen to include multiple

instances of each nucleoside frequency. For example, we analyzed twelve different

sequences with one thymine, seven different sequences with two thymines, and so
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forth. The sequences and their results, and the equations used, from triplicate
experiments, are shown in Table 2.1 for thymine-specific assay, Table 2.2 for the

cytosine-specific permanganate assay, Table 2.3 for the guanine-specific

permanganate assay, Table 3.1 for the adenosine assay with NaOH cleavage, Table

3.2 for the adenosine assay with DEPC cleavage, Table 3.4 for the purine-specific
BCA/copper assay, and Table 3.5 for the cytosine-specific BCA/copper assay.

These seven nucleobase-specific colorimetric assays were evaluated for their

efficacy in predicting the base composition of 5-mer ssDNA. The results for the

pyrimidine assays are shown in Table 5.1, and the purine assays in Table 5.2. In
these two tables, we report the ∆E for each sequence measured from each of the
seven assays, averaged from triplicate experiments. We also show the predicted

number of nucleobases that were mathematically calculated from the best-fit
equation previously determined for each particular assay as shown, in Figure 2.3C
for thymine, Figure 2.5 for cytosine permanganate, Figure 2.10C guanine
permanganate, Figure 3.3A for adenosine NaOH cleavage, Figure 3.3B for adenosine

DEPC cleavage, Figure 3.3D for total purines BCA/copper, and Figure 3.3E for

cytidine BCA/copper. For example, the first sequence, 5’AACAG3’, in Table 5.1 gave a

measured ∆E of 1.6 for the thymine-specific assay. This value can be substituted for

y and solved for predicted frequency (x) of thymines in the equation x = (y -

1.32)/7.702), which was extrapolated from the best-fit equation y = 7.702x + 1.32
from Chapter 2, Figure 2.3C. The calculated x value is rounded to the nearest 10th

giving a prediction of 0.0 thymines (TP) for the sequence 5’AACAG3’. In the cytosine-

specific permanganate assay, this same sequence gave a measured ∆E of 5.8. This

number can be substituted for the y value in the equation x = (y – 0.8714)/7.0214),

which was extrapolated from the best-fit equation y=7.0214x+0.8714 in Chapter 2,

Figure 2.5. This calculation predicts 0.7 cytosines (CP), which predicts about one
cytosine base in the sequence 5’AACAG3’. Using the measured ∆E of 20.3 value for

the cytosine-specific BCA/copper assay, the predicted x value equals 1.3 cytosines
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(CB). This value also predicts about one cytosine base in the sequence 5’AACAG3’.

Taken together, the predicted frequency of thymine and cytosine for 5’AACAG3’ is
zero thymines and one cytosine.

Similarly, the measured ∆E values from the guanine, adenine, and purine assays
(Table 5.2) for the sequence 5’AACAG3’ can be used to solve for x in their respective

best-fit equation. These calculations predict 0.3 guanines (GP), 3.1 adenines (AB-N or
AB-D), and a total of 3.3 purines (PB). Thus, the sequence 5’AACAG3’ is predicted to

have approximately one guanine, three adenines, and three to four purines. When

we combine the measured single ∆E values and best-fit equations for each of our

seven assays from the pyrimidine Table 5.1 and the purine Table 5.2, we predict the

base composition of the sequence 5’AACAG’3 to be zero thymines, one cytosine, one

guanine, three adenines, and three or four purines. Since one guanine and three
adenines are predicted, this suggests that the number of purines should be four (not
three). Therefore, we have used a combination of seven colorimetric assays to

correctly predict the frequency of each nucleobase in the sequence 5’AACAG’3.

We illustrate the use of our base composition approach by estimating base

frequency for 17 sequences shown in Table 5.1 and Table 5.2. For each of these

oligomers were estimated base frequency using our colorimetric assays and best-fit
equations. In our example above (5’AACAG3), we demonstrate that the nucleobase

prediction values provide a frequency indicative of the correct frequency of

thymines, cytosines, adenines, and guanines. Considering there are 56 base

composition possibilities for each 5-mer ssDNA, the application of using these

nucleobase-specific CIENA assays to estimate the frequency of each nucleobase
within the DNA oligomer, is remarkably effective. As shown in Tables 5.1 and 5.2,

most of the 5-mer ssDNA sequences examined had accurate prediction of
nucleobase frequency when simple rounding rules are used to get whole base

number predictions. There are however, instances where the prediction of
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nucleobase frequency is less accurate. These predictions are usually within one base
of being accurate, but do not predict correct whole number of bases. For example, in
the thymine-specific permanganate assay, sequences 5’ATGTT3’, 5’CACCC3’, and

5’CCCCC3’ were predicted to have 2.3, 0.5, and 0.6 thymines (TP), respectively. The

actual number of thymines in each of these sequences however is 3, 0, and 0. It is

not too surprising that a 5-mer ssDNA sequence with a high cytosine content would

give a higher than expected ∆E value for thymines, since cytosines also react with
permanganate. For situations like these, we suggest that by combining the results of

all seven assays, we adjust some predictions to accurately estimate the correct
frequency of thymines, cytosine, guanines, and adenines in these oligomers.

To elaborate more on how the combined assays can be used together to increase the

accuracy of base composition prediction, we can evaluate the two cytosine assays
and the two adenine assays. For the cytosine permanganate assay, the 5-mer ssDNA
oligomer 5’AGAGC3’ results in a predicted cytosine frequency of 1.8 (CP). However,

the cytosine BCA/copper assay predicted the oligomer to have a frequency of 1.4

(CB). Because the predicted frequencies for the other bases are 0.0 (TP) for thymine,
1.9 (GP) for guanine, and 1.5 (AB-N) to 2.0 (AB-D) for adenine, and 3.6 (PB) for total
purine (Table 5.1 and 5.2), we can expect this 5-mer ssDNA to have only one

cytosine. A 5-mer ssDNA containing four purines (adenine and guanine) could only

have one pyrimidine (thymine and cytosine). The purine total can also be used to
reason whether the mathematically predictions for guanine and adenine are correct.

5.3.1 Thymine Permanganate CIENA Assay to Estimate Base Composition of
5-mer Single Stranded DNA

The first assay to be applied is the thymine-specific assay. This assay is extremely
beneficial to determining not only the frequency of thymines present, it can also

provide helpful information regarding cytosines and purines. This assay estimated
thymine frequency correctly for 76% of the sequences analyzed in Table 5.1.
Moreover, a benefit to this assay is that it is complete for thymine frequency
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detection within the first 5 minutes, as there is no procedural cleavage step, so the
results can be readily visualized on the same day. By allowing the reaction to

proceed for 40 minutes or longer, however, the color of the reaction is diagnostic of

high purine content. For example, 5’GAAAA3’, remains the same violet purple as the
control (no DNA) even after the next day. In addition, if there are no thymines

present, but there are cytosines present, the reaction will become a shade of orange
over time (data not shown). This is qualitative color information that is helpful in

combination with the other nucleobase frequency predictions when the predicted
frequency is not clear.

5.3.2 Cytosine Permanganate and Cytosine Bicinchoninic Acid/Copper

CIENA Assays to Estimate Base Composition of 5-mer Single Stranded
DNA

The second and third assays to be applied are the cytosine-specific assays using

permanganate and BCA/copper reagents. The cytosine-specific permanganate assay
is easy to perform and provides CIENA analysis on the same day. This assay

estimated the cytosine frequency of 14 sequences within Table 5.1, 86% correctly.

This assay was not used to evaluate three of the sequences within this table because
those sequences contained three or more thymines. However, being dependent on
the number of thymines present in the 5-mer ssDNA, is a limit to this assay,

whereas, the cytosine-specific BCA/copper assay is independent of thymines. The
reason the permanganate assay is dependent on the number of thymines, is that

thymines and cytosines both are oxidized by permanganate at neutral pH; albeit,
thymines are oxidized at a faster rate. Nevertheless, the permanganate cytosine

assay is an informative assay for 5-mer ssDNA oligomers, especially with two or

fewer thymines. Rather, the BCA/copper assay detects the cleaved cytidine-specific

N-glycosidic bond, and therefore, can estimate the cytosine frequency regardless of
the number of thymines present. In the analyses of all 17 sequences listed in Table
5.1, this assay estimated the cytosine frequency 94% correctly. Although the

BCA/copper assay can estimate cytosine frequency independent of thymines, it does
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require a cleavage step, followed by a buffer exchange protocol to remove the excess
hydroxylamine. This protocol requires several days before CIENA analysis can be
performed. Moreover, this assay would likely be better applied to longer DNA

oligomers rather than the 5-mers, due to the required buffer exchange cellulose

tubing size. The cytosine-specific cleavage reactions produce ssDNA fragments of

lower molecular weight than that of the starting 5-mer ssDNA. To remove

hydroxylamine (molecular weight 33 g/mole), nearly any commercially available

molecular weight cut off (MWCO) dialysis tubing would work, but unfortunately the
lowest commercially available MWCO cellulose tubing is 100-500Da. For such a
small oligonucleotide as a 5-mer that contains all cytosines, the hydroxylamine

cleavage step produces low molecular weight fragments of DNA that cannot all be

retained inside the tubing. Therefore, a quantitative analysis for cytosine frequency
within oligomeric DNA would be more reproducible and accurate on longer DNA

strands or for 5-mer ssDNA containing fewer cytosines (less fragmented DNA). This
is exemplified in the CIENA assay for the 5’CCCCC3’oligomer. The cytosine-specific
BCA/copper assay frequency prediction 3.2 (CB) is low. Being aware of this

limitation, however, one can combine the data from the other CIENA assays (purine
specific BCA/copper assay prediction of -0.3 (PB) suggesting zero purines are
present and the cytosine-specific permanganate assay prediction 5.2 (CP),

suggesting five cytosines are present) to estimate the overall base composition of
this particular 5-mer ssDNA.

5.3.3 Guanine Permanganate CIENA Assay to Estimate Base Composition of
5-mer Single Stranded DNA

The fourth assay to be applied is the guanine-specific permanganate assay. This

assay predicted the number of guanines present in each of the 5-mer ssDNA

oligomers tested correctly. There are several advantages to the guanine prediction

value of this assay. This assay produces a spectrum of different colors in a short time
(one minute), which is beneficial in discerning the number of guanines present at

the lower end verses the number of guanines present at the upper end. Moreover,
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the ΔE values between each of the number of guanines present (between zero and
four) is nearly ten ΔE units difference. This sensitivity, along with the information

from the other purine and pyrimdine assays, facilitate base composition prediction
with high confidence; in 15 out of the 17 sequences, guanines were estimated
correctly (88%).

5.3.4 Adenosine –Specific NaOH cleavage and Adenosine-Specific DEPC

cleavage Bicinchoninic Acid/Copper CIENA Assays to Estimate Base
Composition of 5-mer ssDNA Oligomers

The adenosine-assay with NaOH cleavage and the adenosine-assay with DEPC

cleavage BCA/copper both estimated the frequency of adenosines present in 100%
of the 17 sequences evaluated in Figure 5.2. Both reactions require a cleavage step

prior to the addition of freshly prepared BCA/copper colorimetric reagent, however,
these incubation times are short (3 hours for NaOH cleavage and 90 minutes for

DEPC cleavage). Therefore, CIENA analysis can still be performed on the same day of
the experiment. In addition, adding the predicted adenosine frequency with the

predicted guanine frequency, these combined results provide the total number of
purines within the nucleic acid oligomer. Moreover, this simple mathematical

addition can be confirmed within one nucleobase accuracy using the total purine
bicinchoninic acid/copper CIENA assay.

5.3.5 Total Purine Bicinchoninic Acid/Copper CIENA Assay to Estimate
Base Composition of 5-mer Single Stranded DNA

The last assay is the purine-specific BCA/copper assay which can be used to confirm
the sum total of purines from both the guanine and adenine assays. If the purine-

specific assay and the summed total of the guanine and adenine assays are equal,

then the purine predicted content should be accurate. This assay predicted 71% of
the 17 sequences analyzed in Table 5.2. In addition, four of the five sequences that
were estimated incorrectly were only underestimated by a single purine

nucleobase. Moreover, this assay serves two important roles; one, it confirms the
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adenine and guanine assay predictions are correct, and two, if the sum of the

adenine (AB-N) and guanine (GB) assays equal the purine assay predictions (PB), then
this assay reveals the number of remainder bases, which are the total pyrimidine
(i.e. thymine and cytosine) count.
5.4

Results and Discussion for Five CIENA Assays to Estimate Base

Composition of Four Unknown 5-mer Single Stranded DNA Samples

Developing each of the colorimetric assays for the identity and nucleobase

frequency determination within a 5-mer single stranded DNA required taking
known sequences of oligomers and mathematically calculating their color

differences from the control (no DNA) sample to establish a correlation. This data
was compiled in tables throughout Chapters 2 and 3. However, in order to fully

understand the futility of this application, a blind study on unknown 5-mer ssDNA

samples was performed. Four samples containing enough material to run five of the
seven colorimetric assays evaluated in Tables 5.1 and 5.2 (thymine-permanganate,
guanine-permanganate, adenosine-assay with NaOH cleavage, cytidine-

bicinchoninic acid/copper, and total purine-bicinchoninic acid/copper assays) were
utilized for base composition prediction. Each assay, except the cytidine-

bicinchoninic acid/copper, used calibration curves generated during the same
experiment to generate best fit curves (equations), in which, the nucleobase

frequency could be mathematically estimated. Same day calibration curves were my
preference simply to use the same lot/batch of reagents for each assay. This is not
necessarily needed. Due to the limited number of plastic dialysis tubing clips

required for the buffer exchange protocol in the cytidine-bicinchoninic acid/copper

assay, our laboratory was limited in number of samples that could be evaluated in a
single experiment, therefore, the cytidine bicinchoninic acid/copper assay graph in
Chapter 3, Figure 3.3E provided the needed mathematical equation for cytosine

estimation. The mathematical equation is shown in Table 5.1 which was used to

estimate the frequency of cytidines within the unknown 5-mer ssDNA samples. In

addition, each experiment followed the material and methods procedures listed in
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the previous Chapters 2 and 3. The L*, a*, b* values generated for the controls (no
DNA) and 5-mer ssDNA sequences used in the calibration curves can be found in
Tables 5.3 and 5.4. All unknown samples were tested in triplicate.

Table 5.3. Average L*, a*, b*, and ∆E values for calibration 5-mer ssDNAs
and unknowns in the pyrimidine assays (thymine and cytidine).

Nucleobase
Sequences
L* value
a* value
b* value
∆E Value
Frequency
Thymine Permanganate Calibration Curve and Unknowns A, B, C, and D
(Supporting Figure 5.1)

Control (no DNA)
0 Thymines

GGAGG

2 Thymines

CTCTC

1 Thymines
3 Thymines
4 Thymines

Unknown A
Unknown B
Unknown C

Unknown D

CATGC

ATGTT
TTGTT

51.3 ± 0.6

80.3 ± 0.6

-27.3 ± 0.6

51

70

3

49

26

1.5
7.8
14.2
16.8
19.1

80.0± 0.0

-24.7 ± 2.1

0.6 ± 0.6

81.3 ± 1.2

-27.3 ± 1.5

0.6 ± 0.1

77

60
61

53

19

48

31

51

63

51.3 ± 0.6
55.0 ± 1.0

70.7 ± 1.5

53.0 ± 0.0

82.0 ± 0.0

52.0 ± 1.0

-23

-0.3 ± 0.6

-21.3 ± 1.5

6.7 ± 0.3

Cytidine Bicinchoninic Acid/Copper Assay for Unknowns A, B, C, and D
(Supporting Figure 5.2)

Control (no DNA)

89.3 ± 0.6

-8.3 ± 0.6

9.3 ± 1.2

Unknown B

66.3 ± 1.2

20.7 ± 2.1

-13.3 ± 3.2

Unknown A
Unknown C

80.0 ± 1.7

1.7 ± 2.1

80.7 ± 2.5

1.0 ± 4.0

1.6 ± 0.3

0.0 ± 0.2

13.5 ± 5.0

0.7 ± 2.3

13.1 ± 8.0

38.5 ± 0.7

Unknown D
63.3 ± 6.4
23.7 ± 8.1
-17.0 ± 4.4
40.5 ± 4.7
Each value is the average of three independent assays except for the thymine permanganate assay 5-mer
ssDNA sequences used for the calibration curve where one replicate was used.
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Table 5.4. Average L*, a*, b*, and ∆E values for calibration 5-mer ssDNAs
and unknowns in the purine assays (guanine, adenosine, and total purine).

Nucleobase
Sequences
L* value
a* value
b* value
∆E Value
Frequency
Guanine Permanganate Calibration Curve and Unknowns A, B, C, and D
(Supporting Figure 5.3)

Control (no DNA)
0 Guanines

59.3 ± 0.6

50.0 ± 2.0

22.0 ± 1.7

14.8 ± 0.6

29.3 ± 1.2

43.0 ± 3.6

27.3 ± 1.1

47.7 ± 0.6

31.4 ± 0.4

AGAGC

65.3 ± 1.5

3 Guanines

GTGGC

Unknown A

-25.7 ± 1.2

60.0 ± 1.7

AACAG

4 Guanines

79.0 ± 1.7

CCTCC

1 Guanines
2 Guanines

53.3± 0.6

GGAGG

Unknown B

65.0 ± 4.4
32.3 ± 3.2

66.3 ± 1.2
67.3 ± 2.9

24.0 ± 4.6

66.7 ± 1.5

22.0 ± 1.0

56.0 ± 1.0

Unknown C

65.7 ± 4.0

59.3 ± 4.2

Unknown D

-6.7 ± 1.5

41.0 ± 5.0
47.3 ± 5.0
-5.7 ± 0.6

55.3 ± 8.3

12.3 ± 5.1

84.7 ± 2.5

1.0 ± 1.0

-2.0 ± 1.0

77 ± 1.0

11.0 ± 1.0

-9.7 ± 2.3

57.3 ± 2.5

36.7 ± 3.8

57.7 ± 1.2

54.3 ± 3.1

17.0 ± 1.7

5.5 ± 0.6

25.2± 1.8

30.6 ± 3.0
5.2 ± 0.4

11.2 ± 2.6
12.5 ± 0.9

Adenosine Assay with NaOH Cleavage Calibration Curve and Unknowns A, B, C, and D
(Supporting Figure 5.4)

Control (no DNA)
0 Adenines

TTGTT

1 Adenine

GGAGG

3 Adenine

AACAG

2 Adenine
4 Adenine

Unknown A

83.3 ± 1.5

AGAGC

70.7 ± 2.1

AATAA

59.7 ± 4.7

Unknown B

2.3 ± 3.1

Unknown D

3.2 ± 2.2

20.3 ± 2.1

-17.0 ± 1.0

15.5 ±1.4

35.0 ± 4.6

-27.3 ± 3.5

77.7 ± 5.0

-15.0 ± 1.7

59.3 ± 5.5

32.0 ± 6.1

73.7 ± 3.8

Unknown C

-3.3 ± 1.5

15.7 ± 2.3

82.3 ± 1.5

4.7 ± 1.2

9.6 ± 2.3

-29.0 ± 3.6

25.4 ± 1.4

-12.0 ± 1.0

12.2 ± 1.1

-12.3 ± 1.2
-24.7 ± 3.8
-3.7± 0.6

23.8 ± 2.2
12.7 ± 2.0
24.0 ± 3.0
3.9 ± 0.7

Total Purine Bicinchoninic Acid/Copper Assay Calibration Curve and Unknowns A, B, C, and
D (Supporting Figure 5.5)
Control (no DNA)
0 Purines
1 Purine

CCTCC

TTGTT

2 Purine

GATGC

4 Purine

AACAG

3 Purine
5 Purine

Unknown A
Unknown B
Unknown C

GTGGC

GGAGG

51.3 ± 0.6

80.3 ± 0.6

56.3 ± 5.0

19.0 ± 5.6

45.7 ± 1.5

32.7 ± 1.2

74.0 ± 1.0

-4.7 ± 3.1

43.3 ± 4.0
40.7 ± 5.0
33.0 ± 5.3
45.7 ± 4.2

16.0 ± 2.6
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-25.0 ± 1.0

44.0 ± 3.1

-28.3 ± 3.1

31.3 ± 4.2

Unknown D
59.3 ± 1.2
Each value is the average of three independent assays.

35.6 ± 2.0

36.7 ± 4.2
5.7 ± 1.2

7.8 ± 3.7

16.7 ± 4.5

-26.3 ± 3.2

37.3 ± 0.6

65.3 ± 0.6

-0.3 ± 2.1

34.0 ± 5.0
38.7 ± 2.5

36.3 ± 0.6

-27.3 ± 0.6

-30.0 ± 2.0
-29.7 ± 1.2
-8.0 ± 1.0
-5.7 ± 2.9

-15.0 ± 1.7

45.4 ± 4.1
47.7 ± 3.1

55.0 ± 4.7
49.1 ± 0.5
23.7 ± 1.5
41.2 ± 3.1
32.1 ± 1.3

The first experiment estimated the thymine frequency within the unknown samples
labeled A, B, C, and D shown in Figure 5.1. A calibration curve (Figure 5.1A) and

representative color swatches (Figure 5.1B) using the 5-mer ssDNA sequences listed
in Figure 5.1B, provided the needed information to estimate thymine frequency

within the unknown DNA samples. The linear equation generated was y=4.42x+3.04
with a correlation factor of R2 = 0.9479, in which the measured ∆E values (Figure

5.1B) from the unknown sample images (Figure 5.1B) were entered for the y value

and solved for x, frequency of thymines (x=y-3.04/4.42) to mathematically provide

an estimated value rounded to the nearest 10th place (Tp). For unknown A, this value
was -0.5 (zero thymines), unknown B was 0.8 (one thymines), unknown C was -0.6
(zero thymines), and unknown D was -0.3 (zero thymines). Due to the larger

differences in ∆E values for 5-mer ssDNAs containing 0-2 thymines as compared to

3-5 thymines, the lower range predictions (number of thymines ≤ 2 provide a more
accurate prediction).
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A
Thymine Permanganate
Calibration Curve
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B

y = 4.42x + 3.04
R² = 0.9479
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A,C,D

0
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4

5

Thymine Frequency
Control

GGAGG

CATGC

CTCTC

ATGTT

TTGTT

∆E

1.5

7.8

14.2

16.8

19.1

B

Control

Unknown
A

Unknown
B

Unknown
C

Unknown
D

∆E

0.6 ± 0.6

6.7 ± 0.3

0.6 ± 0.1

1.6 ± 0.3

TP

-0.5

0.8

-0.6

-0.3

Figure 5.1. CIENA analysis prediction of thymine frequency in unknown 5mer ssDNA. Panel A: A thymine permanganate calibration curve was
generated using the 5-mer ssDNA oligomers in the represented color
swatches. There was no standard deviation associated with these ΔE values
as only one assay was performed. The ΔE values for each of the unknown
samples are indicated along the graph. Panel B: Results of a control (no
DNA) and unknowns A, B, C, and D illustrating the visual color for each and
its average color change (ΔE) value. Each control and unknown sample was
performed in triplicate.
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The cytosine frequency for each unknown sample was evaluated using the cytidinebicinchoninic acid/copper assay. In Figure 5.2A, the color swatches from Figure 3.2
Panel E and the graph from Figure 3.3E were reproduced here to provide the

polynomial equation y=-2.593x2+21.093x+1.9936, in which the ∆E values from the

unknown experiments (Figure 5.2B) were entered in for y and solved for frequency
of cytosines, x, where x = [-21.093 + SQRT{(21.093*21.093) – (4* -2.593*(1.9936–
y))}]/(2*-2.593). This assay estimated the frequency of cytosines (CB) for each

unknown A, B, C, and D, to be 0.6 (one cytosines), 2.5 (three cytosines), 0.6 (one
cytosines), 2.8 (three cytosines), respectively.
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A
Cytosine Bicinchoninic Acid/Copper Assay
Calibration Curve
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y = -2.593x2 + 21.093x + 1.9936
R² = 0.9908

10
C

0
0

1
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3

4

5

Cytosine Frequency
Control

TTTTT

∆E

2.5 ± 1.0

GAGAC

CGATC

CATCC

CACCC

CCCCC

18.6 ± 7.8 32.8 ± 1.3 40.9 ± 0.8 47.4 ± 9.6 41.2 ± 2.8

B

Control

Unknown
A

Unknown
B

Unknown
C

Unknown
D

∆E

13.5 ± 5.0

38.5 ± 0.7

13.1 ± 8.0

40.5 ± 4.7

CB

0.6

2.5

0.6

2.8

Figure 5.2. CIENA analysis prediction of cytosine frequency in unknown 5mer ssDNA.. Panel A: A cytosine bicinchoninic acid/copper calibration
curve from Figure 3.3E is reproduced to provide the polynomial equation to
solve for cytosine frequencies within the unknown samples The
representative color swatches were also reproduced from Figure 3.2 Panel
E for a visual color analysis of the unknowns. The location of the ΔE values
for each of the unknown samples are indicated along the graph. Panel B:
Results of a control (no DNA) and unknowns A, B, C, and D illustrating the
visual color for each and its average color change (ΔE) value. Each control
and unknown sample was performed in triplicate.
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The guanine frequency for each unknown sample was evaluated using the guaninepermanganate assay. For this assay, a calibration curve was generated as shown in
Figure 5.3A to produce a polynomial equation y=-1.45x2+12.07x+5.24 with a

correlation factor of .9881, in which the resultant ∆E values of the unknown samples

A, B, C, and D (Figure 5.3B) were entered in for y and solved for guanine frequency, x
(x = [-12.07 + SQRT{(12.07*12.07) – (4* -1.45*(5.24–y))}]/(2*-1.45)) to provide an
estimate (GP) of 3.7 (four guanines), 0.0 (zero guanines), 0.5 (zero or one guanine),

and 0.7 (one guanine), respectively. Sequences with a large number of adenines can
give a larger ∆E value in this assay than sequences without adenines. Therefore,

estimates such as 0.5 guanine need to be rounded with caution such as taking into
consideration the adenine assay data.
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Guanine Permanganate
Calibration Curve
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B

Control

Unknown
A

Unknown
B
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C
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D
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11.2 ± 2.6

12.5 ± 0.9
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3.7

0.0
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Figure 5.3. CIENA analysis prediction of guanine frequency in unknown 5mer ssDNA. Panel A: A guanine permanganate calibration curve was
generated using the 5-mer ssDNA oligomers in the represented color
swatches. The plotted average ΔE values are the result of three individual
experiments. The location of the ΔE values for each of the unknown samples
are indicated along the graph. Panel B: Results of a control (no DNA) and
unknowns A, B, C, and D illustrating the visual color for each and its average
color change (ΔE) value. Each control and unknown sample was performed
in triplicate.
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Adenosine frequency for each unknown sample was evaluated using the adenosine
assay with NaOH cleavage. A calibration curve was generated using the 5-mer

ssDNA sequences (assays performed in three independent experiments) shown

along with their representative color swatches in Figure 5.4A. A polynomial best-fit
equation y=-0.8571x2+9.1286x+2.3857, with a correlation factor of 0.9495 (Figure
5.4B), was produced to mathematically estimate the frequency of adenosines

present within the unknown samples (Figure 5.4B). The resultant average ∆E

values from the unknown experiments (Figure 5.4B) were entered in for y and

solved for frequency of adenines, x, where x = [-9.1283 + SQRT{(9.1286*9.1286) –

(4* -0.8571*(2.3857–y))}]/(2*-0.8571). Thus, the x values for each unknown

sample A, B, C, and D (Figure 5.4B) gave a predicted value of adenines (AB-N) of 1.3
(one adenine), 1.4 (one adenine), 3.0 (three adenines), and 0.2 (zero adenines),

respectively.
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Adenosine Assay with NaOH Cleavage
Calibration Curve
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3.9 ± 0.7
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1.3
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Figure 5.4. CIENA analysis prediction of adenosine frequency in unknown
5-mer ssDNA.. Panel A: An adenosine assay with NaOH cleavage calibration
curve was generated using the 5-mer ssDNA oligomers in the represented
color swatches. The plotted average ΔE values are the result of three
individual experiments. The location of the ΔE values for each of the
unknown samples are indicated along the graph. Panel B: Results of a
control (no DNA) and unknowns A, B, C, and D illustrating the visual color
for each and its average color change (ΔE) value. Each control and unknown
sample was performed in triplicate.
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Total purine frequency for each unknown sample was evaluated using the total

purine-specific BCA/copper assay. A calibration curve was generated using the 5-

mer ssDNA sequences (assays performed in three independent experiments) shown
along with their representative color swatches in Figure 5.5A. The calibration using
5-mer ssDNA sequences provided a polynomial best-fit equation y=-

1.7013x2+16.414x+12.493, with a correlation factor of 0.9142. The resultant

average ∆E values from each of the unknown samples A, B, C, and D were put in for y
and solved in terms of x (frequency of purines) in the following equation, x = [-

16.414 + SQRT{(16.414*16.414) – (4* -1.7013*(12.493–y))}]/(2*-1.7013). The

mathematical solutions for each unknown sample A-D provided an estimate of total

purines within the oligomeric DNA, (PB) of 3.5 (four purines), 0.7 (one purine), 2.3

(two purines), and 1.4 (one purine), respectively. Conventional rounding rules were
applied to provide whole number purine values in parenthesis.
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A
Total Purine Bicinchoninic Acid/Copper Assay
Calibration Curve
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Figure 5.5. CIENA analysis prediction of purine frequency in unknown 5mer ssDNA. Panel A: A total purine assay calibration curve was generated
using the 5-mer ssDNA oligomers in the represented color swatches. The
plotted average ΔE values are the result of three individual experiments.
The location of the ΔE values for each of the unknown samples are
indicated along the graph. Panel B: Results of a control (no DNA) and
unknowns A, B, C, and D illustrating the visual color for each and its average
color change (ΔE) value. Each control and unknown sample was performed
in triplicate
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The combination of the five colorimetric assays applied to the unknown samples
were compiled in Table 5.5 to predict the overall base composition of each of

unknowns (A, B, C, and D). The predicted values from Figures 5.1B-5.5B are listed

within this table. Combining all five assays for such an application of predicting the
overall base composition within an oligonucleotide required a particular strategy.
This strategy is required for several of the following reasons. One, in a base

composition prediction, each base is a discrete number. For example, there is either

one thymine or zero thymines, but never 0.7 thymines as the mathematical equation
estimates thymine frequency in the unknown sample B. Second, each assay, except

the thymine-specific assay, produced a polynomial best-fit correlation equation

used for the estimation of specific nucleobase frequencies. For this reason, the lower

predicted values tend to be more accurate (more linear portion of the curve which is
best for the prediction of concentrations or in our case nucleobase frequencies).

Therefore, to use the compilation of the estimated nucleobases from each assay, the
following strategy/logic was applied to make an overall base composition

prediction. First, the assumption that there exists, exactly five nucleobases within

the unknown ssDNA oligomer. Second, a predicted mathematical value of two or less
(the more linear portion of the polynomial curves) is considered correct and

therefore, the predicted number is rounded to the nearest whole number to assign a
predicted nucleobase value for that particular assay. And third, the assigned

nucleobases are then subtracted from the total nucleobases present (in this case

five), to adjust the predicted value for any nucleobase that is greater than two (since
this is within the polynomial portion of the calibration curves). For example, this

strategy applied to unknown A, predicted zero thymines (-0.1), one cytosine (0.6),

and one adenine (1.3) for the assigned number nucleobases within the 5-mer ssDNA
oligomer. This total of assigned number of nucleobases (those that produced a
predicted value mathematically of two or less), two, subtracted from five (five

nucleobases within a 5-mer ssDNA), leave three unassigned nucleobases. Looking at
Table 5.3, unknown A, the guanines have yet to be assigned a number because a 3.7

value is greater than two which makes the guanine frequency nucleobase prediction
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within the polynomial portion of the curve. For this reason, the number of

unassigned nucleobases (three) is assigned to the guanine frequency. Therefore, the
3.7 predicted value is estimated to be three rather than four. Combining the now

assigned nucleobases to unknown sample A, the predicted base composition is 0T,

1C, 3G, and 1A. This predicted base composition was confirmed to be correct and the

correct sequence is 5’-GCGAG-3’.

The same base prediction strategy was applied to unknowns B, C, and D. For B, 0.7
thymine frequency predicts one assigned thymine; 0.0 guanine frequency predicts

zero guanines; 1.4 adenine frequency, predicts one adenine to provide two assigned
nucleobases. Subtracting the assigned nucleobases from five nucleobases, produces
three unassigned nucleobases. Looking at Table 5.3, unknown B cytosine frequency

of 2.5 (greater than two), this number of predicted cytosines is therefore adjusted to
three to provide a base composition estimation of 1T, 3C, 0G, and 1A. This overall

base composition prediction, was shown to be correct with a sequence of 5’-CATCC3’. This strategy applied to unknown D predicted the base composition of 0T, 4C, 1G,
and 0A, which was confirmed correct as well (correct sequence for unknown D was

5’- CGCCC-3’). However, unknown C was predicted on a second trial as the first

estimated base composition was not entirely correct. Applying the same strategy to

unknown C, predicts zero thymines (-0.1), one cytosine (0.6), and one guanine (0.5)

for the assigned nucleobases. Subtracting two assigned nucleobases from the 5-mer,
produces three unassigned nucleobases. Since the adenine frequency is predicted at
3.0, my base composition prediction was 0T, 1C, 1G, and 3A. This however, was

incorrect. Given a second trial prediction, I rounded the guanine frequency to zero

(0.5) since the adenine assay gave a large ∆E value (the guanine assay with zero to
one guanines give a higher ∆E value in the presence of adenines), and applied the
same strategy which adjusts the adenine frequency from three to four, giving the
predicted base composition 0T, 1C, 0G, and 4A. The second trial prediction was

confirmed correct with a sequence 5’-AACAA-3’.
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Table 5.5 Predicted base composition of unknown A, B, C, and D samples based on
nucleobase frequencies (T, C, G, A, and total purines).
Unknowns

A

B

C

D

Thymine Frequency

-0.1

0.7

-0.1

0.2

Adenine Frequency
Total Purine
Frequency
Sum of Adenines and
Guanines
Sum of the Predicted
Nucleobases
Predicted Base
Composition
Actual Sequence

1.3

1.4

3.0

0.2

Cytosine Frequency
Guanine Frequency

0.6
3.7
4.0
5.0
5.5

0T, 1C, 3G,
1A
5’-GCGAG-3’

2.5
0.0
1.4
1.4
4.6

1T, 3C, 0G,
1A
5’-CATCC-3’

0.6

2.8

0.5

0.7

3.2

2.3

3.5
4

0T, 1C, 1G, 3A
5’-AACAA-3’*

0.9
3.9

0T, 4C, 1G,
0A
5’-CGCCC-3’

*This base composition (0T, 1C, 0G, and 4A) was predicted correctly on the second
trial. On the second trial, the 0.5 guanine frequency was rounded down to zero
guanines rather than up, to one guanines.

In addition, the comparison of the mathematical sum of adenines and guanines to

the total purine frequency from the purine BCA/copper assay are informative when
predicting the overall base composition. For unknown A, this 5-mer ssDNA,

obviously contained a larger frequency of purines, as the sum of the adenines and
guanines were 5.0 from the combined assays, and the total purine BCA/copper

assay indicated a high number of purines (4.0). Unknown B, totals of the adenine

and guanine frequency (1.4) equaled the total purine BCA/copper assay. This was
correct as 5’-CATCC-3’ contains only one purine in its base composition.

Futhermore, unknown C, indicated three or four purines to be present within the
unknown as a reasonable estimate. And unknown D, indicated either one or two
purines present. This information is great for evaluating the overall base
composition predictions and to ensure that the assays are accurate.
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5.5

Conclusions of Combined CIENA Assays to Estimate Base Composition
of 5-mer Single Stranded DNA

In this chapter, we have demonstrated how a panel of seven (or even just five)

colorimetric assays can be used to quantify the number of thymines, cytosines,

guanines, adenines, and total purines in 5-mer ssDNAs. The first part of this chapter
compiled 17 5-mer ssDNA sequences through seven nucleobase-specific

colorimetric assays to provide a way to predict/estimate the identity and frequency
of each nucleobase within the DNA oligomer. The guanine-permanganate assay

predicted the frequency of guanines 84% correctly. The adenosine assay with NaOH
cleavage and adenosine assay with DEPC cleavage predicted all the adenine

frequencies within the 17 sequences correctly. The thymine permanganate assay
predicted 76% of the frequency of thymines within the 17 sequences, and the

cytidine BCA/copper assay predicted 94% of the cytosine frequencies accurately. In
addition , five of these nucleobase-specific assays were tested on four unknowns to
predict the base composition of each nucleobase 90% accurately (four unknowns,
each with 5 nucleobases each gives a total of 20 nucleobases; 18 out of 20 were

predicted correctly in Table 5.5). This is a proof-of-concept application, where the
base composition of DNA oligomers were predicted using colorimetric assays,

digital image capture, CIELAB and ∆E color analyses techniques (CIENA).

Furthermore, this approach could be used by itself or with established spectroscopy
methods (MS, UV, HPLC) for prediction of base composition of an unknown DNA
oligmer. Nevertheless, an approach to estimate DNA base compositions was

established and implemented in this report. It is beneficial that these assays are

relatively inexpensive and applicable to a variety of laboratory and non-laboratory

settings.
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Chapter 6

Future Directions

This chapter discusses several future directions for the CIENA assays. All potential
projects are preliminary data that I have generated in the laboratory. These future
directions include one, the application of base composition 5-mer ssDNA CIENA

assays to longer ssDNA sequences (i.e. 20-mer ssDNA). Another specific direction,

two, includes exploring other potential chromophores that did not work out for the
5-mer ssDNA base composition application, but, may be of use in other nucleic acid
colorimetric applications. Also included is future direction, three, exploring the
potential of using the BCA/copper assay for the detection of abasic sites within
ssDNA.

6.1

Future Direction I: Obtaining Base Composition for longer DNA
Sequences

Testing CIENA assays for use in different lengths of DNA sequences is an important
next step in assessing the utility of these assays. The assays optimized for the

monomeric and 5-mer ssDNA oligomers outlined in Chapter 2 and 3 were applied to
20-mer ssDNA sequences to generate the preliminary data shown here. Of the

assays, the permanganate thymine-specific assay (Table 6.1 and Figure 6.1), the
BCA/copper cytidine-specific assay (Table 6.1 and Figure 6.2), the adenosinespecific NaOH cleavage BCA/copper assay (Table 6.3 and Figure 6.3), and the

BCA/copper purine-specific assay (Table 6.4 and Figure 6.4) appear to successfully

colorimetrically quantify each nucleobase of interest when applied to longer ssDNA
(i.e. 20-mer single-stranded DNA oligmers). There is a linear correlation for the

increase in frequency of specific nucleobases frequency with the difference between
the sample relative to the control (no DNA) in the assays. In the future, performing
the experiment on a larger set of 20-mer ssDNA as well as on varying lengths of
ssDNA oligomers should be explored to generate more accurate formulas for
predicting base composition for longer ssDNA oligomers.
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6.1.1 Materials and Methods for Future Direction I

This section of the chapter includes references and modifications of five CIENA

assay materials and methods sections from chapter 2 (permanganate reactions) and
Chapter 3 (bicinchoninic acid/copper reactions). The five CIENA assays used to
evaluate whether CIENA assays can be applicable to 20-mer ssDNA include the
following: thymine assay (Section 2.4), adenosine assay with NaOH cleavage
(Section 3.5), adenosine assay with DEPC cleavage (Section 3.5), cytidinebicinchoninic acid/copper assay (Section 3.5), and purine-bicinchoninic

acid/copper assay (Section 3.5). Both guanine assays (permanganate and

BCA/copper) were performed (data not shown), but were not predictive of guanine
frequency and therefore are not included in this chapter. The 20-mer ssDNA

sequences used in the study were purchased from Integrated DNA Technologies
(Coralville, IA) and can be found in Tables 6.1, 6.2, 6.3, 6.4, and 6.5.

Table 6.1. Average L*, a*, b*, and ∆E values for thymine-specific permanganate
assay of 20-mer DNA.
#
Thymines
Control
0
3
5
10

Sequences

No DNA
GAAAGGAGAGAAGGAAGAAA
GTGGGAGGTGGTGCGGAAGA
GTTAATAGCACTCGAATACAG
TTCCTCTCTCTTCTCCTCCT

L* value

56.0 ± 0.0
55.0 ± 0.0
57.0 ± 0.0
63.0 ± 2.6
73.7 ± 1.2

a* value

86.0 ± 0.0
85.0 ± 0.0
76.7 ± 0.6
54.3 ± 4.9
22.0 ± 1.7

b* value

-25.0 ± 0.0
-24.7 ± 1.5
-5.0 ± 1.0
21.3 ± 1.2
43.3 ± 1.2

Average ΔE

1.1 ± 0.1
7.9 ± 0.2
22.0 ± 1.7
47.2 ± 1.6

Each value is the average of three independent assays. ∆E is the quantitative measure of the difference in color
between DNA-containing samples and no-DNA control samples.

Table 6.2. Average L*, a*, b*, and ∆E values for cytidine-specific BCA assay of 20mer DNA.
#
Cytosines
Control
0
1
4
10

Sequences

No DNA
GAAAGGAGAGAAGGAAGAAA
GTGGGAGGTGGTGCGGAAGA
GTTAATAGCACTCGAATACAG
TTCCTCTCTCTTCTCCTCCT

L* value

96.0 ± 1.0
94.0 ± 0.0
86.0 ± 1.0
69.7 ± 1.5
43.0 ± 8.7

a* value

-9.7 ± 0.6
-8.7 ± 0.6
1.7 ± 2.9
25.0 ± 4.4
50.3 ± 4.0

b* value

9.0 ± 1.0
8.0 ± 1.0
0.0 ± 2.6
-17.0 ± 3.6
-34.7 ±5.7

Average ΔE

1.7 ± 0.7
13.9 ± 6.1
41.3 ± 0.4
60.5 ± 6.1

Each value is the average of three independent assays. ∆E is the quantitative measure of the difference in color
between DNA-containing samples and no-DNA control samples.
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Table 6.3. Average L*, a*, b*, and ∆E values for adenosine-specific NaOH cleavage of
20-mer DNA.
#
Adenines
Control
0
4
8
12

Sequences

No DNA
TTCCTCTCTCTTCTCCTCCT
GTGGGAGGTGGTGCGGAAGA
GTTAATAGCACTCGAATACAG
GAAAGGAGAGAAGGAAGAAA

L* value

88.3 ± 1.2
89.3 ± 0.6
85.0 ± 0.0
79.7 ± 0.6
76.3 ± 1.5

a* value

0.7 ± 0.6
4.0 ± 1.0
11.7 ± 1.2
19.3 ± 1.2
25.3 ± 2.5

b* value

-2.3 ± 1.5
-4.0 ± 2.6
-9.7 ± 0.6
-14.7 ± 2.3
-18.7 ± 2.5

Average ΔE
1.5 ± 0.4
5.6 ± 1.2
10.4 ± 0.7
13.3 ± 1.5

Each value is the average of three independent assays. ∆E is the quantitative measure of the difference in color
between DNA-containing samples and no-DNA control samples.

Table 6.4. Average L*, a*, b*, and ∆E values for adenosine-specific DEPC cleavage of
20-mer DNA.
#
Adenines
Control
0
4
8
12

Sequences

No DNA
TTCCTCTCTCTTCTCCTCCT
GTGGGAGGTGGTGCGGAAGA
GTTAATAGCACTCGAATACAG
GAAAGGAGAGAAGGAAGAAA

L* value

91.7 ± 0.6
90.3 ± 1.5
74.3 ± 0.6
68.0 ± 1.7
55.3 ± 0.6

a* value

-13.3 ± 0.6
-9.0 ± 0.0
16.7 ± 0.6
24.0 ± 4.4
43.0 ± 1.0

b* value

7.0 ± 1.0
3.7 ± 0.6
-12.7 ± 0.6
-18.0 ± 2.6
-28.7 ± 0.6

Average ΔE
1.8 ± 0.3
29.9 ± 0.4
33.0 ± 0.6
40.2 ± 0.6

Each value is the average of three independent assays. ∆E is the quantitative measure of the difference in color
between DNA-containing samples and no-DNA control samples.

Table 6.5. Average L*, a*, b*, and ∆E values for purine-specific cleavage of 20-mer
DNA.
#
Purines
Control
0
12
16
20

Sequences

No DNA
TTCCTCTCTCTTCTCCTCCT
GTTAATAGCACTCGAATACAG
GTGGGAGGTGGTGCGGAAGA
GAAAGGAGAGAAGGAAGAAA

L* value

92.0 ± 1.0
87.7 ± 0.6
78.3 ± 1.5
75.3 ± 1.5
72.3 ± 0.6

a* value

-12.0 ± 5.2
-13.3 ± 1.2
0.7 ± 0.6
6.0 ± 1.0
11.7 ± 1.2

b* value

15.3 ± 0.6
6.0 ± 1.0
-5.0 ± 0.0
-7.7 ± 0.6
-12.3 ± 0.6

Average ΔE
1.6 ± 0.9
15.5 ± 2.9
23.9 ± 2.4
29.1 ± 1.8

Each value is the average of three independent assays. ∆E is the quantitative measure of the difference in color
between DNA-containing samples and no-DNA control samples.
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6.1.2 Modifications to CIENA Assays for 20-mer Oligonucleotides

All the selective cleavage methods from Chapter 3 remained the same, including

using 1 mM of 20-mer ssDNA in the assays. All concentrations of permanganate and
bicinchoninic acid/copper solutions remain the same as the methods in chapters 2

and 3. After chemical cleavage of cytosine within the 20-mer DNA oligomers, excess
hydroxylamine was removed by a buffer exchange protocol that involves

transferring samples to 500-1000 Da MWCO dialysis tubing, followed by placing

each in 1 L solutions (0.3 M sodium phosphate pH 7 for 24 hours then 0.2 M sodium

phosphate pH 7 for 24 hours and finally 0.1 M sodium phosphate pH 7 for 24 hours)
with slight stirring at room temperature. The image capture time period in the

CIENA protocols were modified from 5 minutes to 15 minutes for the thymine assay
however, the constants, kL, kC, and kH in the ΔE equation remained the same. For the

CIENA analysis in these experiments, the permanganate reactions were allowed to
incubate at room temperature 15 minutes. The BCA reaction was allowed to

incubate at room temperature for 1 minute for the adenosine assay with NaOH

cleavage, 20 minutes for the adenosine assay with DEPC cleavage, 1 minute for the

cytidine assay, and 40 minutes for the purine assay, at which time a digital image of
each solution was captured (examples shown in Figures 6.1-6.5).

Adobe Photoshop was then used to compute the L*, a*, and b* values for each color-

calibrated image (L*, a*, b* values with standard deviation or each 20-mer ssDNA

samples measured in three independent experiments are provided in Tables 6.1,

6.2, 6.3, 6.4, and 6.5). These values were then inserted into the color change (ΔE)
equation (Appendix I (20)) to quantify the color relative to a no-DNA control

sample. A control was run for each sample in triplicate used to generate the ΔE

which is shown in the tables above not shown. The constants, kL, kC, and kH, in the

ΔE equation (Appendix I) were set to 1, 1.5, and 1, respectively in the bicinchoninic

acid/copper assay and 2.5, 1.5, and 1.5 respectively in the permanganate assays. The
constants are weight factors used within the ΔE equation and are application

specific. Therefore, these constants are optimized for each assay depending on the
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differences within the difference of the L*, a*, b* values. For example, within the
bicinchoninic acid/copper assay, the color remains similar (shades of violet)

between samples of varying number of specific nucleobases greater than one.

Therefore, the L* value changes the most between samples containing varying

numbers of specific nucleobases being evaluated. Within the permanganate assay,
the chroma parameter, b*, varies the most between samples depending on the

number of specific nucleobases being measured. In addition, all data shown are the
compilation of at least three independent experiments.

6.1.3 Results for Obtaining Base Composition for Longer DNA Oligomers

In this report, we show preliminary data that when compared to control (no DNA)
reactions, the ∆E value can be used to measure the identity and frequency of

thymines, adenosines, cytidines, and total purines in 20-mer ssDNA polymers.
Future experiments to evaluate and optimize conditions (such as DNA

concentrations and image capture times) on a larger set of 20-mer ssDNA oligmers
of varying sequences through all five of the colorimetric assays could possibly
provide a colorimetric base composition approach to longer ssDNAs such as

primers. In addition, new colorimetric assays for guanosine would need to be

developed because the longer 20-mer ssDNA oligomers did not show a colorimetric
correlation for the standard guanosine-specific assays (data not shown). This could
be due to secondary structure forming within the guanosine-specific BCA

colorimetric assay. Moreover, the guanine-specific permanganate assay for longer

strands of DNA is limited by a large amount of colorimetric interference. This may
be due to thymine oxidation because thymine is very reactive with permanganate
even under the conditions used for the guanine assay. Perhaps optimizing the

reaction conditions (milder guanine cleavage conditions, the amount of DNA added
to each assay, or the image capture time) could produce a colorimetric guaninespecific correlation that could be used for base composition of longer DNA

sequences. Experiments evaluating each reaction parameter, different lengths of
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DNA, and different base compositions within the longer DNA oligomers would be of
a value.
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Figure 6.1. Experimental results of 20-mer ssDNA thymine-specific
reaction at 15 minutes. Panel A: Image capture of one of the three
replicates. Panel B: Results from the three replicates in the reaction.
Panel C: Graph illustrating the correlations of average color change (ΔE)
values with the number of thymines present in the analyzed 20-mer
ssDNAs. Averaged ΔE values are from three independent experiments.
The control samples do not contain DNA.
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Figure 6.2. Experimental results of 20-mer ssDNA cytidine-specific BCA
reaction at 1 minute. Panel A: Image capture of one of the three replicates.
Panel B: Results from the three replicates in the reaction. Panel C: Graph
illustrating the correlations of average color change (ΔE) values with the
frequency of cytidines present in the analyzed 20-mer ssDNAs. Averaged ΔE
values are from three independent experiments. The control samples do not
contain DNA.
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Figure 6.3. Experimental results of 20-mer ssDNA adenosine-specific NaOH
cleavage at 1 minute. Panel A: Image capture of one of the three replicates.
Panel B: Results from the three replicates in the reaction. Panel C: Graph
illustrating the correlations of average color change (ΔE) values with the
frequency of adenosines present in the analyzed 20-mer ssDNAs. Averaged
ΔE values are from three independent experiments. The control samples do
not contain DNA.
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Figure 6.4. Experimental results of 20-mer ssDNA adenosine-specific DEPC
cleavage reaction at 10 minutes. Panel A: Image capture of one of the
three replicates. Panel B: Results from the three replicates in the reaction.
Panel C: Graph illustrating the correlations of average color change (ΔE)
values with the number of adenines present in the analyzed 20-mer
ssDNAs. Averaged ΔE values are from three independent experiments. The
control samples do not contain DNA.
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Figure 6.5. Experimental results of 20-mer ssDNA purine-specific reaction
at 20 minutes. Panel A: Image capture of one of the three replicates. Panel
B: Results from the three replicates. Panel C: Graph illustrating the
correlations of average color change (ΔE) values with the number purines
present in the analyzed 20-mer ssDNAs. Averaged ΔE values are from three
independent experiments. The control samples do not contain DNA.
The preliminary data shown here consists of only four 20-mer ssDNA oligomeric

sequences. These results are plotted similarly to provide equations for predicting

nucleobase frequency. This would provide greater applicability for these developed
colorimetric assays. These assays would need to be further optimized, however, to
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provide a greater discrimination for closer number of frequencies (for example,
eight and nine thymines).
6.2

Future Direction II: Ninhydrin for Colorimetric Identification of DNA
Nucleobases

Organic reagents and modification reactions for the colorimetric detection of nucleic
acids, especially those with specificity for a particular heterocyclic component, are
investigated within our laboratory. Several chromophores were explored on
monomeric DNA but did not meet the criteria needed for the CIENA base

composition of oligomers. Nevertheless, the a chromophore that did produce an
interesting result is ninhydrin for cytosine and cytidine nucleobase.

6.2.1 Ninhydrin Cytosine/Cytidine Specific Chromophore in Monomeric
DNA

Ninhydrin has historically been used as a colorimetric probe for amino acids (49).
Herein describes a novel protocol for ninhydrin as a colorimetric probe for
monomeric cytosine.

Although ninhydrin has not been able to colorimetrically detect cytosine within

oligomeric DNA, it is still included in this dissertation due to its novel application as
a colorimetric probe for monomeric cytosine. Not only are such color reactions of

value as novel next generation sequencing tools (50), they could be used as aids in

biological studies of nucleic acids (51), they could be used for structural probing of

secondary structures in nucleic acids, and they could be used to distinguish cytosine
derivatives within the field of epigenetics (52). Colorimetric methods are simple to
interpret, have small nucleic acid sample volumes, and inexpensive.

Ninhydrin was the first chemical reagent investigated in our laboratory toward
developing colorimetric reactions specific for cytosine derivatives. Ninhydrin’s
application to nucleic acids has been limited. Shapiro characterized an adduct
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formed with cytosine derivatives and ninhydrin nearly 50 years ago (53). Moreover,
Shapiro noted that an adduct of ninhydrin and guanine was labile under mildly
alkaline conditions, and that adenine and uracil derivatives do not react with

ninhydrin (53). We used this information to try to develop a colorimetric method

using ninhydrin to detect cytosine. Scheme 6.1 proposes the reaction mechanism

that ultimately leads to the desired blue diketohydridylidene-diketohydrindamine
(DYDA) pyridinium salt VI (49). This salt can only form by the trapping of the

aromatic nitrogen of the cytosine derivatives by elimination or the release of the
exocyclic nitrogen. Normally, aromatic amines do not react with ninhydrin to

produce the blue color (54). However, under our alkaline conditions, the cytosine
derivatives are likely undergoing deamination, leading to the generation of uracil
derivatives V. We generated this blue color used to identify cytosine derivatives
within the solution.
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Scheme 6.1. Proposed mechanism for the production of the blue
chromophore VI with ninhydrin II and IV and cytosine/cytidine I.
6.2.2 Materials and Methods for Future Direction II
6.2.2.1 Chemicals

All chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise
specified. This includes: 5’-monophosphodeoxyguanosine (dGMP, 5’-

monophosphodeoxyadenosine (dAMP), 5’-monophosphodeoxycytidine (dCMP), 5’106

monophosphodeoxythymine (dTMP), potassium chloride (KCl), pyridine, potassium
cyanide (KCN).

6.2.2.2 Samples, Working Solutions, and Reaction Procedures

Samples of different monomers of nucleic acids are prepared in 100mM quantities

in water and stored in the freezer. The reagents developed by Troll and Cannan (55)
and later modified by Merrifield (56) are used with some slight changes.

In an eppendorf tube, add 5 uL of the 100 mM solution of the nucleic acid sample.
To this same tube, add 25 uL of the cyanide-pyrimidine solution (20 uL of 0.01 M
KCN in 1.0 mL of pyridine) followed by the addition of 25 uL of ninhydrin-

pyrimidine solution (43 mg of ninhydrin in 100 uL of pyridine and 900 ul of

ethanol). Transfer this mixture to a quartz semi-micro cuvette (0.4 mL, 10 mm cell, 1
cm) (Science Outlet; Hong Kong, Hong Kong). Add 44-49 uL of 1 N NaOH to the
cuvette to make the total volume of sample to be analyzed 100 uL.
6.2.2.3 CIENA Procedure

For this analysis, a digital image of each solution was captured at 15 minutes

(example shown in Figure 6.6). A more detailed CIENA procedure is presented in

section 2.4.4 of this dissertation. The constants, KL, KC, and KH, in the ΔE equation

(Appendix I) were set to 2.5, 1.5, and 1.5, respectively. All data shown are the
compilation of at least three independent experiments.

6.2.3 Results and Discussion: Ninhydrin Cytosine/Cytidine Specific
Chromophore in Monomeric DNA

Ninhydrin is a water soluble white solid that forms a blue color when two ninhydrin
molecules trap an ammonia molecule from a deamination event that readily takes

place in proteins. When ninhydrin and pyridium solutions one and two are added to
the monomeric DNA solutions with sodium hydroxide, a blue chromophore is
107

generated specifically for cytidine and dCMP (Figure 6.6). The purines (dGMP and
dAMP) as well as dTMP remain the same clear color as the no-DNA control.
Control

Cytidine

dCMP

dTMP

dAMP

dGMP

Figure 6.6. Experimental results of ninhydrin
generating a blue chromophore specific for cytidine
and 5’dCMP.
This blue chromophore was not successfully generated in oligomeric ssDNA.

Although the mechanism preventing color formation in oligomeric ssDNA samples is
not known, it is likely due to the instability of the blue ninhydrin chromophore. This
chromophore is unstable in an aqueous environments due to its susceptibilty to

hydrolysis (54). In addition, oligomeric ssDNA may prevent a deamination event
within the cytidine molecule. The mechanism at which the blue chromophore is

formed requires an ammonia molecule to be trapped by two ninhydrin molecules

(54). Typical deamination events for cytosine require harsh conditions, incubation

100οC overnight in supersaturated sodium bisulfite (57). Sodium bisulfite is a strong

reducing reagent and therefore is incompatible with all the color generating

reagents we have used to date. Other, less severe conditions for the deamination
should be explored.

Much effort has been spent optimizing the conditions of the ninhydrin cytosine
specific reaction. Such parameters include the reproducibility, stability, and
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specificity of the blue chromophore. The reproducibility of the color yield would be
better if the reaction of cytosine derivatives I with ninhydrin IV (Scheme 6.1) was
quantitative, and if the competing reactions leading to color loss were minimized.
The competing reactions leading to the color loss have been thoroughly explored

and minimized for the colorimetric application of ninhydrin with proteins (56). We
have modified our colorimetric procedure to minimize these color loss reactions.
Some of these modifications include: keeping the nucleic acid very concentrated
(100 mM initially to 6 mM final), minimizing the amount of water in the overall

solution using excess ninhydrin IV, running the reaction at room temperature, the
addition of potassium cyanide (KCN) as a reducing agent to generate reduced
ninhydrin II, and using pyridine to enhance the blue color VI.

6.2.4 Limitations for Future Direction II: Ninhydrin as a Colorimetric
Indicator of DNA Nucleobases

The correlation of color change with cytosines is not consistent throughout repeated
trials. This has been an issue with ninhydrin reacting with proteins (56) The

required deamination of cytosine and its derivatives is likely not quantitative.

Future experiments can be performed on the UV spectrophotometer to evaluate the
extent of deamination of cytosine to uridine, however, only when this nitrogen is
trapped with ninhydrin can the blue color form. Moreover, once the blue salt, VI

(Scheme 6.1), is formed, equilibrium reactions cause dissociation of this salt that

also leads to variation in the blue color. For these reasons, this method would best
be applied for qualitative analysis of cytosine derivatives.
6.3

Future Direction III: Using CIENA to Identify Abasic Sites Within DNA

Abasic sites within DNA are location that contain a deoxyribose sugar without a

nucleobase, often, resulting from the hydrolysis of an N-glycosidic bond (Scheme

6.1) (40). This is a frequent lesion that can occur spontaneously or from alkylating
agents, radiation, or from the enzymatic removal of modified or abnormal bases
109

(40). If apurinic/apyrimidinic (AP) sites are left unrepaired, these sites can lead to
DNA mutations that ultimately could lead to medical issues including cancer (41).

Therefore, detection of AP sites could be important in research on DNA mutations.
Current AP detection is accomplished by immunodetection methods using an

aldehyde reactive probe (58), (59) or a derivatization reaction coupled with highperformance liquid chromatography and tandem mass spectroscopy (41).

Biological systems often utilize a process known as the base excision repair pathway
(BER) to repair abnormal nucleobases in DNA. Specific DNA glycosylases remove

the modified or abnormal nucleobase, thus generating abasic sites (40). Uracil DNA
glycosidase (UDG) is an example of an enzyme that catalyzes the release of free
uracil from uracil containing DNA (60).

Uracil is found naturally in DNA but only as a result of undesirable cytosine

deamination (61). When cytosine is deaminated, thus becoming uracil DNA, UDG
removes the uracil nucleobase by hydrolyzing the N-glycosidic bond, leaving an

abasic site (62). This abasic site is an equilibrium mixture of α- and β- hemiacetals,
aldehyde, and hydrated aldehyde (Scheme 6.1) (62). We demonstrate here, with
preliminary data, that this abasic site can be colorimetrically detected using
BCA/copper.

6.3.1 Materials and Methods for Future Direction III
6.3.1.1 Chemicals

All chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise

specified. This includes: phenol/chloroform, sodium phosphate dibasic (Na2HPO4),

and sodium phosphate monobasic (NaH2PO4), and PierceTM BCA Protein Assay Kit

(Reagent A, 23225; Reagent B, 23227). Uracil DNA glycosylase (UDG) and 10X UDG

Buffer (contains 20 mM Tris-HCl, 1 mM EDTA, 1 mM dithiothreitol) were purchased

from New England BioLabs Inc (Ipswich, MA). Two 11-mer single stranded DNAs, 5’GCCGTCAGGTA-3’ (C 11-mer), and 5’-GCCGT-deoxyU-AGGTA-3’ (deoxyU 11-mer),
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were purchased from Integrated DNA Technologies (Coralville, IA). Biotech CE
Tubing MWCO 500-1000 Da Catalog #131046 was purchased from Spectrum
Laboratories (Rancho Dominguez, CA).

6.3.1.2 Procedure for Uracil DNA Glycolase (UDG) Abasic Detection
Experiment

In labeled eppendorf tubes, 5 uL of 5000 U/mL of UDG and 5 uL of UDG Buffer 10x

was added to each. To the control sample (no DNA), water was added; to the T-DNA

sample, 40 uL of 1 mM 11-mer T-DNA (5’-GCCGTTAGGTA-3’) was added; and for

samples A, B, and C, 40 uL of 1 mM 11-mer U DNA (5’-GCCGTUAGGTA-3’) was added
according to the protocol by Roberts et. al. (41). All samples were then incubated in

a water bath at 37οC for 1 hour, followed by phenol/chloroform extraction, and

buffer exchange 2X (Dialysis in 2L 0.1M sodium phosphate pH 7 using Biotech CE

Tubing MWCO 500-1000 Da Catalog #131046). For sample analysis, transfer sample
to disposable cuvettes, add 150 uL of BCA solution 50:1 Reagent A:B (described in
section 3.7.3). The CIENA image capture is at 22 hours.

Since BCA/copper is a colorimetric detection assay for proteins, UDG had to be
removed from the samples to avoid colorimetric interference of the abasic site
detection. Therefore, the controls and samples underwent phenol/chloroform

extraction to remove the UDG enzyme. The more dense bottom layer was then
added to Biotech CE Tubing MWCO 500-1000 Da Catalog #131046 for buffer

exchange 2X (Dialysis in 2L 0.1 M sodium phosphate pH 7) to then remove aqueous

soluble phenol. Phenol reduces copper and therefore causes colorimetric

interference for abasic site detection as well. After the phenol was removed by

dialysis, controls and samples were incubated with the BCA/copper solution in a

50:1 ratio of reagent A: reagent B followed by a CIENA image capture at 22 hours
(Figure 6.9).
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6.3.1.3 CIENA

For this analysis, a digital image of each solution was captured at 22 hours (example
shown in Figure 6.9). A more detailed CIENA procedure is presented in section 2.4.4
of this dissertation. The constants, KL, KC, and KH, in the ΔE equation (Appendix I)

were set to 1.0, 1.5, and 1.0, respectively. All data shown are the compilation of at
least three independent experiments.

6.3.2 Results: Using CIENA to Quantify Abasic Sites Within DNA

Figure 6.9 illustrates preliminary data for three independent samples of 11-mer U

DNA compared to samples containing no DNA and 11-mer T DNA. Both control (no
DNA sample and T DNA sample) contain UDG in UDG buffer. Since thymine is

naturally found in DNA, the T DNA sample is not cleaved by UDG as indicative of the
teal color. UDG does however cleave the uracil found in U DNA, thus, producing an

abasic site (an aldehyde functional group as a result of the N-glycosidic bond

hydrolysis) detected by the bicinchoninic acid/copper reagent. The T DNA sample
differs from no DNA sample by an average ∆E value of 5.2, whereas, the triplicate

samples (A, B, and C) all containing the U DNA , differ from the no DNA sample by an

average ∆E value of 16.7. This violet color in samples A, B, and C is indicative of

abasic sites generated in-situ from the UDG enzymatic removal of uracil from the 11mer U DNA oligomer.
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A

B

No-DNA

T-DNA

U-DNA
A

U-DNA
B

U-DNA
C

No DNA

T-DNA

Samples A, B, and C

L*

75.0 ± 1.0

57.7 ± 4.5

a*

-4.0 ± 2.6

22.0 ± 2.6

b*

-2.7 ± 3.5

-22.0 ± 1.7

∆E

5.2 ± 4.1

16.7 ± 1.9

Figure 6.7. Experimental results of using bicinchoninic acid/copper to
detect abasic sites in 11-mer ssDNA. Panel A: Image capture of an UDG
abasic site detection reaction at 22 hours. Panel B: Results from an UDG
abasic site detection reaction at 22 hours. Control 1 samples do not
6.4.3 Conclusions: Using CIENA to Quantify Abasic Sites Within DNA
contain DNA whereas Control 2 samples contain 11-mer T DNA. Sample
A, B, and C contains 11-mer U DNA.
In this report, we show preliminary data of a novel colorimetric abasic site detection
assay using bicinchoninic acid (BCA) and copper as a chromogen. The mechanism of
how the violet chromophore is generated by BCA/copper is discussed in Chapter 3.

This preliminary study uses an established in-situ protocol to generate an abasic site

within an 11-mer ssDNA oligomer (41). The 11-mer ssDNA contains a uracil within

its sequence while the control 11-mer ssDNA contains a thymine. Uracil is naturally
found in RNA and not in DNA. Therefore, when the 11-mer ssDNA’s are incubated
with uracil DNA glycosidase (UDG), an abasic site is generated.
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The preliminary data in this section illustrates how BCA/copper can be used to

colorimetrically detect abasic sites generated from a commonly used repair enzyme
(UDG) to remove uracil from DNA. Since abasic sites have been implicated in the

formation of cancer (41), a low-cost, easy to read colorimetric assay for abasic site

detection may be of great value for a diagnostic application. For this reason, future

studies regarding the BCA/copper colorimetric assay’s detection level (sensitivity)
and its application to cellular DNA should be explored.
6.3.3 Conclusions for Future Direction III

In developing these colorimetric assays, a novel colorimetric application for
BCA/copper

was

discovered.

Mechanistically

BCA/copper’s

ability

to

colorimetrically detect and quantify abasic sites within DNA could offer future

diagnostic assays related to DNA damage. Often metabolites within urine or blood
can be colorimetrically detected that can be indicative of diseases, such as cancer
(63). These metabolites include DNA fragements that could be analyzed using the

CIENA method with BCA/copper detection of cleaved nucleobases to quantify abasic
site levels and correlate them with specific disease states.
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APPENDIX

Appendix I. The ∆E2000 equation (20).

The overall ∆E2000 Equation is Equation 1.

∆E2000 = [(∆L’/kL SL)2 + (∆C’/kC SC)2 +(∆H’/kH SH)2 + RT(∆C’/kC SC)(∆H’/kH SH)]1/2
The single number generated from the ∆E2000 equation is the difference in a

reference color (control sample) L1*, a1*, b1* and another color (the sample of
interest) L2*, a2*, b2* (20). The CIE ∆E2000 equation added corrections to the

previous formulas, including a hue rotation term (RT) to deal with the problematic

blue regions, compensation for neutral colors (L*C*h prime values), compensation
for lightness (SL), compensation for chroma (SC), and compensation for hue (SH)
(20).

The only values needed to solve equation 1 are the L1*, a1*, and b1* values from a

control (no DNA) and L2*, a2*, and b2* values from a sample. The kL, kC, and kH values

are the parametric weighting factors (described in the methods sections). These

factors are optimized to create the largest mathematical difference in the ∆E values
between samples SL, SC, or SH values. For example, the bicinchoninic acid/copper

assay displays a larger difference in SL values between samples with varying shades
of violet proportional to the nucleobase frequency being measured, whereas, the

permanaganate assay displays a larger difference between samples in the SC and SH
values due to the changing colors from violet to red-orange to yellow. In this way,
optimizing the parametric weighting factors for each application offers more
sensitivity in the ∆E value.

Herein is an example to demonstrate how equation 1 is solved using the L*, a*, and

b* values from color images captured in the guanine permanganate assay (see figure
below). The difference in color, ∆E value, from a control (no DNA) sample, L1*, a1*,
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b1* values and a 5-mer ssDNA sequence (GGGGG), L2*, a2*, and b2* values are

evaluated in the solved example equation. The following L*, a*, b* values and
parametric weighting factors were used:
Control

GGGGG

L1*

56.0

L2*

80.3

b1*

-18.7

b2*

75.3

a1*

85.7

a2*

17.3

Parametric weighting factors: kL = 2.5; kC = 1.5; kH = 1.5
In order to solve Equation 1, I have broken down the entire equation into the
following four terms:

Term 1 is (∆L’/kL SL)2

Term 2 is (∆C’/kC SC)2

Term 3 is (∆H’/kH SH)2

Term 4 is RT (∆C’/kC SC)(∆H/kH SH)

After each of these four terms are solved, then each term can be added together, and
taken the square root to provide the ∆E value in Equation 1.

Term 1 is (∆L’/kL SL)2; the only values needed are the L1*, L2*, and the kL.
∆L’ = L2* - L1*

Term 1.1

SL = 1 + [0.015(L’avg -50)2]/[20 + (L’avg-50)2]1/2

Term 1.2

Equation 1.1: ∆L’ = 80.3 – 56.00 = 24.3

To solve for SL, the L’avg value must first be calculated.
L’avg = (L1* + L2*)/2
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Term 1.3

Equation 1.2: SL = 1 + 0.015(68.15-50)2/[20 + (68.15-50)2]1/2
Equation 1.3:

SL = 1.26434

L’avg = (56.0 + 80.3)/2 = 68.15

Term 2 is (∆C’/KC SC)2; the only values needed are the a1*, b1*, a2*, b2*, and the kC.

∆C’ = C2’ – C1’

Term 2.1

SC = 1 + 0.045(C’avg)

Term 2.2

In order to solve for Term 2.1 and 2.2; C1’, C2’, and C’avg must first be calculated.
C’avg = (C1’ + C2’)/2

Term 2.3

In order to calculate C1’ and C2’, both a* and b* values will be mathematically

combined for each control and each corresponding sample; then, the control and

sample pair will be averaged to generate a G value. This G value is needed to convert

the a* value into an a’ value. This a’ value is used in the C’ calculation. For this reason
the next few mathematical operations (Terms 2.5-2.8) are needed for the
conversion of the a* into the a’ for the C’ calculation (Term 2.4).
C1’ = [(a1’)2 + (b1*)2]1/2

and

C2’ = [(a2’)2 + (b2*)2]1/2

Term 2.4

The b1* and b2* values are from the CIELAB color space. The a1’ and a2’ values,
however, are calculated with the following equations.

C1*ab = [(a1*)2 + (b1*)2]1/2 and C2*ab = [(a2*)2 + (b2*)2]1/2
Equation 2.5: C1*ab = [(85.7)2 + (17.3)2]1/2 = 87.7165

Term 2.5

C2*ab = [(17.3)2 + (75.3)2]1/2 = 77.2618

C*ab avg = (C1*ab + C2*ab)/2

Equation 2.6: C*ab avg = (87.7165 + 77.2618)/2 = 82.48915
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Term 2.6

The C*ab avg (Equation and Term 2.6) is used to calculate the G value (Term 2.7),

required to convert the a* value into the a’ value (Term 2.8).
G = 0.5 [1-(C*ab avg7/ C*ab avg7 + 257)
Then,

a1’ = (1 + G) a1*

and

a2’ = (1 + G) a2*

Term 2.7
Term 2.8

Equation 2.7: G = 0.5[1-[(82.48915)7/[(82.48915)7 + (25)7]]1/2] = 0.0001175
Equation 2.8: a1’ = (1 + 0.0001175) 85.7 = 85.7101

Equation 2.8: a2’ = (1 + 0.0001175) 17.3 = 17.3020
Now that a* has been modified into a’, example equations (2.1, 2.3, and 2.4) can all
be solved, which completes term 2 of equation 1.
C1’ = [(a1’)2 + (b1*)2]1/2

and

C2’ = [(a2’)2 + (b2*)2]1/2

Equation 2.4: C1’ = [(85.7101)2 + (-18.7)2]1/2= 87.7263

Term 2.4

Equation 2.4: C2’ = [(17.3020)2 + (75.3)2]1/2 = 77.2622
C’avg = (C1’ + C2’)/2

Term 2.3

∆C’ = C2’ – C1’

Term 2.1

Equation 2.3: C’avg = (87.7263+ 77.2622)/2 = 82.4943
Equation 2.1: ∆C’ = (77.2622 - 87.7263) = -10.4641
SC = 1 + 0.045(C’avg)

Equation 2.2: SC = 1 + 0.045(82.4943) = 4.7122

Term 2.2

Term 3 of equation 1 is (∆H’/kH SH)2; which requires C1’ and C2’ from Term 2.4 for

the ∆H’ and SH calculations. kH is a weighting factor that is provided in the CIENA
methods (refer to Chapter 2, Section 2.2.4).

∆H’ = 2 (C1’ C2’)1/2 sin (∆h’/2)

Term 3.1

SH = 1 + 0.015 (C’avg) T

Term 3.2
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∆h’ is needed to solve Term 3.1 and is the difference in the modified h1’ and h2’

values (using a four-quandrant arctangent solution). Note that it is important to use
degrees in this calculation (between 0o and 360o).

Values h1’ and h2’ are calculated using the following condition stated in Term 3.3.
This Term 3.3, requires a1’ and a2’ values solved in Term 2.8.
h1’ = 0 if b1* = a1’ = 0; otherwise tan-1(b1*/ a1’) and likewise;

h2’ = 0 if b2* = a2’= 0, otherwise tan-1(b2*/ a2’)

Term 3.3

If these functions give a negative hue angle then 360ο must be added to the result.

Equation 3.3: h1’ = tan-1 (-18.7 / 85.7101) = -12.3078

Since h1’ is < 0, then h1’ + 360ο = -12.3078 + 360ο = 347.6922

Equation 3.3: h2’ = tan-1 ( 75.3 / 17.3020) = 77.0595

Since h2’ is > 0, then answer is correct as is.

Now that h1’ and h2’ are obtained, one of the following four conditions (all

dependent on the multiplication of C1’ C2’ values from the Term 2.4) apply to the

calculation of the ∆h’ value needed for Term 3.1:

Term 3.3.1

If C1’ C2’ = 0, then ∆h’ = 0, otherwise one of the following three conditions apply:
If the absolute value of h2’-h1’ is ≤ 180o then ∆h’ = h2’ – h1’, otherwise if the

difference (not absolute) of h2’-h1’ is > 180o (h then ∆h’ = (h2’ – h1’) – 360o;

otherwise if the difference (not absolute) of h2’-h1’ is < -180o, then ∆h’ = (h2’ – h1’) +

360o.

Equation 3.3.1

C1’ * C2’ = 87.7263 * 77.2622 = 6777. 9269 does not = 0

The absolute value of 77.0595 - 347.6922= 270.6327 which is

not ≤ 180o; Also, 77.0595 - 347.6922= -270.6327 is not > 180o,
but 77.0595 - 347.6922= -270.6327 is < -180o therefore ∆h’ =

(77.0595- 347.6922) + 360o = 89.3673
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∆H’ can now be solved accordingly:
∆H’ = 2 (C1’ C2’)1/2 sin (∆h’/2)

Term 3.1

Equation 3.1: ∆H’ = 2 (87.7263*77.2622)1/2 sin (89.3673/2)
∆H’ = 164.6563*0.7032 = 115.78

To calculate the h’avg value, values h1’ and h2’ (previously calculated in Term 3.3.1)
are used to satisfy one of the following four conditions (all dependent on the

multiplication of C1’ C2’ values from Term 2.4). Depending on which of the four

conditions apply, the h’avg value is calculated accordingly for Term 3.4.

If C1’ C2’ = 0, then h’avg = (h1’ + h2’), otherwise one of the following three conditions

apply:

Term 3.3.2

If the absolute value of h1’-h2’ is ≤ 180o then h’avg= (h1’+ h2’/2), otherwise if the

absolute value of h1-h2’ is > 180o and h1’+ h2’ is < 360o, then h’avg=(h1’+ h2’+360o )/2;

otherwise if the absolute value of h1’- h2’ is > 180o and h1’+ h2’ is ≥ 360o, then h’avg =
(h1’ + h2’ - 360o )/2.
Equation 3.3.2

C1’ * C2’ = 87.7263 * 77.2622 = 6777. 9269 does not = 0

Absolute value of 347.6922-77.0595 = 270.6327 which is >

180o and 347.6922 + 77.0595 = 424.7517 which is ≥ 360o, then
h’avg = (347.6922 + 77.0595 - 360ο)/2= 32.3759

To solve Term 3.2, SH = 1 + 0.015 C’avg T, C’avg and T values are needed. The C’avg

value was calculated in Term 2.3, but the T value will need to be calculated here. The
T value requires the h’avg value solved in Term 3.3.2

T= 1 - 0.17 cos (h’avg -30o) + 0.24 cos (2h’avg) + 0.32 cos (3h’avg + 6o) -0.20 cos (4h’avg

– 63o)

Equation 3.4

Term 3.4

T = 1-0.17 cos (32.3759 – 30 o) + 0.24 cos (2* 32.3759) + 0.32

cos (3 * 32.3759 + 6 o) – 0.20 cos (4 * 32.3759 - 63 o) = 0.7801
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SH = 1 + 0.015 (C’avg )T

Term 3.2

Equation 3.2: SH = 1 + 0.015 (82.4943)(0.7801)
SH = 1.9653

Term 4 of equation 1 is RT (∆C’/KC SC)(∆H/KH SH); uses term 2, ∆C’/KC SC), and term
3, (∆H/KH SH) which were previously calculated. The only new variable in term 4 is
RT.

RT = -sin(2∆θ) Rc

Term 4

To solve RT, you need to solve for ∆θ and Rc.

∆θ = 30 exp {-[ h’avg - 275 o/25]2}

Term 4.1

Equation 4.1: ∆θ = 30 exp {-[ 32.3759 - 275 o/25]2}

∆θ = 30 exp {-[ 32.3759 - 275 o/25]2} = 3.74 X 10-40

Rc = 2((C’avg)7/((C’avg)7+257))1/2

Term 4.2

Equation 4.2: Rc= 2((82.4943)7/((82.4943)7+257))1/2
Rc= 1.99972

RT= -sin(2∆θ) Rc

Equation 4:

Term 4

RT = -sin(2*3.74 X 10-40)1.99972
RT =-2.609 X 10-41

∆E2000 = [(∆L’/kL SL)2 + (∆C’/kC SC)2 +(∆H’/kH SH)2 + RT(∆C’/kC SC)(∆H’/kH SH)] 1/2
∆L’ = 24.3

SL = 1.2643

∆C’ = -10.4641
SC = 4.7122

∆H’ = 115.78
SH = 1.9653

RT =-2.609 X 10-41

Parametric weighting factors: kL = 2.5; kC = 1.5; kH = 1.5
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Equation 1:

∆E2000 = [(24.3/(2.5*1.2643)2 + (-10.4641/1.5*4.7122)2 +

(115.78/1.5* 1.9653)2 + (-2.609 X 10-41)[(-10.4641/1.5*4.7122)(115.78/1.5*

1.9653)]1/2

∆E2000 = [59.1061 + 2.1917 + 1542.506 + 1.51 X 10-39] 1/2
∆E2000 = 40.0475

Control

GGGGG

L1*

56.0

L2*

80.3

b1*

-18.7

b1*

75.3

a1*

85.7

a2*
∆E

17.3
40.0475
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Appendix II. This section contains L*, a*, b* values of control samples (no-DNA). The
reported values are from three independent assays. This data is used for the ∆E

calculations corresponding to the 5-mer ssDNA sequences in each assay throughout

this dissertation. For example Table 2.1 in Chapter 2 contains average L*, a*, b*, and
∆E values for each 5-mer ssDNA used in the thymine-specific permanganate assay.
Note that controls for the 20-mers are already shown in Tables 6.1-6.5. The

calculated ∆E values show in Table 2.1 used the corresponding L*, a*, b* values from
the controls shown here in Table 2.1A (Appendix II). The other tables shown here

are labeled as Table 2.2A, 2.3A, 3.1A-3.5A, and 4.1A to correspond directly with the
Tables 2.2, 2.3, 3.1-3.5, and 4.1 in Chapters 2, 3, and 4.
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Table 2.1A. Average L*, a*, and b* values for controls used in the
thymine-specific 5-mer DNA.
# Thymines
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
3
3
3
3
3
3
3
4
4
4
4
5

Sequences
GCGGG
AGAGC
CCCCC
GAGAC
CACCC
AACAG
GGAGG
GGGGG
AGAGC
AGGGG
CCGCC
CGAGC
GAAAA
CATGC
CGTCC
AACTG
CGAGT
GTCCC
ATAAG
AACGT
GTGGA
GTGGC
TCGGA
GCTGC
CCTCC
TGTGC
TAAAT
TTGAA
CCGTT
AGTAT
TGGTG
CTCTC
ATGTT
TTTGA
CGTTT
GTTTA
TCTGT
ATTTC
TATCT
CTTTT
TTTCT
TTATT
TTGTT
TTTTT

L* value

a* value

64.7 ± 1.2
56.7 ± 0.6
56.7 ± 0.6
56.7 ± 0.6
57.7 ± 0.6
52.7 ± 1.5
54.3 ± 0.6
56.7 ± 1.2
56.7 ± 0.6
54.3 ± 0.6
54.0 ± 1.0
56.0 ± 0.0
54.7 ± 2.9
54.7 ± 2.9
54.7 ± 2.9
52.7 ± 1.5
52.7 ± 0.6
57.0 ± 1.0
55.7 ± 1.2
59.0 ± 5.6
56.0 ± 0.0
54.7 ± 1.5
55.7 ± 1.2
56.3 ± 0.6
56.0 ± 0.0
54.7 ± 1.5
56.0 ± 0.0
54.7 ± 1.5
57.0 ± 1.0
52.7 ± 1.5
56.3 ± 0.6
52.7 ± 0.6
54.0 ± 1.0
54.7 ± 1.5
56.0 ± 0.0
60.3 ± 0.6
60.3 ± 0.6
60.3 ± 0.6
60.3 ± 0.6
60.3 ± 0.6
60.3 ± 0.6
60.3 ± 0.6
57.7 ± 0.6
60.3 ± 0.6

Each value is the average of three independent assays.

.
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97.0 ± 1.7
87.3 ± 0.6
87.3 ± 0.6
87.3 ± 0.6
88.0 ± 1.0
83.0 ± 1.0
83.7 ± 1.5
86.7 ± 1.2
87.3 ± 0.6
83.7 ± 1.5
83.7 ± 1.2
86.3 ± 0.6
84.7 ± 2.9
84.7 ± 2.9
84.7 ± 2.9
83.0 ± 1.0
82..7 ± 0.6
87.0 ± 1.0
85.7 ± 2.1
89.0 ± 6.6
86.3 ± 0.6
85.3 ± 2.5
85.7 ± 2.1
85.3 ± 3.1
86.3 ± 0.6
85.3 ± 2.5
85.7 ± 1.5
85.3 ± 2.5
87.0 ± 1.0
83.0 ± 1.0
86.7 ± 1.2
82..7 ± 0.6
83.7 ± 1.2
85.3 ± 2.5
86.3 ± 0.6
91.7 ± 0.6
91.7 ± 0.6
91.7 ± 0.6
91.7 ± 0.6
91.3 ± 0.6
91.3 ± 0.6
91.3 ± 0.6
88.0 ± 1.0
91.3 ± 0.6

b* value

-39.3 ± 0.6
-30.7 ± 0.6
-30.7 ± 0.6
-30.7 ± 0.6
-32.0 ± 1.0
-28.3 ± 0.6
-27.3 ± 1.2
-30.0 ± 1.7
-30.7 ± 0.6
-27.3 ± 1.2
-30.0 ± 1.0
-30.0 ± 0.6
-29.7 ± 1.2
-29.7 ± 1.2
-29.7 ± 1.2
-28.3 ± 0.6
-29.0 ± 0.0
-29.3 ± 0.6
-29.3 ± 1.5
-40.3 ± 2.5
-30.0 ± 0.6
-33.3 ± 2.1
-29.3 ± 1.5
-29.7 ± 1.2
-30.0 ± 0.6
-33.3 ± 2.1
-29.7 ± 1.2
-33.3 ± 2.1
-29.3 ± 0.6
-28.3 ± 0.6
-28.7 ± 1.2
-29.0 ± 0.0
-30.0 ± 1.0
-33.3 ± 2.1
-30.0 ± 0.6
-32.7 ± 0.6
-32.7 ± 0.6
-32.7 ± 0.6
-32.7 ± 0.6
-33.3 ± 0.6
-33.3 ± 0.6
-33.3 ± 0.6
-32.0 ± 1.0
-33.3 ± 0.6

Table 2.2A. Average L*, a*, b* values for the controls used in the
cytosine-specific 5-mer DNA.
# Thymines

Sequences

2

TGGTG

2
2
2
2
2
2

1
1

CTCTC

GAGTA
GTGGA
GTGGC

CGAGT
GCTGC

CATGC
CATCC
CGTCC

0

GAAAA

0

AGGGG

0
0
0
0
0
0
0

5

CACTT

CCTCC

0

4

-34.0 ± 1.7

1
0

3

81.7 ± 6.0

CATAC

1

0

0

72.7 ± 2.5

TACTA

1
1

-23.7 ± 0.6

TACTG

AGTAT

AACTG

1

# Cytosines

-34.0 ± 1.7

1
1

b* value

81.7 ± 6.0

AATAA

1

a* value

72.7 ± 2.5

1
1

L* value

TAAAT

GGGGG

GGAGG
AACAG

AGAGC
GAGAC
ACACA
CGCGC
CACCC
CCGCC
CCCCC

ATGTT
TTGTT
TTTTT

72.7 ± 2.5
53.3 ± 0.6
78.0 ± 0.0
78.0 ± 0.0

78.0 ± 0.0
78.0 ± 0.0
80.3 ± 1.2
66.0 ± 0.0
80.3 ± 1.2
53.0 ± 1.0

81.7 ± 6.0
82.7 ± 1.2
65.7 ± 0.6
65.7 ± 0.6
65.7 ± 0.6
65.7 ± 0.6
58.7 ± 2.1
98.7 ± 0.6
58.7 ± 2.1
82.3 ± 1.2

66.0 ± 0.0

98.0 ± 0.0

67.7 ± 0.6

94.7 ± 0.6

53.3 ± 0.6
80.3 ± 1.2
67.7 ± 0.6
67.7 ± 0.6
67.7 ± 0.6
69.3 ± 0.6
71.0 ± 2.8
53.3 ± 0.6
53.3 ± 0.6
69.3 ± 0.6
53.3 ± 0.6
69.3 ± 0.6
69.3 ± 0.6
68.7 ± 2.3
68.7 ± 2.3
68.7 ± 2.3
68.7 ± 2.3
53.3 ± 0.6
71.0 ± 2.8
72.3 ± 1.2

82.7 ± 1.2
58.7 ± 2.1
94.7 ± 0.6

94.7 ± 0.6
94.7 ± 0.6
91.0 ± 1.7
85.5 ± 7.8
82.7 ± 1.2
82.3 ± 0.6
91.0 ± 1.7
82.3 ± 0.6
91.0 ± 1.7
91.0 ± 1.7
92.3 ± 5.8
92.3 ± 5.8
92.3 ± 5.8
92.3 ± 5.8
82.3 ± 0.6
85.5 ± 7.8
82.7 ± 2.9

Each value is the average of three independent assays.
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-34.0 ± 1.7
-30.3 ± 0.6
-30.3 ± 0.6
-30.3 ± 0.6
-30.3 ± 0.6
-27.3 ± 0.6
-34.0 ± 1.0
-27.3 ± 0.6
-23.7 ± 1.2
-33.7 ± 0.6
-23.7 ± 0.6
-27.3 ± 0.6
-36.0 ± 1.0
-36.0 ± 1.0
-36.0 ± 1.0
-36.0 ± 1.0
-36.0 ± 1.0
-35.5 ± 2.1
-23.7 ± 0.6
-23.7 ± 1.5
-36.0 ± 1.0
-23.7 ± 1.5
-36.0 ± 1.0
-36.0 ± 1.0
-35.0 ± 1.0

-35.0 ± 1.0
-35.0 ± 1.0
-35.0 ± 1.0
-23.7 ± 1.5
-35.5 ± 2.1
-35.0 ± 0.0

0
0
1
1
2
3
0
0
0
1
1
1
2
2
2
3
3
4
0
0
0
0
1
1
1
2
3
3
4
5
0
0
0

Table 2.3A. Average L*, a*, b* values for the controls used in the guaninespecific 5-mer DNA.
# Guanines
Sequences
L* value
0
CTCTC
50.7 ± 0.6
0
TACAC
57.0 ± 0.0
0
TCCCT
54.3 ± 2.1
0
CCCCC
56.7 ± 0.6
0
TCTTC
62.0 ± 1.0
0
TTTCT
56.0 ± 1.0
0
TACTA
53.3 ± 1.5
0
CACCC
53.3 ± 1.5
0
CCTCC
55.3 ± 1.2
0
AAAAA
55.3 ± 0.6
0
TTTTT
55.3 ± 0.6
1
TTTTG
56.3 ± 0.6
1
GAAAA
53.0 ± 2.0
1
CATGC
53.0 ± 2.0
1
CCGCC
50.7 ± 0.6
1
AACAG
51.3 ± 0.6
1
TTTTG
56.3 ± 0.6
1
ATGTT
50.7 ± 0.6
1
AACTG
51.3 ± 0.6
1
AGTAT
51.3 ± 0.6
1
CGTCC
53.0 ± 2.0
1
GTCCC
57.0 ± 0.0
1
TTGTT
55.0 ± 1.0
1
TTGAA
57.0 ± 0.0
1
TTTGA
57.0 ± 0.0
2
GAGTA
58.0 ± 0.0
2
GCTCG
56.0 ± 1.0
2
GCTGC
56.0 ± 1.0
2
CGAGT
50.7 ± 0.6
2
TCGGA
56.0 ± 1.0
2
AGAGC
56.7 ± 0.6
2
CCCGG
57.7 ± 0.6
2
GAGAC
56.7 ± 0.6
2
CGAGC
56.7 ± 0.6
3
TGGTG
61.0 ± 0.0
3
GGGAC
55.7 ± 1.2
3
GTGGC
56.0 ± 1.0
3
CGGCG
57.0 ± 1.0
3
GAAGG
55.0 ± 1.0
3
GTGGA
55.3 ± 1.2
3
GAGGA
57.0 ± 0.0
4
GCGGG
57.0 ± 1.0
4
GGGGA
57.0 ± 0.0
4
AGGGG
57.0 ± 0.0
4
GGAGG
57.0 ± 0.0
4
GGGAG
57.0 ± 0.0
5
GGGGG
57.0 ± 0.0
Each value is the average of three independent assays.
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a* value
79.3 ± 1.5
87.0 ± 0.0
83.0 ± 2.6
86.3 ± 1.2
93.0 ± 1.0
82.3 ± 7.2
81.3 ± 0.6
81.3 ± 0.6
84.7 ± 1.5
85.0 ± 1.0
85.0 ± 1.0
87.0 ± 0.0
82.7 ± 3.1
82.7 ± 3.1
79.3 ± 1.5
80.0 ± 1.0
87.0 ± 0.0
79.3 ± 1.5
80.0 ± 1.0
80.0 ± 1.0
82.7 ± 3.1
87.0 ± 0.0
84.7 ± 1.5
87.0 ± 0.0
87.0 ± 0.0
88.7 ± 0.6
86.0 ± 1.0
86.0 ± 1.0
79.3 ± 1.5
86.0 ± 1.0
86.3 ± 1.2
87.7 ± 0.6
86.3 ± 1.2
86.3 ± 1.2
91.0 ± 0.0
85.7 ± 1.5
86.0 ± 1.0
87.0 ± 1.0
84.7 ± 1.5
84.7 ± 1.5
86.5 ± 0.7
87.0 ± 1.0
86.5 ± 0.7
86.0 ± 0.0
86.0 ± 0.0
86.0 ± 0.0
86.0 ± 0.0

b* value
-20.0 ± 1.0
-25.7 ± 0.6
-23.3 ± 1.5
-25.0 ± 0.0
-28.0 ± 1.0
-25.3 ± 2.1
-22.0 ± 1.0
-22.0 ± 1.0
-23.7 ± 1.5
-25.3 ± 1.5
-25.3 ± 1.5
-27.0 ± 1.7
-21.7 ± 2.1
-21.7 ± 2.1
-20.0 ± 1.0
-21.0 ± 1.0
-27.0 ± 1.7
-20.0 ± 1.0
-21.0 ± 1.0
-21.0 ± 1.0
-21.7 ± 2.1
-25.7 ± 0.6
-26.0 ± 1.0
-25.7 ± 0.6
-25.7 ± 0.6
-31.0 ± 1.0
-23.7 ± 0.6
-23.7 ± 0.6
-20.0 ± 1.0
-23.7 ± 0.6
-25.0 ± 0.0
-26.3 ± 1.2
-25.0 ± 0.0
-25.0 ± 0.0
-23.3 ± 2.1
-26.3 ± 0.6
-23.7 ± 0.6
-26.0 ± 1.0
-26.0 ± 1.0
-23.7 ± 1.5
-21.0 ± 4.2
-26.0 ± 1.0
-21.0 ± 4.2
-18.3 ± 1.5
-18.3 ± 1.5
-18.3 ± 1.5
-18.3 ± 1.5

Table 3.1A. Average L*, a*, b* values for the controls used in the
adenosine-specific assay with NaOH cleavage of 5-mer DNA.
# Adenosines
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
3
3
3
4
4
5

Sequences
TTTTT
TTCTT
CTCTC
CCTCC
CGTCC
CGCGC
CCGCC
CCCCC
TTGTT
GGGGG
GCGGG
GTGGC
TGGTG
GCTGC
CGGCG
AGGGG
GGGGA
ATGTT
GGAGG
GTGGA
TTATT
TATCT
TACTG
CACTT
CGAGT
CATGC
CACCC
AGAGC
GAGAC
ATATT
AGTAT
TACTA
GAGTA
AACTG
GAGTA
TAAAT
AACAG
ACACA
GAAAA
AATAA
AAAAA

L* value

100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
91.5 ± 0.7
91.5 ± 0.7
90.3 ± 2.1
91.5 ± 0.7
90.3 ± 2.1
93.0 ± 1.0
93.3 ± 1.2
93.0 ± 1.0
93.0 ± 1.0
90.3 ± 2.1
100 ± 0.0
98.0 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
93.0 ± 1.0
90.3 ± 2.1
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
100 ± 0.0
98.0 ± 0.0
100 ± 0.0
100 ± 0.0

Each value is the average of three independent assays.

130

a* value

0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
-2.0 ± 0.0
-2.0 ± 0.0
-2.7 ± 0.6
-2.0 ± 0.0
-2.7 ± 0.6
-3.0 ± 1.0
-1.0 ± 0.0
-3.0 ± 1.0
-3.0 ± 1.0
-2.7 ± 0.6
0.0 ± 0.0
1.3 ± 0.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
-3.0 ± 1.0
-2.7 ± 0.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
1.3 ± 0.6
0.0 ± 0.0
0.0 ± 0.0

b* value

0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
4.5 ± 0.7
4.5 ± 0.7
-2.3 ± 0.6
4.5 ± 0.7
-2.3 ± 0.6
-2.0 ± 2.0
-2.3 ± 1.2
-2.0 ± 2.0
-2.0 ± 2.0
-2.3 ± 0.6
0.0 ± 0.0
-3.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
-2.0 ± 2.0
-2.3 ± 0.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
-3.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0

Table 3.2A. Average L*, a*, b* values for the controls used in the
adenosine-specific assay with DEPC cleavage of 5-mer DNA.
# Adenosines
0
0
0

Sequences

L* value

CGTCC

91.0 ± 1.0

CTCTC
CCTCC

0

GTGGC

0

GGGGG

0
0
1

CCCCC

TTGTT
CGATC

1

GGAGG

1

CATGC

1
1
1

AGGGG
ATGTT
CACCC

2

GAGGA

3

AACAG

2
2
3

AGAGC

GAGAC

CAAGA

3

GGAAA

4

ACAAA

3
4
4
4
4
5

ATAAG

AAATA
AACAA

GAAAA
AATAA

AAAAA

a* value

b* value

-11.7 ± 0.6

6.3 ± 1.5

91.3 ± 1.2

-12.3 ± 0.6

90.3 ± 0.6

-12.7 ± 0.6

91.0 ± 1.0
88.7 ± 0.6
90.7 ± 1.2
88.7 ± 0.6
91.3 ± 1.2
91.3 ± 1.2
91.0 ± 1.0
90.7 ± 1.2
87.7 ± 1.2
91.3 ± 1.2
90.3 ± 0.6
90.7 ± 1.2
87.7 ± 1.2
91.7 ± 0.6
90.3 ± 0.6
92.3 ± 1.2
92.3 ± 1.2
92.3 ± 1.2
90.7 ± 1.5
91.7 ± 0.6
92.3 ± 1.2
90.7 ± 1.5

88.7 ± 0.6

-11.7 ± 0.6
-9.0 ± 1.0

-11.7 ± 0.6
-9.0 ± 1.0

-12.3 ± 0.6
-12.3 ± 0.6
-11.7 ± 0.6
-11.7 ± 0.6
-6.0 ± 2.6

-12.3 ± 0.6
-12.7 ± 0.6
-11.7 ± 0.6
-6.0 ± 2.6

-13.3 ± 0.6
-12.7 ± 0.6
-12.3 ± 0.6
-12.3 ± 0.6
-12.3 ± 0.6
-13.0 ± 0.0
-13.3 ± 0.6
-12.3 ± 0.6
-13.0 ± 0.0

Each value is the average of three independent assays.
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-9.0 ± 1.0

6.0 ± 1.0
6.3 ± 1.5
7.0 ± 1.0
5.7 ± 0.6
6.7 ± 2.1

5.7 ± 0.6
6.0 ± 1.0
6.0 ± 1.0
6.0 ± 1.7
6.7 ± 2.1
2.3 ± 1.5
6.0 ± 1.0
7.0 ± 1.0
6.7 ± 2.1
2.3 ± 1.5
7.0 ± 1.0
7.0 ± 1.0
6.7 ± 0.6
6.7 ± 0.6
6.7 ± 0.6
7.7 ± 1.5
7.0 ± 1.0
6.7 ± 0.6
7.7 ± 1.5
5.7 ± 0.6

Table 3.3A. Average L*, a*, b* values for the controls used in the
guanosine-specific assay of 5-mer DNA.
# Guanosines

Sequences

0

TTTTT

0
0
1
1
1
2
2

-17.7 ± 9.3

1.7 ± 3.2

-18.3 ± 1.2

TTGTT

88.0 ± 3.6

-17.7 ± 9.3

CCGCC

ATGTT
GCTGC

AGAGC

4

GGAGG

5

b* value

83.0 ± 1.0

CCCCC

GTGGA

4

a* value

CTCTC

3
3

L* value

TGGTG

AGGGG
GGGGG

94.3 ± 2.9
88.0 ± 3.6
83.0 ± 1.0
89.7 ± 4.0
88.7 ± 1.5
89.3 ± 0.6
88.7 ± 1.5
88.7 ± 1.5
83.0 ± 1.0
88.7 ± 1.5

88.7 ± 1.5

-11.0 ± 1.0
-18.3 ± 1.2
-23.0 ± 1.0
-26.7 ± 1.5
-25.3 ± 0.6
-26.7 ± 1.5
-26.7 ± 1.5
-18.3 ± 1.2
-26.7 ± 1.5
-26.7 ± 1.5

Each value is the average of three independent assays.
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1.7 ± 1.5
0.7 ± 0.6
1.7 ± 3.2
1.7 ± 1.5
3.7 ± 0.6
6.7 ± 1.2
5.7 ± 1.5
6.7 ± 1.2
6.7 ± 1.2
1.7 ± 1.5
6.7 ± 1.2
6.7 ± 1.2

Table 3.4A. Average L*, a*, b* values for the controls used in the total
purine-specific bicinchoninic acid/copper assay of 5-mer DNA.
# Purines

Sequences

0

CCCCC

0
0
0
1
1
1

77.3 ± 1.5

TTTTT

93.7 ± 2.1

CCTCC

CACCC

CGTCC
CCGCC

1

TTGTT

2

TACTA

1
2
2

TATCT

CATGC

TACTG

2

ATGTT

3

TGGTG

3

AGTAT

2
3
3
3

GCTGC

GTGGC

CGAGT

AACTG

4

GAGTA

4

GTGGA

4
4
4

GAGAC

AACAG

AGAGC

5

GGAGG

5

GAAAA

5
5
5
5
5

L* value

CCTCC

GGGGA

AGGGG

AAAAA
GGGGG

AAAGA

a* value

b* value

-8.3 ± 1.2

2.0 ± 1.7

-30.0 ± 1.0

96.3 ± 0.6

-9.7 ± 0.6

93.7 ± 2.1

-8.3 ± 1.2

84.3 ± 1.2

-16.3 ± 1.2

93.7 ± 2.1

-8.3 ± 1.2

84.3 ± 1.2

-16.3 ± 1.2

83.7 ± 1.5

-15.7 ± 0.6

93.7 ± 2.1

-8.3 ± 1.2

75.0 ± 0.0

-29.7 ± 0.6

83.7 ± 1.5

-15.7 ± 0.6

84.0 ± 1.7

-16.0 ± 2.0

75.7 ± 0.6

-19.7 ± 17.0

77.3 ± 1.5

30-.0 ± 1.0

93.7 ± 2.1

-8.3 ± 1.2

96.3 ± 0.6

-9.7 ± 0.6

90.3 ± 2.1
94.7 ± 0.6
96.3 ± 0.6
97.7 ± 0.6
96.3 ± 0.6
75.7 ± 0.6
84.0 ± 1.7

5.0 ± 1.7
5.0 ± 1.7
4.7 ± 0.6
2.0 ± 1.7
2.0 ± 1.7
9.3 ± 0.6
2.0 ± 1.7
1.3 ± 0.6
4.7 ± 0.6

-2.3 ± 0.6

-9.7 ± 0.6

1.3 ± 0.6

-0.3 ± 1.2
5.7 ± 1.5

-0.3 ± 0.6

-19.7 ± 17.0

8.7 ± 0.6

84.3 ± 1.2
93.3 ± 1.2
75.3± 0.6
75.3± 0.6

Each value is the average of three independent assays.
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2.0 ± 1.7

-7.0 ± 1.0

94.7 ± 0.6

94.7 ± 0.6

1.3 ± 0.6

-2.7 ± 0.6
-7.0 ± 1.0

83.7 ± 1.5

94.7 ± 0.6

9.7 ± 1.5

-9.7 ± 0.6

-16.0 ± 2.0
-15.7 ± 0.6

8.7 ± 0.6
1.3 ± 0.6
9.7 ± 1.5
5.7 ± 1.5

4.7 ± 0.6

-7.0 ± 1.0

-0.3 ± 1.2

-30.3 ± 0.6

10.3 ± 1.2

-8.7 ± 1.5

2.3 ± 1.2

-16.3 ± 1.2
-1.0 ± 0.0

-30.3 ± 0.6
-8.7 ± 1.5

5.0 ± 1.7

-2.3 ± 1.2

10.3 ± 1.2
2.3 ± 1.2

Table 3.5A. Average L*, a*, b* values for the controls used in the cytidinespecific assay of 5-mer DNA.
# Cytidines

Sequences

0

ATGTT

0
0
0

-8.0 ± 1.7

1

CGAGT

1

GTGGA
TTGTT

GGGGG
TTTTT

GTGGC

1

GAGAC

2

CATGC

1
1
2
2
2
2
3
3
3
3
4
4
4
5

9.7 ± 2.1

95.0 ± 1.0

AAAAA

0

-8.7 ± 1.5

AGTAT

GAAAA

0
0

b* value

-9.7 ± 0.6

AGGGG

0

a* value

95.7 ± 0.6

0
0

L* value

GGAGG

AGAGC

AACAG
TGCAC
CGATC
CCATT
CTCTT
CTCTC

CGTCC

ATCCC
CATCC
CGCCC
CCTCC

CACCC
CCCCC

97.0 ± 1.0
95.7 ± 1.2
95.7 ± 1.2
94.3 ± 0.6
94.3 ± 0.6
96.3 ± 0.6
96.3 ± 0.6
96.3 ± 0.6
96.3 ± 0.6
95.0 ± 1.0
97.0 ± 1.0
95.7 ± 1.2
94.3 ± 0.6
95.7 ± 0.6
95.0 ± 1.0
95.7 ± 1.2

95.7 ± 1.2
94.3 ± 0.6
95.7 ± 0.6
97.0 ± 1.0
95.7 ± 1.2
95.7 ± 1.2
95.3 ± 1.2
95.3 ± 1.2
95.3 ± 1.2
95.3 ± 1.2

Each value is the average of three independent assays.
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-9.0 ± 0.0
-9.0 ± 0.0
-9.3 ± 1.2
-9.3 ± 1.2
-7.7 ± 1.5
-7.7 ± 1.5
-7.7 ± 1.5
-7.7 ± 1.5
-8.0 ± 1.7
-9.0 ± 0.0
-9.0 ± 0.0
-9.3 ± 1.2
-9.7 ± 0.6
-8.0 ± 1.7
-8.7 ± 1.5
-9.0 ± 0.0
-9.3 ± 1.2
-9.7 ± 0.6
-9.0 ± 0.0
-8.7 ± 1.5

-9.0 ± 0.0
-8.3 ± 2.1
-8.3 ± 2.1
-8.3 ± 2.1
-8.3 ± 2.1

9.0 ± 1.0
9.7 ± 1.2
8.0 ± 1.7
9.7 ± 0.6

9.7 ± 1.7
9.7 ± 1.7
7.7 ± 0.6
7.7 ± 0.6
7.7 ± 0.6
7.7 ± 0.6
8.0 ± 1.7
9.7 ± 1.2
9.7 ± 0.6
9.7 ± 1.7
9.0 ± 1.0
8.0 ± 1.7
9.7 ± 2.1
9.7 ± 0.6
9.7 ± 1.7
9.0 ± 1.0
9.7 ± 1.2
9.7 ± 2.1
9.7 ± 0.6
8.7 ± 2.5
8.7 ± 2.5
8.7 ± 2.5
8.7 ± 2.5

Table 4.1A. Average L*, a*, b* values for the controls used in the total purinespecific diphenylamine assay of 5-mer DNA.
# Purines

Sequences

0

TTTCT

0
0
0
1
1
1
1
1

TCTTC

TATCT
TCCTG

ATTTC
TACCT

CGTAT
TACAC
GACTC

3

CGAAT

3

GCCGG

3
4

GCATG

TGGTG

GCGAG

4

AGTGA

5

GGAGG

4
4
5
5

0.0 ± 0.0

0.7 ± 1.2

100.0 ± 0.0

TCGAC

3

100.0 ± 0.0

99.7 ± 0.6

TCTGT

TTTTT

2
2

b* value

100.0 ± 0.0

GTTTA

2

a* value

CTTTT

2
2

L* value

AGAAC
GCGGG

AAAGA
AAAGG

100.0 ± 0.0

0.3 ± 0.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0

100.0 ± 0.0

-0.7 ± 0.6

100.0 ± 0.0

-0.7 ± 0.6

100.0 ± 0.0
100.0 ± 0.0
100.0 ± 0.0
100.0 ± 0.0
100.0 ± 0.0
99.7 ± 0.6

100.0 ± 0.0
100.0 ± 0.0
100.0 ± 0.0

-0.7 ± 0.6
-0.7 ± 0.6
-0.7 ± 0.6
-0.3 ± 0.6
0.0 ± 0.0
0.3 ± 0.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0

100.0 ± 0.0

-0.7 ± 0.6

100.0 ± 0.0

0.0 ± 0.0

100.0 ± 0.0
100.0 ± 0.0

0.0 ± 0.0
0.0 ± 0.0

100.0 ± 0.0

-0.3 ± 0.6

100.0 ± 0.0

-0.7 ± 0.6

100.0 ± 0.0
100.0 ± 0.0
100.0 ± 0.0

Each value is the average of three independent assays.
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-0.3 ± 0.6
-0.7 ± 0.6
0.0 ± 0.0

0.0 ± 0.0
0.7 ± 1.2
0.7 ± 1.2
0.7 ± 1.2
1.0 ± 1.0
1.0 ± 1.0
1.0 ± 1.0
1.0 ± 1.0
1.0 ± 1.0
0.3 ± 0.6
0.3 ± 0.6
0.0 ± 0.0
0.7 ± 1.2
0.7 ± 1.2
0.7 ± 1.2
1.0 ± 1.0
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
0.3 ± 0.6
0.3 ± 0.6
1.0 ± 1.0
1.0 ± 1.0
0.3 ± 0.6
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